-- phpMyAdmin SQL Dump
-- version 4.8.3
-- https://www.phpmyadmin.net/
--
-- Host: localhost:3306
-- Generation Time: Nov 28, 2018 at 01:21 PM
-- Server version: 5.6.41-log
-- PHP Version: 7.2.7

SET SQL_MODE = "NO_AUTO_VALUE_ON_ZERO";
SET AUTOCOMMIT = 0;
START TRANSACTION;
SET time_zone = "+00:00";


/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */;
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */;
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */;
/*!40101 SET NAMES utf8mb4 */;

--
-- Database: `mymonthl_mims_dev`
--

-- --------------------------------------------------------

--
-- Table structure for table `country_data`
--

CREATE TABLE `country_data` (
  `CountryName` varchar(100) CHARACTER SET utf8 NOT NULL,
  `StateName` varchar(100) CHARACTER SET utf8 NOT NULL,
  `CityName` varchar(100) CHARACTER SET utf8 NOT NULL
) ENGINE=MyISAM DEFAULT CHARSET=latin1;

--
-- Dumping data for table `country_data`
--

INSERT INTO `country_data` (`CountryName`, `StateName`, `CityName`) VALUES
('Bangladesh', 'Dhaka', 'Dhaka'),
('Bangladesh', 'Chittagong', 'Chittagong'),
('Bangladesh', 'Khulna', 'Khulna'),
('Bangladesh', 'Rajshahi', 'Rajshahi'),
('Bangladesh', 'Dhaka', 'Narayanganj'),
('Bangladesh', 'Rajshahi', 'Rangpur'),
('Bangladesh', 'Dhaka', 'Mymensingh'),
('Bangladesh', 'Barisal', 'Barisal'),
('Bangladesh', 'Dhaka', 'Tungi'),
('Bangladesh', 'Khulna', 'Jessore'),
('Bangladesh', 'Chittagong', 'Comilla'),
('Bangladesh', 'Rajshahi', 'Nawabganj'),
('Bangladesh', 'Rajshahi', 'Dinajpur'),
('Bangladesh', 'Rajshahi', 'Bogra'),
('Bangladesh', 'Sylhet', 'Sylhet'),
('Bangladesh', 'Chittagong', 'Brahmanbaria'),
('Bangladesh', 'Dhaka', 'Tangail'),
('Bangladesh', 'Dhaka', 'Jamalpur'),
('Bangladesh', 'Rajshahi', 'Pabna'),
('Bangladesh', 'Rajshahi', 'Naogaon'),
('Bangladesh', 'Rajshahi', 'Sirajganj'),
('Bangladesh', 'Dhaka', 'Narsinghdi'),
('Bangladesh', 'Rajshahi', 'Saidpur'),
('Bangladesh', 'Dhaka', 'Gazipur');

-- --------------------------------------------------------

--
-- Table structure for table `mims_addresscategory`
--

CREATE TABLE `mims_addresscategory` (
  `ID` int(11) NOT NULL,
  `Name` varchar(100) NOT NULL,
  `CreatedBY` bigint(20) NOT NULL,
  `LastUpdate` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `IsActive` tinyint(1) NOT NULL DEFAULT '1'
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `mims_addresscategory`
--

INSERT INTO `mims_addresscategory` (`ID`, `Name`, `CreatedBY`, `LastUpdate`, `IsActive`) VALUES
(2, '24 hours Pharmacy', 1, '2018-09-13 16:14:39', 1),
(3, 'Ambulance Service', 1, '2018-09-20 06:51:22', 1),
(4, 'Blood Bank', 1, '2018-09-20 06:51:22', 1),
(5, 'Cancer Hospital', 1, '2018-09-20 06:51:54', 1),
(6, 'Cardiac Hospitals', 1, '2018-09-20 06:51:54', 1),
(7, 'Eye Hospital', 1, '2018-09-20 06:52:18', 1),
(8, 'Gastroliver Clinics and Hospitals', 1, '2018-09-20 06:52:18', 1),
(9, 'Govt. Medical Colleges, Hospitals, University and Institutes', 1, '2018-09-20 06:52:43', 1),
(10, 'Kidney & Urology Hospitals', 1, '2018-09-20 06:52:43', 1),
(11, 'Mother & Child Hospitals', 1, '2018-09-20 06:53:16', 1),
(12, 'Neurology hospitals', 1, '2018-09-20 06:53:16', 1),
(13, 'Orthopedic & Spinal Hospitals', 1, '2018-09-20 06:53:42', 1),
(14, 'Pathological Laboratories and Imaging Centers', 1, '2018-09-20 06:53:42', 1),
(15, 'Pharmaceuticals company Web Link', 1, '2018-09-20 06:54:06', 1),
(16, 'Physiotherapy Clinic', 1, '2018-09-20 06:54:06', 1),
(17, 'Physhiatric & Drug Treatment Hospitals', 1, '2018-09-20 06:54:34', 1),
(18, 'Private Clinic and Hospitals, General', 1, '2018-09-20 06:54:34', 1),
(19, 'Private Medical Colleges & Institutes', 1, '2018-09-20 06:54:57', 1),
(20, 'Respiratory Disease, Asthma and Allergy Center', 1, '2018-09-20 06:54:57', 1),
(21, 'Shops for Spectacles', 1, '2018-09-20 06:55:10', 1);

-- --------------------------------------------------------

--
-- Table structure for table `mims_addressinformation`
--

CREATE TABLE `mims_addressinformation` (
  `ID` bigint(20) NOT NULL,
  `AddressCategoryID` int(11) NOT NULL,
  `Name` varchar(200) NOT NULL,
  `Address` varchar(500) NOT NULL,
  `ContactNumber` varchar(200) DEFAULT NULL,
  `CreatedBy` bigint(20) NOT NULL,
  `LastUpdate` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `IsActive` tinyint(1) NOT NULL DEFAULT '1'
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `mims_addressinformation`
--

INSERT INTO `mims_addressinformation` (`ID`, `AddressCategoryID`, `Name`, `Address`, `ContactNumber`, `CreatedBy`, `LastUpdate`, `IsActive`) VALUES
(1, 2, 'Al-Helal Medicine Corner', '150, Rokeya Sarani, Senpara Porbata, Section 10, Mirpur, Dhaka', 'Tel: +880-2-9006820, +880-2-9008181 Ext 108', 1, '2018-07-17 18:52:33', 1),
(4, 2, 'Al-Sami Hospital With 24 Hour Pharmacy', 'South Badda, Dhaka', NULL, 1, '2018-09-20 06:57:17', 1),
(5, 2, 'Aysha Memorial Specialized Hospital, Pharmacy', '74/G, Peacock Square, New Airport Road, Mohakhali, Dhaka-1215', 'Tel: +880-2-9122689-90, +880-2-8142370-71, +8801919-372647', 1, '2018-09-20 06:57:17', 1),
(6, 2, '24-hours Pharmacy', 'Plot 14/E, Road 6, Gonoshastaya Nagar Hospital Bhaban, Dhanmondi, Dhaka', 'Tel: +880-2-9670397, +880-2-9673512, +880-2-9673507', 1, '2018-09-20 06:57:48', 1);

-- --------------------------------------------------------

--
-- Table structure for table `mims_advertisementinformation`
--

CREATE TABLE `mims_advertisementinformation` (
  `ID` bigint(20) NOT NULL,
  `Organization` varchar(200) DEFAULT NULL,
  `Title` varchar(200) DEFAULT NULL,
  `BodyText` varchar(500) DEFAULT NULL,
  `LinkURL` varchar(200) DEFAULT NULL,
  `ImagePath` varchar(200) DEFAULT NULL,
  `PublishDate` datetime NOT NULL,
  `UnpublishedDate` datetime NOT NULL,
  `AdvertisementPositionID` smallint(20) NOT NULL,
  `CreatedBy` bigint(20) NOT NULL,
  `LastUpdate` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `IsActive` tinyint(1) NOT NULL DEFAULT '1',
  `ContactPerson` varchar(100) DEFAULT NULL,
  `EmailID` varchar(100) DEFAULT NULL,
  `MobileNo` varchar(50) DEFAULT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `mims_advertisementinformation`
--

INSERT INTO `mims_advertisementinformation` (`ID`, `Organization`, `Title`, `BodyText`, `LinkURL`, `ImagePath`, `PublishDate`, `UnpublishedDate`, `AdvertisementPositionID`, `CreatedBy`, `LastUpdate`, `IsActive`, `ContactPerson`, `EmailID`, `MobileNo`) VALUES
(5, 'Beacon', 'Lenvanix', '', '', 'd81ebc8c6802a7bf78ff2eaa58e57a11.jpg', '2018-11-26 00:00:00', '2018-12-15 00:00:00', 140, 3, '2018-11-26 07:03:36', 1, '', NULL, ''),
(6, 'Beacon', 'Flexibac', '', '', '4bdecd075caf4a1ca8d1da78a46fe266.jpg', '2018-11-26 00:00:00', '2018-12-15 00:00:00', 140, 3, '2018-11-26 07:04:56', 1, '', NULL, ''),
(7, 'MIMS', 'MIMS', '', '', '33c9390ad60a9a25856bb292b351b5e7.jpg', '2018-11-26 00:00:00', '2018-12-15 00:00:00', 140, 3, '2018-11-26 07:05:33', 1, '', NULL, ''),
(8, 'MIMS', 'MIMS', '', '', '897791f97f60dad39a4d82de27277c55.jpg', '2018-11-26 00:00:00', '2018-12-15 00:00:00', 141, 3, '2018-11-26 07:47:44', 1, '', NULL, ''),
(9, 'MIMS', 'MIMS', '', '', '8042b11950ec4a7166184757457c0a01.jpg', '2018-11-26 00:00:00', '2018-12-15 00:00:00', 142, 3, '2018-11-26 07:49:18', 1, '', NULL, ''),
(10, 'MIMS', 'MIMS', '', '', '7a694ef7207f9801175d8a3b93c55415.png', '2018-11-26 00:00:00', '2018-12-15 00:00:00', 145, 3, '2018-11-26 07:59:08', 1, '', NULL, ''),
(11, 'Beacon', 'Flexibac', '', '', 'bc62b9791ef2240647ffb9b365b43f5c.jpg', '2018-11-26 00:00:00', '2018-12-15 00:00:00', 144, 3, '2018-11-26 08:01:20', 1, '', NULL, ''),
(12, 'MIMS', 'MIMS', '', '', '8b44893d5c8beb6e094674c6cf878f95.jpg', '2018-11-27 00:00:00', '2018-12-21 00:00:00', 140, 3, '2018-11-27 16:57:23', 1, '', NULL, ''),
(13, 'MIMS', 'MIMS', '', '', '2c01aa493541926f1e37a7b393c79c85.jpg', '2018-11-27 00:00:00', '2018-12-21 00:00:00', 173, 3, '2018-11-27 17:15:10', 1, '', NULL, ''),
(14, 'MIMS', 'MIMS', '', '', '5f1e54b7a856b6060704e9e2079a1880.jpg', '2018-11-27 00:00:00', '2018-12-21 00:00:00', 172, 3, '2018-11-27 17:33:54', 1, '', NULL, ''),
(15, 'Beacon', 'Flexibac', '', '', 'c7ab2f27e18561efdd6fb5a29429f26f.jpg', '2018-11-27 00:00:00', '2018-12-21 00:00:00', 171, 3, '2018-11-27 18:03:00', 1, '', NULL, ''),
(16, 'Beacon', 'Hexinor', '', '', '963e4a0f441d9724e8bf4489bc83cfa3.jpg', '2018-11-28 00:00:00', '2018-12-22 00:00:00', 174, 3, '2018-11-27 18:31:06', 1, '', NULL, ''),
(17, 'Beacon', 'Hexinor', '', '', '94aa9eba776e5faf69d1e63a87cc6f75.jpg', '2018-11-28 00:00:00', '2018-12-22 00:00:00', 146, 3, '2018-11-27 18:35:13', 1, '', NULL, ''),
(18, 'MIMS', 'MIMS', '', '', '702a5bfe11920780518f370a9255c7ae.jpg', '2018-11-28 00:00:00', '2018-12-22 00:00:00', 149, 3, '2018-11-27 18:37:55', 1, '', NULL, ''),
(19, 'MIMS', 'MIMS', '', '', '6aa08c787d0b741e6e0c12add1cf9dc7.jpg', '2018-11-28 00:00:00', '2018-12-22 00:00:00', 169, 3, '2018-11-27 18:39:39', 1, '', NULL, '');

-- --------------------------------------------------------

--
-- Table structure for table `mims_advertisementpositioninformation`
--

CREATE TABLE `mims_advertisementpositioninformation` (
  `ID` smallint(6) NOT NULL,
  `Name` varchar(100) NOT NULL,
  `ClassName` varchar(100) NOT NULL,
  `ImageWidth` smallint(6) NOT NULL,
  `ImageHeight` smallint(6) NOT NULL,
  `NumberOfAdvertisement` tinyint(4) NOT NULL DEFAULT '1',
  `Interval` smallint(6) NOT NULL DEFAULT '0',
  `PriceInBDT` int(11) NOT NULL DEFAULT '0',
  `CreatedBy` bigint(20) NOT NULL,
  `LastUpdate` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `IsActive` tinyint(1) NOT NULL DEFAULT '1'
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `mims_advertisementpositioninformation`
--

INSERT INTO `mims_advertisementpositioninformation` (`ID`, `Name`, `ClassName`, `ImageWidth`, `ImageHeight`, `NumberOfAdvertisement`, `Interval`, `PriceInBDT`, `CreatedBy`, `LastUpdate`, `IsActive`) VALUES
(140, 'Home Page Product Slider Advertisement', 'home-product-slider', 370, 232, 0, 6, 1000, 1, '2018-08-30 08:54:27', 1),
(141, 'Home Page Container1 Advertisement', 'home-advert-container1', 1170, 147, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(142, 'Home Page Container2 Advertisement', 'home-advert-container2', 1170, 147, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(143, 'Doctor Page Sidebar Advertisement', 'doctor-sidebar-advert', 333, 256, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(144, 'Doctor Page Top Left Advertisement', 'doctor-advert-top-left', 523, 120, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(145, 'Doctor Page Top Right Advertisement', 'doctor-advert-top-right', 523, 120, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(146, 'Doctor Page Bottom Advertisement', 'doctor-advert-bottom', 756, 138, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(147, 'Address Page Sidebar Advertisement', 'address-sidebar-advert', 333, 256, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(148, 'Address Page Top Left Advertisement', 'address-advert-top-left', 523, 120, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(149, 'Address Page Top Right Advertisement', 'address-advert-top-right', 523, 120, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(150, 'Address Page Bottom Advertisement', 'address-advert-bottom', 756, 138, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(151, 'Job Circular Page Sidebar Advertisement', 'job-circular-sidebar-advert', 333, 256, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(152, 'Job Circular Page Top Left Advertisement', 'job-circular-advert-top-left', 523, 120, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(153, 'Job Circular Page Top Right Advertisement', 'job-circular-advert-top-right', 523, 120, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(154, 'Job Circular Page Bottom Advertisement', 'job-circular-advert-bottom', 756, 138, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(155, 'Job Circular Detail Page Sidebar Advertisement', 'job-circular-detail-sidebar-advert', 333, 256, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(156, 'Job Circular Detail Page Top Left Advertisement', 'job-circular-detail-advert-top-left', 523, 120, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(157, 'Job Circular Detail Page Top Right Advertisement', 'job-circular-detail-advert-top-right', 523, 120, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(158, 'Job Circular Detail Page Bottom Advertisement', 'job-circular-detail-advert-bottom', 756, 138, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(159, 'Local News Page Sidebar Advertisement', 'news-sidebar-advert', 333, 256, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(160, 'Local News Page Top Left Advertisement', 'news-advert-top-left', 523, 120, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(161, 'Local News Page Top Right Advertisement', 'news-advert-top-right', 523, 120, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(162, 'Local News Page Bottom Advertisement', 'news-advert-bottom', 756, 138, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(163, 'Special Report Page Sidebar Advertisement', 'special-report-sidebar-advert', 333, 256, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(164, 'Special Report Page Top Left Advertisement', 'special-report-advert-top-left', 523, 120, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(165, 'Special Report Page Top Right Advertisement', 'special-report-advert-top-right', 523, 120, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(166, 'Special Report Page Bottom Advertisement', 'special-report-advert-bottom', 756, 138, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(167, 'Resource Page Sidebar Advertisement', 'resource-sidebar-advert', 333, 256, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(168, 'Resource Page Top Left Advertisement', 'resource-advert-top-left', 523, 120, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(169, 'Resource Page Top Right Advertisement', 'resource-advert-top-right', 523, 120, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(170, 'Resource Page Bottom Advertisement', 'resource-advert-bottom', 756, 138, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(171, 'Brand Search Result Page Sidebar Advertisement', 'brand-sidebar-advert', 333, 256, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(172, 'Brand Search Result Page Top Left Advertisement', 'brand-advert-top-left', 523, 120, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(173, 'Brand Search Result Page Top Right Advertisement', 'brand-advert-top-right', 523, 120, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(174, 'Brand Search Result Page Bottom Advertisement', 'brand-advert-bottom', 756, 138, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(175, 'Generic Search Result Page Sidebar Advertisement', 'generic-sidebar-advert', 333, 256, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(176, 'Generic Search Result Page Top Left Advertisement', 'generic-advert-top-left', 523, 120, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(177, 'Generic Search Result Page Top Right Advertisement', 'generic-advert-top-right', 523, 120, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(178, 'Generic Search Result Page Bottom Advertisement', 'generic-advert-bottom', 756, 138, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(179, 'Indication Search Result Page Sidebar Advertisement', 'indication-sidebar-advert', 333, 256, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(180, 'Indication Search Result Page Top Left Advertisement', 'indication-advert-top-left', 523, 120, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(181, 'Indication Search Result Page Top Right Advertisement', 'indication-advert-top-right', 523, 120, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(182, 'Indication Search Result Page Bottom Advertisement', 'indication-advert-bottom', 756, 138, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(183, 'Manufacturer Search Result Page Sidebar Advertisement', 'manufacturer-sidebar-advert', 333, 256, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(184, 'Manufacturer Search Result Page Top Left Advertisement', 'manufacturer-advert-top-left', 523, 120, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(185, 'Manufacturer Search Result Page Top Right Advertisement', 'manufacturer-advert-top-right', 523, 120, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(186, 'Manufacturer Search Result Page Bottom Advertisement', 'manufacturer-advert-bottom', 756, 138, 0, 1, 1000, 1, '2018-08-30 08:54:27', 1),
(187, 'International Health Page Sidebar Advertisement', 'international-health-sidebar-advert', 333, 256, 0, 1, 1000, 1, '2018-08-30 13:54:27', 1),
(188, 'International Health Page Top Left Advertisement', 'international-health-advert-top-left', 523, 120, 0, 1, 1000, 1, '2018-08-30 13:54:27', 1),
(189, 'International Health Page Top Right Advertisement', 'international-health-advert-top-right', 523, 120, 0, 1, 1000, 1, '2018-08-30 13:54:27', 1),
(190, 'International Health Page Bottom Advertisement', 'international-health-advert-bottom', 756, 138, 0, 1, 1000, 1, '2018-08-30 13:54:27', 1);

-- --------------------------------------------------------

--
-- Table structure for table `mims_brandinformation`
--

CREATE TABLE `mims_brandinformation` (
  `ID` bigint(20) NOT NULL,
  `Name` varchar(100) NOT NULL,
  `GenericID` bigint(20) NOT NULL,
  `ManufacturerID` bigint(20) NOT NULL,
  `DosageFormID` int(11) NOT NULL,
  `StrengthID` bigint(20) NOT NULL,
  `PackSizeID` int(11) NOT NULL,
  `ImagePath` varchar(300) DEFAULT NULL,
  `PriceInBDT` decimal(10,0) NOT NULL,
  `IsHighlighted` tinyint(1) NOT NULL DEFAULT '0',
  `IsNewProduct` tinyint(1) NOT NULL DEFAULT '0',
  `IsNewBrand` tinyint(1) NOT NULL DEFAULT '0',
  `IsNewPresentation` tinyint(1) NOT NULL DEFAULT '0',
  `CreateDate` datetime DEFAULT NULL,
  `LastUpdate` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `CreatedBy` bigint(20) NOT NULL,
  `IsActive` tinyint(1) NOT NULL DEFAULT '1'
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `mims_brandinformation`
--

INSERT INTO `mims_brandinformation` (`ID`, `Name`, `GenericID`, `ManufacturerID`, `DosageFormID`, `StrengthID`, `PackSizeID`, `ImagePath`, `PriceInBDT`, `IsHighlighted`, `IsNewProduct`, `IsNewBrand`, `IsNewPresentation`, `CreateDate`, `LastUpdate`, `CreatedBy`, `IsActive`) VALUES
(260, 'ALENIA ', 1, 148, 43, 98, 203, '', '320', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(261, 'ALENIA ', 1, 148, 43, 138, 156, '', '210', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(262, 'ALTON ', 1, 156, 88, 98, 159, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(263, 'ALTON ', 1, 156, 88, 138, 159, '', '241', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(264, 'ALTON ', 1, 156, 56, 146, 132, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(265, 'EMA ', 1, 158, 43, 98, 192, '', '420', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(266, 'EMA ', 1, 158, 43, 138, 159, '', '270', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(267, 'EMA ', 1, 158, 88, 98, 159, '', '143', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(268, 'EMA ', 1, 158, 88, 138, 159, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(269, 'EMA ', 1, 158, 56, 146, 132, '', '80', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(270, 'EMEP ', 1, 140, 43, 98, 189, '', '420', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(271, 'EMEP ', 1, 140, 43, 138, 162, '', '360', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(272, 'EMEP ', 1, 140, 56, 138, 132, '', '90', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(273, 'EMEP ', 1, 140, 88, 98, 189, '', '300', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(274, 'EPRAZOL ', 1, 166, 43, 98, 189, '', '421', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(275, 'EPRAZOL ', 1, 166, 43, 138, 156, '', '301', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(276, 'ESCAP 20MG ', 1, 187, 43, 98, 181, '', '400', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(277, 'ESCAP 20MG ', 1, 187, 43, 138, 188, '', '400', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(278, 'ESMAX ', 1, 147, 88, 98, 192, '', '301', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(279, 'ESMAX ', 1, 147, 43, 98, 108, '', '700', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(280, 'ESMAX ', 1, 147, 43, 138, 186, '', '160', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(281, 'ESMOSEC ', 1, 193, 88, 98, 168, '', '160', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(282, 'ESO ', 1, 142, 88, 98, 108, '', '500', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(283, 'ESO ', 1, 142, 88, 138, 159, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(284, 'ESOCARE ', 1, 176, 43, 98, 174, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(285, 'ESOCARE ', 1, 176, 43, 138, 113, '', '270', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(286, 'ESOCON ', 1, 146, 43, 98, 189, '', '360', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(287, 'ESOCON ', 1, 146, 43, 98, 99, '', '600', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(288, 'ESOCON ', 1, 146, 43, 138, 162, '', '360', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(289, 'ESOCON ', 1, 146, 57, 138, 132, '', '65', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(290, 'ESOGEL ', 1, 180, 43, 98, 99, '', '602', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(291, 'ESOGEL ', 1, 180, 43, 138, 148, '', '225', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(292, 'ESOPROL  ', 1, 196, 43, 98, 202, '', '280', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(293, 'ESOPROL  ', 1, 196, 43, 138, 172, '', '224', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(294, 'ESOLOK ', 1, 160, 88, 98, 156, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(295, 'ESOLOK ', 1, 160, 88, 138, 156, '', '210', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(296, 'ESOLOK ', 1, 160, 43, 98, 189, '', '390', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(297, 'ESOLOK ', 1, 160, 43, 138, 166, '', '384', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(298, 'ESOLOK ', 1, 160, 56, 138, 132, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(299, 'ESOM E', 1, 154, 88, 98, 159, '', '150', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(300, 'ESOMEP ', 1, 135, 88, 98, 156, '', '121', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(301, 'ESOMEP ', 1, 135, 88, 98, 174, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(302, 'ESOMEP ', 1, 135, 88, 138, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(303, 'ESOMEP ', 1, 135, 43, 98, 174, '', '350', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(304, 'ESOMEP ', 1, 135, 43, 138, 162, '', '360', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(305, 'ESOMEP ', 1, 135, 57, 138, 132, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(306, 'ESOMILOC', 1, 125, 88, 98, 181, '', '250', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(307, 'ESOMILOC', 1, 165, 88, 138, 159, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(308, 'ESOLIN ', 1, 186, 88, 98, 181, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(309, 'ESOLIN ', 1, 186, 88, 34, 181, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(310, 'ESONIX ', 1, 162, 88, 98, 174, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(311, 'ESONIX ', 1, 162, 88, 138, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(312, 'ESONIX ', 1, 162, 43, 98, 179, '', '392', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(313, 'ESONIX ', 1, 162, 43, 138, 156, '', '270', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(314, 'ESONIX ', 1, 162, 56, 138, 132, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(315, 'ESONIX 20 DR', 1, 169, 86, 98, 156, '', '210', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(316, 'ESOPRA ', 1, 137, 88, 98, 156, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(317, 'ESOPRA ', 1, 137, 88, 138, 156, '', '270', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(318, 'ESOPREX ', 1, 143, 43, 98, 197, '', '393', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(319, 'ESOPREX ', 1, 143, 43, 138, 188, '', '270', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(320, 'ESOPREX ', 1, 143, 57, 138, 135, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(321, 'ESORAL ', 1, 155, 50, 98, 99, '', '500', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(322, 'ESORAL ', 1, 155, 50, 138, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(323, 'ESORAL ', 1, 155, 43, 98, 189, '', '420', 0, 0, 1, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(324, 'ESORAL ', 1, 155, 43, 138, 156, '', '270', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(325, 'ESORAL ', 1, 155, 57, 138, 132, '', '90', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(326, 'ESOTAC ', 1, 173, 88, 98, 189, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(327, 'ESOTAC ', 1, 173, 88, 138, 156, '', '210', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(328, 'ESOTAC ', 1, 173, 43, 98, 189, '', '361', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(329, 'ESOTAC ', 1, 173, 43, 138, 156, '', '241', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(330, 'ESOTID ', 1, 179, 88, 98, 116, '', '251', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(331, 'ESOTID ', 1, 179, 88, 138, 116, '', '400', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(332, 'ESOTID ', 1, 179, 43, 98, 118, '', '542', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(333, 'ESOTID ', 1, 179, 43, 138, 113, '', '270', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(334, 'ESOTID ', 1, 179, 56, 138, 132, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(335, 'ESOTOR ', 1, 174, 88, 98, 174, '', '251', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(336, 'ESOTOR ', 1, 174, 88, 138, 156, '', '241', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(337, 'ESOTRON-20 ', 1, 164, 88, 98, 159, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(338, 'ESOTRON-40 ', 1, 164, 88, 138, 159, '', '240', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(339, 'ESOZOL ', 1, 170, 43, 98, 181, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(340, 'ESRU ', 1, 149, 88, 98, 181, '', '200', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(341, 'EXIUM ', 1, 184, 43, 98, 99, '', '752', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(342, 'EXIUM ', 1, 184, 43, 138, 189, '', '572', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(343, 'EXOR ', 1, 181, 43, 98, 108, '', '700', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(344, 'EXOR ', 1, 181, 43, 138, 159, '', '270', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(345, 'EXOR ', 1, 181, 57, 138, 132, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(346, 'MAXIMA ', 1, 136, 43, 98, 114, '', '280', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(347, 'MAXIMA ', 1, 136, 43, 138, 185, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(348, 'MAXIMA ', 1, 136, 88, 98, 108, '', '500', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(349, 'MAXIMA ', 1, 136, 88, 138, 168, '', '320', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(350, 'MAXIMA ', 1, 136, 57, 138, 132, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(351, 'MAXPRO ', 1, 185, 50, 98, 108, '', '700', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(352, 'MAXPRO ', 1, 185, 50, 138, 159, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(353, 'MAXPRO ', 1, 185, 49, 98, 131, '', '672', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(354, 'MAXPRO ', 1, 185, 42, 138, 117, '', '600', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(355, 'MAXPRO ', 1, 185, 58, 138, 132, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(356, 'NEPTOR ', 1, 175, 43, 98, 199, '', '648', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(357, 'NEPTOR ', 1, 175, 43, 138, 114, '', '480', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(358, 'NEXCAP ', 1, 194, 47, 98, 172, '', '196', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(359, 'NEXCAP ', 1, 194, 47, 138, 172, '', '252', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(360, 'NEXE ', 1, 138, 88, 98, 156, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(361, 'NEXE ', 1, 138, 88, 98, 174, '', '250', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(362, 'NEXE-40 ', 1, 138, 88, 138, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(363, 'NEXPRO ', 1, 194, 88, 98, 156, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(364, 'NEXPRO ', 1, 194, 88, 138, 156, '', '240', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(365, 'NEXUM ', 1, 192, 50, 98, 181, '', '251', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(366, 'NEXUM ', 1, 192, 50, 138, 159, '', '241', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(367, 'NEXUM ', 1, 192, 58, 138, 102, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(368, 'NEXUM CAP ', 1, 192, 43, 98, 189, '', '361', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(369, 'NEXUM CAP ', 1, 192, 43, 138, 188, '', '270', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(370, 'OPTON ', 1, 144, 43, 98, 189, '', '420', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(371, 'OPTON ', 1, 144, 43, 138, 156, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(372, 'OPTON ', 1, 144, 50, 98, 189, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(373, 'OPTON ', 1, 144, 50, 138, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(374, 'OPTON ', 1, 144, 57, 138, 132, '', '110', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(375, 'PROGUT ', 1, 183, 88, 98, 174, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(376, 'PROGUT ', 1, 183, 88, 138, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(377, 'PROGUT ', 1, 183, 43, 95, 99, '', '700', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(378, 'PROGUT ', 1, 183, 43, 136, 174, '', '450', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(379, 'PROGUT ', 1, 183, 56, 138, 132, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(380, 'PRONEX ', 1, 152, 88, 98, 179, '', '283', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(381, 'PRONEX ', 1, 152, 88, 138, 99, '', '600', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(382, 'PRONEX ', 1, 152, 43, 95, 174, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(383, 'PRONEX ', 1, 152, 43, 136, 148, '', '224', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(384, 'PRONEX ', 1, 152, 62, 138, 132, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(385, 'S-OME ', 1, 190, 88, 98, 174, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(386, 'S-OME ', 1, 190, 88, 138, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(387, 'S-OME ', 1, 190, 43, 98, 162, '', '280', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(388, 'SERGEL ', 1, 159, 88, 98, 99, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(389, 'SERGEL ', 1, 159, 88, 138, 156, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(390, 'SERGEL ', 1, 159, 43, 98, 189, '', '0', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(391, 'SERGEL ', 1, 159, 43, 138, 156, '', '0', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(392, 'SERGEL ', 1, 159, 56, 138, 132, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(393, 'APULDON ', 2, 140, 88, 59, 99, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(394, 'APULDON ', 2, 140, 71, 176, 191, '', '35', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(395, 'APULDON ', 2, 140, 73, 177, 127, '', '25', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(396, 'APULDON ', 2, 140, 85, 77, 102, '', '60', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(397, 'APULDON ', 2, 140, 85, 132, 102, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(398, 'ATIDON ', 2, 142, 88, 59, 181, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(399, 'ATIDON ', 2, 142, 71, 176, 191, '', '28', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(400, 'COSY ', 2, 181, 88, 59, 99, '', '201', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(401, 'COSY ', 2, 181, 71, 176, 100, '', '38', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(402, 'COSY ', 2, 181, 71, 176, 191, '', '28', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(403, 'DEFLUX ', 2, 145, 88, 59, 124, '', '375', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(404, 'DEFLUX ', 2, 145, 71, 176, 100, '', '38', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(405, 'DEFLUX ', 2, 145, 73, 177, 127, '', '20', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(406, 'DEFLUX-DT ', 2, 145, 88, 59, 99, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(407, 'DEGUT ', 2, 148, 88, 59, 174, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(408, 'DEGUT ', 2, 148, 71, 176, 191, '', '28', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(409, 'DOMAID 10 ', 2, 166, 88, 59, 99, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(410, 'DOMIDON ', 2, 196, 88, 59, 108, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(411, 'DOMIDON ', 2, 196, 71, 176, 191, '', '28', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(412, 'DOMILIN ', 2, 156, 88, 59, 108, '', '201', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(413, 'DOMILIN ', 2, 156, 71, 176, 100, '', '40', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(414, 'DOMIN ', 2, 179, 88, 59, 108, '', '201', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(415, 'DOMIN ', 2, 179, 71, 176, 191, '', '28', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(416, 'DOMIN ', 2, 179, 73, 177, 127, '', '20', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(417, 'DOMIN SUPP ', 2, 179, 85, 77, 184, '', '50', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(418, 'DOMIN SUPP ', 2, 179, 85, 132, 184, '', '80', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(419, 'BOMIREN ', 2, 185, 88, 59, 108, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(420, 'BOMIREN ', 2, 185, 71, 176, 100, '', '38', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(421, 'BOMIREN ', 2, 185, 71, 177, 191, '', '35', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(422, 'BOMIREN ', 2, 185, 73, 177, 125, '', '25', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(423, 'DOMILUX ', 2, 183, 88, 59, 139, '', '302', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(424, 'DOMILUX ', 2, 183, 71, 177, 191, '', '35', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(425, 'DOMPI ', 2, 137, 88, 59, 99, '', '200', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(426, 'DOMPI ', 2, 137, 71, 177, 191, '', '28', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(427, 'DON-A ', 2, 136, 88, 59, 99, '', '201', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(428, 'DON-A ', 2, 136, 73, 177, 127, '', '20', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(429, 'DON-A ', 2, 136, 74, 85, 158, '', '25', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(430, 'DON-A ', 2, 136, 71, 176, 95, '', '35', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(431, 'DON-A ', 2, 136, 85, 77, 154, '', '50', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(432, 'DON-A ', 2, 136, 85, 132, 154, '', '81', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(433, 'DOPADON ', 2, 168, 88, 59, 99, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(434, 'DOPADON ', 2, 160, 71, 176, 191, '', '28', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(435, 'DOPAGUT', 2, 122, 88, 59, 108, '', '201', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(436, 'DOPAGUT', 2, 147, 71, 176, 191, '', '35', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(437, 'DORIDON ', 2, 170, 88, 59, 99, '', '200', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(438, 'DORIDON ', 2, 170, 73, 114, 127, '', '25', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(439, 'DUDON ', 2, 165, 88, 59, 108, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(440, 'DUDON ', 2, 165, 71, 176, 191, '', '28', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(441, 'DYSNOV', 2, 194, 88, 59, 174, '', '125', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(442, 'DYSNOV', 2, 194, 71, 176, 101, '', '38', 0, 1, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(443, 'DYSNOV', 2, 194, 73, 176, 127, '', '20', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(444, 'EMIDOM ', 2, 190, 88, 59, 99, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(445, 'EMIDOM ', 2, 190, 71, 176, 191, '', '28', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(446, 'ERIDON ', 2, 149, 88, 59, 108, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(447, 'ERIDON ', 2, 149, 71, 176, 190, '', '25', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(448, 'ESOGUT ', 2, 146, 52, 59, 99, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(449, 'ESOGUT ', 2, 146, 71, 176, 190, '', '28', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(450, 'ESOGUT ', 2, 146, 73, 177, 126, '', '20', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(451, 'GIDONIC ', 2, 176, 88, 59, 99, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(452, 'GIDONIC ', 2, 176, 71, 176, 191, '', '28', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(453, 'GIDORA', 2, 186, 88, 59, 108, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(454, 'GIDORA', 2, 186, 71, 176, 94, '', '30', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(455, 'LOVAL', 2, 164, 52, 59, 108, '', '201', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(456, 'LOVAL', 2, 164, 71, 176, 191, '', '28', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(457, 'MERIN ', 2, 154, 88, 59, 108, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(458, 'MERIN ', 2, 154, 71, 176, 100, '', '38', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(459, 'MOTIFAST', 2, 132, 46, 59, 108, '', '250', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(460, 'MOTIGUT', 2, 192, 88, 59, 99, '', '251', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(461, 'MOTIGUT', 2, 192, 71, 176, 191, '', '35', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(462, 'MOTIGUT', 2, 192, 73, 177, 127, '', '25', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(463, 'MOTILEX', 2, 193, 88, 59, 181, '', '75', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(464, 'MOTILEX', 2, 193, 71, 176, 191, '', '35', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(465, 'NOBURN', 2, 143, 88, 59, 108, '', '201', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(466, 'NUDON', 2, 180, 88, 59, 99, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(467, 'OMIDON ', 2, 162, 88, 59, 99, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(468, 'OMIDON ', 2, 162, 71, 176, 100, '', '38', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(469, 'OMIDON ', 2, 162, 71, 176, 191, '', '35', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(470, 'OMIDON ', 2, 162, 73, 177, 127, '', '25', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(471, 'OMIDON D', 2, 162, 46, 59, 99, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(472, 'PARIDON ', 2, 152, 88, 59, 99, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(473, 'PARIDON ', 2, 152, 71, 73, 101, '', '32', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(474, 'PERION ', 2, 158, 88, 59, 108, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(475, 'PERION ', 2, 158, 71, 176, 100, '', '38', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(476, 'PERION ', 2, 158, 71, 176, 101, '', '30', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(477, 'PROKINET ', 2, 128, 88, 59, 99, '', '202', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(478, 'PROKINET ', 2, 174, 71, 176, 190, '', '35', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(479, 'PROTIX', 2, 138, 88, 59, 99, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(480, 'PROTIX', 2, 138, 71, 176, 100, '', '25', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(481, 'PROTIX', 2, 138, 67, 177, 127, '', '20', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(482, 'RIDON ', 2, 155, 88, 59, 99, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(483, 'RIDON ', 2, 155, 71, 176, 191, '', '30', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(484, 'RIDON EG', 2, 155, 69, 30, 141, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(485, 'SANDOM ', 2, 187, 88, 59, 108, '', '202', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(486, 'SANDOM ', 2, 191, 71, 176, 191, '', '28', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(487, 'SANDOM ', 2, 191, 67, 177, 127, '', '20', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(488, 'VAVE ', 2, 135, 52, 59, 124, '', '302', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(489, 'VAVE ', 2, 135, 71, 176, 100, '', '38', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(490, 'VAVE ', 2, 135, 71, 176, 191, '', '28', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(491, 'VAVE ', 2, 135, 73, 177, 127, '', '20', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(492, 'VAVE-ODT ', 2, 135, 46, 59, 99, '', '500', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(493, 'VOMINO ', 2, 171, 88, 59, 108, '', '200', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(494, 'VOMINO ', 2, 171, 71, 176, 191, '', '28', 0, 1, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(495, 'VOMITOP ', 2, 173, 88, 59, 99, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(496, 'VOMITOP ', 2, 173, 71, 176, 191, '', '28', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(497, 'VOMITOP ', 2, 173, 67, 177, 127, '', '20', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(498, 'AXIDIN ', 3, 194, 88, 98, 99, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(499, 'AXIDIN ', 3, 194, 88, 138, 99, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(500, 'FAMODIN ', 3, 136, 52, 98, 108, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(501, 'FAMODIN ', 3, 136, 52, 138, 108, '', '400', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(502, 'FAMOTACK ', 3, 192, 52, 98, 108, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(503, 'FAMOTACK ', 3, 192, 52, 138, 181, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(504, 'FAMOTID ', 3, 152, 88, 98, 99, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(505, 'FAMOTID ', 3, 152, 88, 138, 99, '', '400', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(506, 'FAMOTIN ', 3, 149, 52, 98, 99, '', '142', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(507, 'FAMOTIN ', 3, 149, 52, 138, 99, '', '380', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(508, 'NOVATAC ', 3, 135, 88, 98, 99, '', '226', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(509, 'NOVATAC ', 3, 135, 88, 138, 99, '', '412', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(510, 'PEPTID ', 3, 179, 88, 98, 108, '', '191', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(511, 'SERVIPEP ', 3, 175, 88, 98, 181, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(512, 'SERVIPEP ', 3, 175, 88, 138, 181, '', '305', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(513, 'YAMADIN ', 3, 145, 52, 98, 139, '', '380', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(514, 'YAMADIN ', 3, 145, 52, 138, 99, '', '382', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(515, 'ASLAN ', 4, 194, 43, 77, 156, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(516, 'ASLAN ', 4, 194, 43, 132, 156, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(517, 'LANSEC', 4, 152, 43, 77, 189, '', '210', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(518, 'LANSEC', 4, 152, 43, 132, 189, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(519, 'LANSINA-30', 4, 160, 43, 132, 147, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(520, 'LANSO ', 4, 192, 43, 77, 181, '', '176', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(521, 'LANSO ', 4, 192, 43, 132, 188, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(522, 'LANSODIN ', 4, 136, 43, 77, 148, '', '99', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(523, 'LANTID', 4, 179, 43, 132, 161, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(524, 'LANZ ', 4, 135, 43, 77, 189, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(525, 'LANZ ', 4, 135, 43, 132, 148, '', '141', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(526, 'LANZOL-30 ', 4, 149, 43, 132, 186, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(527, 'LASOCON ', 4, 146, 43, 132, 148, '', '168', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(528, 'PROTOLON ', 4, 145, 43, 132, 156, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(529, 'ZOTON ', 4, 156, 43, 132, 185, '', '121', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(530, 'MECLID ', 5, 164, 41, 66, 87, '', '36', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(531, 'METOCOL      ', 5, 178, 87, 176, 100, '', '16', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(532, 'METOCOL      ', 5, 178, 73, 85, 127, '', '11', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(533, 'MOTILON', 5, 131, 88, 59, 178, '', '170', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(534, 'MOTILON', 5, 187, 56, 66, 149, '', '38', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(535, 'CYTOMIS ', 6, 162, 88, 53, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(536, 'CYTOMIS ', 6, 162, 88, 96, 156, '', '450', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(537, 'INDULA ', 6, 185, 88, 96, 159, '', '450', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(538, 'ISOVENT ', 6, 192, 88, 53, 159, '', '241', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(539, 'ISOVENT ', 6, 192, 88, 96, 159, '', '452', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(540, 'ISOVENT ', 6, 192, 88, 180, 110, '', '400', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(541, 'MISOCLEAR ', 6, 136, 88, 96, 159, '', '451', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(542, 'MISOPA ', 6, 145, 88, 96, 156, '', '450', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(543, 'MISOTOL ', 6, 196, 88, 96, 150, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(544, 'ASPRA ', 7, 138, 43, 31, 162, '', '200', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(545, 'ASPRA ', 7, 138, 43, 138, 196, '', '168', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(546, 'COSEC ', 7, 152, 43, 98, 189, '', '177', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(547, 'COSEC ', 7, 152, 43, 138, 162, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(548, 'COSEC ', 7, 152, 57, 138, 135, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(549, 'DEU ', 7, 171, 43, 98, 119, '', '192', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(550, 'DEU ', 7, 171, 56, 138, 132, '', '70', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(551, 'EMEZ ', 7, 154, 43, 39, 192, '', '240', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(552, 'EMEZ ', 7, 154, 43, 40, 159, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(553, 'INHIBITA ', 7, 148, 43, 98, 189, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(554, 'INHIBITA ', 7, 148, 43, 138, 141, '', '140', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(555, 'INPRO ', 7, 146, 43, 98, 99, '', '500', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(556, 'INPRO ', 7, 146, 43, 138, 170, '', '141', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(557, 'INPRO ', 7, 146, 56, 138, 132, '', '70', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(558, 'LOSECTIL ', 7, 155, 43, 59, 166, '', '96', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(559, 'LOSECTIL ', 7, 155, 43, 98, 99, '', '500', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(560, 'LOSECTIL ', 7, 155, 43, 98, 173, '', '2500', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(561, 'LOSECTIL ', 7, 155, 43, 138, 189, '', '420', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(562, 'LOSECTIL ', 7, 155, 69, 98, 174, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(563, 'LOSECTIL ', 7, 155, 69, 138, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(564, 'LOSECTIL ', 7, 155, 59, 138, 132, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(565, 'LOSECTIL V ', 7, 155, 43, 98, 99, '', '500', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(566, 'LOSECTIL V ', 7, 155, 43, 138, 189, '', '480', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(567, 'LOSECTIL-DR TAB ', 7, 155, 88, 98, 189, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(568, 'NIL90 ', 7, 177, 91, 138, 132, '', '70', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(569, 'NORAIN ', 7, 157, 43, 98, 108, '', '500', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(570, 'O-20 ', 7, 142, 43, 98, 108, '', '500', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(571, 'O-40 ', 7, 142, 43, 138, 185, '', '140', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(572, 'OP ', 7, 158, 43, 98, 192, '', '285', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(573, 'OP ', 7, 158, 43, 138, 114, '', '320', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(574, 'OP ', 7, 158, 56, 146, 132, '', '70', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(575, 'OMAPRIN CAPSULE ', 7, 149, 43, 98, 114, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(576, 'OME ', 7, 190, 43, 98, 189, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(577, 'OME ', 7, 190, 43, 138, 141, '', '160', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(578, 'OMECARE ', 7, 176, 43, 98, 189, '', '240', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(579, 'OMECARE ', 7, 176, 43, 138, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(580, 'OMECRON ', 7, 174, 43, 98, 174, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(581, 'OMECRON ', 7, 174, 43, 138, 162, '', '321', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(582, 'OMEGUT ', 7, 183, 43, 98, 99, '', '500', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(583, 'OMEGUT ', 7, 183, 43, 138, 174, '', '352', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(584, 'OMEGUT ', 7, 183, 56, 138, 133, '', '80', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(585, 'OMEL ', 7, 170, 43, 98, 108, '', '500', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(586, 'OMEL ', 7, 170, 43, 138, 159, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(587, 'OMENIX ', 7, 162, 43, 98, 198, '', '400', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(588, 'OMENIX ', 7, 162, 43, 138, 141, '', '160', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(589, 'OMENIX ', 7, 162, 56, 138, 132, '', '90', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(590, 'OMEP ', 7, 139, 43, 59, 165, '', '96', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(591, 'OMEP ', 7, 139, 43, 98, 99, '', '500', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(592, 'OMEP ', 7, 139, 43, 138, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(593, 'OMEP ', 7, 139, 57, 138, 132, '', '80', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(594, 'OMEPRA ', 7, 137, 43, 98, 174, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(595, 'OMEPRA ', 7, 137, 43, 138, 156, '', '210', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(596, 'OMEPROL ', 7, 196, 43, 98, 202, '', '224', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(597, 'OMEPROL ', 7, 196, 43, 138, 172, '', '196', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(598, 'OMEPROL ', 7, 196, 57, 138, 132, '', '70', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(599, 'OMETAC-20 ', 7, 173, 89, 98, 99, '', '404', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(600, 'OMETAC-40 ', 7, 173, 43, 138, 145, '', '144', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(601, 'OMETID ', 7, 179, 43, 98, 118, '', '450', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(602, 'OMETID ', 7, 179, 43, 138, 113, '', '211', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(603, 'OMETID ', 7, 179, 57, 138, 132, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(604, 'OMIREX ', 7, 164, 43, 98, 108, '', '501', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(605, 'OMIREX ', 7, 164, 43, 138, 185, '', '160', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(606, 'OMILOC ', 7, 165, 43, 98, 108, '', '500', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(607, 'OMSEC ', 7, 193, 43, 98, 192, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(608, 'OMSEC ', 7, 193, 57, 143, 132, '', '70', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(609, 'OPAL ', 7, 159, 43, 98, 189, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(610, 'OPAL ', 7, 159, 43, 138, 156, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(611, 'OP MAX ', 7, 147, 43, 98, 108, '', '502', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(612, 'OP MAX ', 7, 147, 43, 138, 114, '', '281', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(613, 'PEPTRAL ', 7, 166, 43, 98, 189, '', '360', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(614, 'PEPTRAL ', 7, 166, 43, 138, 156, '', '270', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(615, 'PPI ', 7, 136, 43, 98, 108, '', '501', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(616, 'PPI ', 7, 136, 43, 98, 114, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(617, 'PPI ', 7, 136, 43, 138, 185, '', '161', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(618, 'PPI ', 7, 136, 91, 138, 135, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(619, 'PRAZOLE ', 7, 185, 43, 98, 192, '', '241', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(620, 'PRESEC ', 7, 194, 43, 98, 196, '', '112', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(621, 'PRESEC ', 7, 194, 43, 138, 196, '', '196', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(622, 'PREVAS ', 7, 156, 43, 98, 181, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(623, 'PREVAS ', 7, 156, 43, 138, 159, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(624, 'PREVAS ', 7, 156, 56, 138, 132, '', '80', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(625, 'PROBITOR', 7, 175, 43, 98, 199, '', '568', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(626, 'PROBITOR', 7, 175, 43, 138, 168, '', '404', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(627, 'PROCAP ', 7, 181, 43, 98, 108, '', '500', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(628, 'PROCAP ', 7, 181, 43, 138, 185, '', '160', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(629, 'PROCAP ', 7, 181, 57, 138, 132, '', '90', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(630, 'PROCEPTIN ', 7, 145, 43, 98, 99, '', '500', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(631, 'PROCEPTIN ', 7, 145, 43, 138, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(632, 'PROCEPTIN ', 7, 145, 56, 138, 132, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(633, 'PROLOK ', 7, 161, 43, 98, 189, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(634, 'PROLOK ', 7, 161, 56, 138, 132, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(635, 'REGERD ', 7, 180, 43, 98, 99, '', '502', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(636, 'REGERD ', 7, 180, 43, 138, 148, '', '197', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(637, 'ROME-20 ', 7, 186, 43, 98, 108, '', '500', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(638, 'SECLO ', 7, 192, 43, 98, 131, '', '480', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(639, 'SECLO ', 7, 192, 43, 138, 188, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(640, 'SECLO ', 7, 192, 58, 138, 132, '', '70', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(641, 'SECLO-DR ', 7, 192, 88, 98, 192, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(642, 'STOSEC 20 ', 7, 177, 43, 98, 118, '', '450', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(643, 'STOSEC 21', 7, 177, 57, 138, 135, '', '70', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(644, 'XELDRIN ', 7, 135, 43, 59, 166, '', '96', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(645, 'XELDRIN ', 7, 135, 43, 59, 174, '', '101', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(646, 'XELDRIN ', 7, 135, 43, 98, 99, '', '500', 0, 0, 1, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(647, 'XELDRIN ', 7, 135, 43, 98, 198, '', '322', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(648, 'XELDRIN ', 7, 135, 43, 98, 194, '', '281', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(649, 'XELDRIN ', 7, 135, 43, 138, 162, '', '320', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(650, 'XELDRIN ', 7, 135, 57, 138, 132, '', '80', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(651, 'XELOPES ', 7, 143, 43, 98, 200, '', '602', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(652, 'XELOPES ', 7, 143, 43, 138, 188, '', '211', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(653, 'XELOPES ', 7, 143, 57, 138, 132, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(654, 'XEROSEC ', 7, 187, 43, 98, 108, '', '502', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(655, 'XEROSEC ', 7, 187, 43, 138, 159, '', '241', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(656, 'ZILON ', 7, 182, 43, 98, 189, '', '301', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(657, 'ZILON ', 7, 182, 43, 138, 145, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(658, 'EUROPAN ', 8, 158, 88, 98, 159, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(659, 'EUROPAN ', 8, 158, 88, 138, 159, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(660, 'EUROPAN ', 8, 158, 56, 138, 132, '', '70', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(661, 'EXOPAN ', 8, 154, 88, 98, 181, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(662, 'PAMEL ', 8, 170, 88, 98, 181, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(663, 'PAMEL ', 8, 170, 88, 138, 181, '', '250', 0, 1, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(664, 'PANLOC ', 8, 165, 88, 98, 181, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(665, 'PANLOC ', 8, 165, 88, 138, 159, '', '180', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(666, 'PANORAL ', 8, 155, 88, 98, 162, '', '160', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(667, 'PANORAL ', 8, 155, 88, 138, 162, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(668, 'PANPRO ', 8, 146, 52, 98, 99, '', '500', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(669, 'PANPRO ', 8, 146, 52, 138, 174, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(670, 'PANPRO ', 8, 146, 56, 138, 132, '', '70', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(671, 'PANSEC', 8, 123, 88, 98, 179, '', '283', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(672, 'PANSEC', 8, 152, 88, 138, 179, '', '395', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(673, 'PANSEC', 8, 152, 56, 138, 132, '', '70', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(674, 'PANSOS ', 8, 174, 88, 98, 174, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(675, 'PANSOS ', 8, 174, 88, 138, 174, '', '251', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(676, 'PANTAC ', 8, 173, 88, 98, 189, '', '241', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(677, 'PANTAC ', 8, 173, 88, 138, 156, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(678, 'PANTODAC', 8, 133, 88, 98, 192, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(679, 'PANTODAC', 8, 196, 88, 138, 159, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(680, 'PANTOGUT ', 8, 183, 88, 98, 99, '', '500', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(681, 'PANTOGUT ', 8, 183, 88, 138, 174, '', '350', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(682, 'PANTOGUT ', 8, 183, 56, 138, 96, '', '70', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(683, 'PANTEX ', 8, 135, 88, 98, 174, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(684, 'PANTEX ', 8, 135, 43, 98, 162, '', '120', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(685, 'PANTEX ', 8, 135, 88, 138, 156, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(686, 'PANTEX ', 8, 135, 43, 138, 162, '', '201', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(687, 'PANTEX ', 8, 135, 57, 138, 132, '', '70', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(688, 'PANTID ', 8, 179, 88, 98, 108, '', '400', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(689, 'PANTID ', 8, 179, 88, 138, 108, '', '300', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(690, 'PANTID ', 8, 179, 91, 138, 132, '', '70', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(691, 'PANTIUM ', 8, 182, 88, 98, 189, '', '421', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(692, 'PANTO ', 8, 190, 88, 98, 174, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(693, 'PANTO ', 8, 190, 88, 138, 156, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(694, 'PANTOBEX ', 8, 145, 88, 98, 99, '', '500', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(695, 'PANTOBEX ', 8, 145, 88, 138, 99, '', '700', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(696, 'PANTOBEX ', 8, 145, 56, 138, 132, '', '110', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(697, 'PANTOGEN ', 8, 156, 88, 98, 181, '', '251', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(698, 'PANTOGEN ', 8, 156, 88, 138, 181, '', '352', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(699, 'PANTOLOK ', 8, 161, 88, 98, 174, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(700, 'PANTOLOK ', 8, 161, 88, 138, 156, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(701, 'PANTOLOK ', 8, 161, 56, 138, 132, '', '80', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1);
INSERT INTO `mims_brandinformation` (`ID`, `Name`, `GenericID`, `ManufacturerID`, `DosageFormID`, `StrengthID`, `PackSizeID`, `ImagePath`, `PriceInBDT`, `IsHighlighted`, `IsNewProduct`, `IsNewBrand`, `IsNewPresentation`, `CreateDate`, `LastUpdate`, `CreatedBy`, `IsActive`) VALUES
(702, 'PANTONIX ', 8, 162, 88, 98, 194, '', '350', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(703, 'PANTONIX ', 8, 162, 88, 138, 194, '', '490', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(704, 'PANTONIX ', 8, 162, 56, 138, 132, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(705, 'PANTOPRA ', 8, 137, 88, 98, 156, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(706, 'PANTOPRA ', 8, 137, 88, 138, 156, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(707, 'PANTOSEC ', 8, 193, 56, 138, 132, '', '70', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(708, 'PANTROL ', 8, 138, 88, 98, 102, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(709, 'PANTROL ', 8, 138, 88, 138, 159, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(710, 'PAGERD ', 8, 180, 88, 98, 174, '', '201', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(711, 'PAGERD ', 8, 180, 88, 138, 174, '', '301', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(712, 'PRAMAX ', 8, 147, 88, 98, 181, '', '201', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(713, 'PRAMAX ', 8, 147, 88, 138, 159, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(714, 'PRAZOLIN ', 8, 186, 88, 98, 181, '', '200', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(715, 'PRAZOLIN ', 8, 186, 88, 138, 181, '', '300', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(716, 'PREGEL ', 8, 159, 88, 98, 174, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(717, 'PREGEL ', 8, 159, 88, 138, 156, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(718, 'PROTIUM ', 8, 194, 88, 98, 172, '', '140', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(719, 'PROTIUM ', 8, 194, 88, 138, 172, '', '252', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(720, 'PROTOCID ', 8, 136, 88, 98, 181, '', '201', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(721, 'PROTOCID ', 8, 136, 88, 138, 181, '', '301', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(722, 'PROTOCID ', 8, 136, 58, 138, 132, '', '70', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(723, 'PROTOLOC ', 8, 143, 88, 98, 181, '', '201', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(724, 'PROTOLOC ', 8, 143, 88, 138, 181, '', '301', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(725, 'PROTON-P ', 8, 141, 88, 98, 189, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(726, 'PROTON-P ', 8, 141, 88, 138, 189, '', '420', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(727, 'PROTON-P ', 8, 141, 56, 138, 132, '', '80', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(728, 'PROTONIL ', 8, 185, 48, 98, 181, '', '200', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(729, 'PROTONIL ', 8, 185, 48, 138, 159, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(730, 'P-20 ', 8, 142, 88, 98, 181, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(731, 'P-40 ', 8, 142, 88, 138, 181, '', '300', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(732, 'TOPRA ', 8, 163, 88, 98, 159, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(733, 'TOPRA ', 8, 163, 88, 138, 159, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(734, 'TRUPAN ', 8, 192, 88, 98, 192, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(735, 'TRUPAN ', 8, 192, 88, 138, 192, '', '360', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(736, 'TRUPAN ', 8, 192, 63, 138, 132, '', '70', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(737, 'ACIFIX ', 9, 145, 88, 98, 174, '28b933ace60241956d37ca80bca2f70e.jpg', '250', 1, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(738, 'FINIX ', 9, 179, 88, 115, 121, '', '703', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(739, 'PARICEL ', 9, 135, 88, 98, 156, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(740, 'PARICEL ', 9, 135, 88, 98, 174, '', '251', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(741, 'PARICEL ', 9, 135, 88, 98, 189, '', '301', 0, 1, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(742, 'PROFAST ', 9, 185, 88, 98, 192, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(743, 'PROMPTON ', 9, 184, 88, 98, 189, '', '481', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(744, 'RABIFAST ', 9, 155, 50, 98, 194, '', '350', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(745, 'RABE ', 9, 141, 50, 98, 189, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(746, 'RABECA ', 9, 192, 88, 98, 181, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(747, 'RABECON ', 9, 146, 88, 98, 189, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(748, 'RABEPES ', 9, 143, 88, 98, 182, '', '251', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(749, 'RABEPROL ', 9, 190, 88, 98, 189, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(750, 'RABESEC ', 9, 152, 52, 98, 179, '', '283', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(751, 'RABIGUT ', 9, 183, 88, 98, 99, '', '500', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(752, 'RABIPEP', 9, 180, 88, 98, 181, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(753, 'RABETAC 20 ', 9, 173, 88, 98, 174, '', '251', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(754, 'RABIZOL ', 9, 136, 88, 98, 181, '', '251', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(755, 'RABLET 20 ', 9, 174, 88, 98, 174, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(756, 'RAPO ', 9, 170, 88, 98, 189, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(757, 'RASONIX ', 9, 162, 88, 98, 174, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(758, 'RASONIX ', 9, 162, 43, 59, 179, '', '196', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(759, 'RASONIX ', 9, 162, 43, 98, 179, '', '448', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(760, 'RESPITE ', 9, 187, 88, 98, 181, '', '301', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(761, 'RP ', 9, 158, 88, 98, 181, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(762, 'RUBEE ', 9, 165, 88, 98, 181, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(763, 'XOREL ', 9, 160, 88, 98, 99, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(764, 'ZORAB ', 9, 194, 88, 59, 159, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(765, 'ZORAB ', 9, 194, 88, 98, 159, '', '240', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(766, 'ACEPTIN-R ', 10, 142, 88, 75, 108, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(767, 'ACIN ', 10, 146, 52, 75, 124, '', '301', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(768, 'ACIN ', 10, 146, 87, 189, 101, '', '45', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(769, 'ALIN ', 10, 186, 88, 75, 108, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(770, 'ASINAR ', 10, 187, 88, 75, 108, '', '251', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(771, 'DENITINE ', 10, 149, 52, 75, 99, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(772, 'DURAN ', 10, 193, 87, 189, 100, '', '45', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(773, 'DURAN ', 10, 193, 56, 153, 100, '', '60', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(774, 'EDITIN-R ', 10, 154, 88, 41, 108, '', '223', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(775, 'EDITIN-R ', 10, 154, 56, 42, 144, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(776, 'GASTAB ', 10, 174, 88, 75, 99, '', '201', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(777, 'GASTAB ', 10, 174, 87, 189, 100, '', '45', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(778, 'GASTROLOC ', 10, 143, 88, 75, 108, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(779, 'GEPIN ', 10, 156, 88, 75, 107, '', '201', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(780, 'GEPIN ', 10, 156, 87, 189, 100, '', '45', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(781, 'GEPIN ', 10, 156, 87, 189, 140, '', '81', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(782, 'GEPIN ', 10, 156, 57, 155, 154, '', '100', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(783, 'INRAN ', 10, 171, 88, 75, 108, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(784, 'INRAN ', 10, 171, 56, 150, 102, '', '60', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(785, 'INSEAC ', 10, 160, 52, 75, 99, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(786, 'INSEAC ', 10, 160, 52, 130, 119, '', '184', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(787, 'LUMERAN ', 10, 141, 88, 75, 99, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(788, 'NEOCEPTIN-R ', 10, 145, 88, 75, 124, '', '375', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(789, 'NEOCEPTIN-R ', 10, 145, 88, 75, 130, '', '420', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(790, 'NEOCEPTIN-R ', 10, 145, 87, 189, 104, '', '45', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(791, 'NEOCEPTIN-R ', 10, 145, 56, 155, 149, '', '60', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(792, 'NEOCEPTIN-R IV ', 10, 145, 55, 44, 100, '', '101', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(793, 'NEOTACK ', 10, 192, 52, 75, 109, '', '375', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(794, 'NEOTACK ', 10, 192, 52, 130, 108, '', '450', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(795, 'NEOTACK ', 10, 192, 87, 189, 104, '', '50', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(796, 'NEOTACK ', 10, 192, 90, 155, 154, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(797, 'NORMA-H ', 10, 185, 88, 75, 88, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(798, 'OFF-H ', 10, 180, 88, 75, 98, '', '251', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(799, 'ORTAC ', 10, 181, 88, 75, 108, '', '201', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(800, 'ORTAC INJ ', 10, 181, 56, 155, 154, '', '60', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(801, 'PEPTOSOL IV ', 10, 177, 55, 43, 135, '', '35', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(802, 'PEPTIL-H ', 10, 155, 88, 75, 124, '', '270', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(803, 'PEPTIL-H ', 10, 155, 87, 30, 101, '', '45', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(804, 'PEPTIL-H ', 10, 155, 56, 155, 102, '', '60', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(805, 'RANI-150 ', 10, 137, 88, 75, 99, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(806, 'RANICARE ', 10, 176, 88, 75, 108, '', '139', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(807, 'RANID', 10, 133, 88, 75, 108, '', '110', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(808, 'RANIDIN ', 10, 136, 52, 75, 109, '', '377', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(809, 'RANIDIN ', 10, 136, 52, 130, 108, '', '403', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(810, 'RANIDIN ', 10, 136, 87, 189, 100, '', '45', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(811, 'RANIDIN ', 10, 136, 56, 157, 154, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(812, 'RANILOC ', 10, 165, 88, 75, 128, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(813, 'RANISON ', 10, 164, 52, 75, 108, '', '173', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(814, 'RANISON ', 10, 164, 56, 155, 149, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(815, 'RANITID ', 10, 179, 52, 75, 128, '', '375', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(816, 'RANITID ', 10, 179, 88, 130, 108, '', '402', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(817, 'RANITID ', 10, 179, 87, 189, 100, '', '45', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(818, 'RANITID ', 10, 179, 41, 155, 184, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(819, 'RANITOR ', 10, 183, 88, 75, 124, '', '300', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(820, 'RANUL ', 10, 138, 88, 75, 99, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(821, 'RECODIN ', 10, 147, 88, 75, 128, '', '375', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(822, 'REETAC-R ', 10, 173, 88, 75, 99, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(823, 'RENICON ', 10, 170, 52, 75, 108, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(824, 'RHINE ', 10, 159, 88, 75, 189, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(825, 'TINADIN ', 10, 148, 88, 75, 139, '', '186', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(826, 'TINADIN ', 10, 148, 87, 189, 100, '', '40', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(827, 'ULCAR', 10, 123, 88, 75, 99, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(828, 'ULCAR', 10, 152, 88, 130, 174, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(829, 'ULCAR', 10, 152, 61, 156, 132, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(830, 'ULTRADIN ', 10, 158, 88, 75, 108, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(831, 'XANTID ', 10, 135, 88, 75, 99, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(832, 'XANTID ', 10, 135, 88, 75, 124, '', '375', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(833, 'XANTID ', 10, 135, 56, 155, 102, '', '75', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(834, 'XANTID-HS ', 10, 135, 88, 130, 99, '', '402', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(835, 'ZACTIN ', 10, 194, 88, 75, 99, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(836, 'ZANTAC ', 10, 157, 88, 75, 108, '', '406', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(837, 'ZODIN ', 10, 190, 88, 75, 99, '', '201', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(838, 'ZODIN ', 10, 190, 87, 189, 100, '', '40', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(839, 'GASTALFET ', 11, 145, 88, 149, 99, '', '402', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(840, 'ULSEC ', 11, 142, 88, 52, 201, '', '192', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(841, 'ABDORIN ', 12, 179, 88, 59, 116, '', '101', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(842, 'ABDORIN ', 12, 179, 87, 67, 176, '', '30', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(843, 'COLICON ', 12, 192, 88, 59, 108, '', '201', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(844, 'COLICON ', 12, 192, 87, 67, 176, '', '30', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(845, 'CYCLOPAN ', 12, 162, 88, 59, 99, '', '200', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(846, 'CYCLOPAN ', 12, 162, 87, 57, 176, '', '30', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(847, 'DIVERIN ', 12, 135, 88, 59, 174, '', '101', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(848, 'DIVERIN ', 12, 135, 88, 98, 174, '', '176', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(849, 'DIVERIN ', 12, 135, 87, 67, 176, '', '30', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(850, 'LOVERIN', 12, 121, 88, 59, 174, '', '101', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(851, 'LOVERIN', 12, 145, 87, 67, 176, '', '30', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(852, 'ROBENTYL ', 12, 159, 88, 59, 99, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(853, 'ROBENTYL ', 12, 159, 87, 67, 176, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(854, 'SPALAX ', 12, 173, 88, 59, 93, '', '121', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(855, 'SPALAX ', 12, 173, 87, 67, 176, '', '30', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(856, 'WINSPA ', 12, 138, 87, 67, 100, '', '45', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(857, 'WINSPA ', 12, 138, 87, 67, 176, '', '30', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(858, 'WINSPA TAB ', 12, 138, 88, 59, 174, '', '100', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(859, 'DOT ', 13, 136, 88, 138, 99, '', '176', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(860, 'DOT ', 13, 136, 41, 144, 102, '', '70', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(861, 'DROTAPAN ', 13, 162, 88, 138, 99, '', '175', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(862, 'DROVIN ', 13, 135, 88, 138, 99, '', '176', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(863, 'DROVIN ', 13, 135, 54, 144, 132, '', '10', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(864, 'ESPA ', 13, 192, 88, 138, 99, '', '176', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(865, 'ESPA ', 13, 192, 54, 144, 102, '', '70', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(866, 'RENAPA ', 13, 185, 88, 138, 108, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(867, 'SPAN ', 13, 179, 88, 138, 99, '', '175', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(868, 'TAV', 13, 180, 88, 138, 99, '', '176', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(869, 'TAVERIN', 13, 145, 88, 138, 99, '', '175', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(870, 'BROMID ', 14, 155, 88, 59, 99, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(871, 'BROMID ', 14, 155, 88, 98, 177, '', '175', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(872, 'BUSCON ', 14, 160, 88, 59, 99, '', '182', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(873, 'BUSCON ', 14, 160, 56, 98, 132, '', '70', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(874, 'BUTAPAN ', 14, 187, 88, 59, 115, '', '3450', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(875, 'BUTAPAN ', 14, 187, 88, 98, 108, '', '1364', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(876, 'BYSPA ', 14, 135, 88, 59, 99, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(877, 'COLIK ', 14, 135, 88, 59, 99, '', '344', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(878, 'COLIK ', 14, 135, 88, 98, 99, '', '670', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(879, 'COLIK ', 14, 135, 56, 108, 180, '', '39', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(880, 'HYOSIN ', 14, 148, 88, 59, 99, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(881, 'HYSIN ', 14, 154, 88, 59, 108, '', '348', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(882, 'HYSIN ', 14, 154, 56, 119, 106, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(883, 'HYSOMIDE ', 14, 179, 88, 59, 108, '', '690', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(884, 'HYSOMIDE ', 14, 179, 88, 98, 108, '', '351', 0, 1, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(885, 'HYSOMIDE ', 14, 179, 56, 108, 187, '', '748', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(886, 'JOYTRIP ', 14, 173, 88, 30, 156, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(887, 'SPANIL ', 14, 145, 52, 59, 99, '', '344', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(888, 'SPASMIN ', 14, 149, 52, 59, 99, '', '154', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(889, 'SPASMOSON ', 14, 164, 88, 59, 108, '', '341', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(890, 'SPASMOSON ', 14, 164, 41, 108, 102, '', '79', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(891, 'A-MEB ', 15, 136, 88, 74, 181, '1e23efd0e7719b2fd20b273ab805fa5a.png', '301', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(892, 'EVARIN ', 15, 148, 88, 74, 174, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(893, 'IRIBAN ', 15, 162, 88, 74, 174, '', '300', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(894, 'IRIBAN-SR ', 15, 162, 83, 97, 156, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(895, 'IRISYN ', 15, 160, 88, 74, 181, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(896, 'MAVE ', 15, 179, 88, 74, 116, '', '301', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(897, 'MAVE ', 15, 179, 83, 97, 113, '', '301', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(898, 'MEVERINE ', 15, 152, 88, 74, 174, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(899, 'MEVERINE-SR ', 15, 152, 83, 97, 156, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(900, 'MEVIN ', 15, 192, 88, 74, 181, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(901, 'MEVIN ', 15, 192, 43, 97, 156, '', '300', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(902, 'ROSTIL ', 15, 145, 88, 74, 174, '', '350', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(903, 'ROSTIL ', 15, 145, 83, 97, 156, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(904, 'VERON ', 15, 155, 88, 74, 174, '', '304', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(905, 'A-SPASM ', 16, 136, 88, 158, 99, '', '143', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(906, 'ANTRENEX ', 16, 179, 88, 158, 108, '', '125', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(907, 'ANTRENYL ', 16, 175, 88, 158, 99, '', '410', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(908, 'TIMOTOR ', 17, 192, 88, 54, 181, '', '251', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(909, 'TRIMOTIL', 17, 127, 88, 54, 174, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(910, 'TRITIN ', 17, 185, 88, 54, 159, '', '150', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(911, 'ACTILAC ', 18, 159, 87, 123, 100, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(912, 'ACTILAC ', 18, 159, 87, 123, 140, '', '0', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(913, 'ASILAC ', 18, 142, 70, 123, 101, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(914, 'ASILAC ', 18, 142, 70, 123, 140, '', '230', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(915, 'AVOLAC ', 18, 141, 70, 123, 100, '', '140', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(916, 'AVOLAC ', 18, 141, 70, 123, 140, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(917, 'CONLAX ', 18, 194, 87, 123, 100, '', '140', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(918, 'CONSTILAC ', 18, 185, 70, 123, 100, '', '100', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(919, 'D-LAC ', 18, 152, 68, 122, 176, '', '70', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(920, 'D-LAC ', 18, 152, 68, 30, 100, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(921, 'D-LAC ', 18, 152, 68, 30, 140, '', '220', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(922, 'DILAX ', 18, 194, 79, 121, 100, '', '75', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(923, 'E-LAX ', 18, 154, 87, 183, 100, '', '100', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(924, 'EZYLAX ', 18, 181, 87, 123, 176, '', '50', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(925, 'EZYLAX ', 18, 181, 87, 123, 100, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(926, 'INOLAC ', 18, 162, 70, 123, 100, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(927, 'LACLOSE ', 18, 179, 87, 127, 100, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(928, 'LACLOSE ', 18, 179, 87, 127, 140, '', '230', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(929, 'LACTOMOSE ', 18, 171, 70, 30, 100, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(930, 'LACTU ', 18, 146, 70, 128, 100, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(931, 'LACTU ', 18, 146, 70, 128, 140, '', '200', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(932, 'LAX ', 18, 170, 70, 127, 100, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(933, 'LAXOL ', 18, 173, 70, 123, 176, '', '50', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(934, 'LAXOL ', 18, 173, 70, 123, 100, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(935, 'LAXOL ', 18, 173, 70, 123, 140, '', '201', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(936, 'LAXOLAC ', 18, 158, 71, 126, 100, '', '115', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(937, 'LEAXE ', 18, 137, 87, 123, 97, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(938, 'LEAXE ', 18, 137, 87, 123, 140, '', '230', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(939, 'NIPROLAC ', 18, 174, 70, 123, 100, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(940, 'ORALAX ', 18, 190, 87, 124, 100, '', '140', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(941, 'OSMOLAX ', 18, 192, 70, 127, 100, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(942, 'OSMOLAX ', 18, 192, 70, 127, 140, '', '230', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(943, 'REGULOSE ', 18, 156, 87, 123, 100, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(944, 'RELACS ', 18, 135, 70, 123, 100, '', '66', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(945, 'REWAT ', 18, 165, 70, 126, 97, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(946, 'SERELOSE ', 18, 145, 70, 123, 100, '', '130', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(947, 'SINALAC ', 18, 160, 70, 125, 191, '', '50', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(948, 'SINALAC ', 18, 160, 70, 127, 100, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(949, 'SINALAC ', 18, 160, 70, 127, 140, '', '200', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(950, 'SINALAC ', 18, 160, 70, 127, 164, '', '450', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(951, 'TULAC ', 18, 155, 70, 58, 100, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(952, 'TULAC ', 18, 155, 70, 58, 140, '', '230', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(953, 'TULOS ', 18, 136, 70, 123, 100, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(954, 'TULOS ', 18, 136, 70, 123, 140, '', '231', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(955, 'XYLOSE ', 18, 148, 79, 123, 100, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(956, 'XYLOSE ', 18, 148, 79, 123, 140, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(957, 'REUMAZIN ', 19, 141, 88, 149, 174, '', '260', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(958, 'SALAZINE ', 19, 179, 88, 149, 116, '', '261', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(959, 'SALAZINE ', 19, 179, 85, 149, 184, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(960, 'SULFACOL ', 19, 151, 52, 149, 159, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(961, 'SULFAZIN ', 19, 183, 88, 149, 156, '', '157', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(962, 'ZULFIDIN ', 19, 194, 88, 149, 156, '', '210', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(963, 'IMOTIL ', 20, 192, 43, 116, 143, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(964, 'LOPAMID ', 20, 136, 43, 116, 108, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(965, 'LOPERIN ', 20, 179, 43, 116, 108, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(966, 'NOMOTIL ', 20, 196, 43, 116, 143, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(967, 'BILICIR ', 21, 135, 88, 75, 113, '', '550', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(968, 'BILICIR ', 21, 135, 88, 130, 110, '', '600', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(969, 'LICONOR ', 21, 179, 88, 75, 113, '', '331', 0, 0, 1, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(970, 'LICONOR ', 21, 179, 88, 130, 110, '', '201', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(971, 'LICONOR ', 21, 179, 71, 110, 175, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(972, 'LIVERIC ', 21, 145, 88, 75, 156, '', '330', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(973, 'LIVERIC ', 21, 145, 88, 130, 156, '', '600', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(974, 'OXYCOL ', 21, 194, 88, 75, 141, '', '400', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(975, 'OXYCOL ', 21, 194, 88, 130, 141, '', '720', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(976, 'UDCA ', 21, 146, 88, 149, 102, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(977, 'UDIHEP ', 21, 172, 88, 75, 159, '', '380', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(978, 'UDIHEP FORTE ', 21, 172, 88, 129, 181, '', '1175', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(979, 'ULIV ', 21, 136, 88, 75, 150, '', '242', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(980, 'ULIV ', 21, 136, 88, 130, 134, '', '201', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(981, 'URSO ', 21, 192, 88, 75, 141, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(982, 'URSO ', 21, 192, 88, 130, 102, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(983, 'URSODIL ', 21, 156, 88, 130, 134, '', '201', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(984, 'URSODEX ', 21, 160, 88, 75, 162, '', '480', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(985, 'URSODEX ', 21, 160, 88, 130, 141, '', '400', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(986, 'URSOLIC ', 21, 152, 88, 75, 141, '', '240', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(987, 'URSOLIC ', 21, 152, 88, 130, 102, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(988, 'AMIZIDE ', 22, 187, 88, 37, 111, '', '144', 0, 1, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(989, 'KALTIDE ', 22, 135, 88, 37, 99, '', '201', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(990, 'ACUDIPIN ', 23, 147, 88, 158, 181, '', '251', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(991, 'AMDIN ', 23, 137, 88, 158, 174, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(992, 'AMDIN ', 23, 137, 88, 59, 156, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(993, 'AMDOCAL ', 23, 145, 88, 158, 99, '', '500', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(994, 'AMDOCAL ', 23, 145, 88, 59, 189, '', '420', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(995, 'AMLOCARD ', 23, 152, 88, 158, 99, '', '450', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(996, 'AMLOCARD ', 23, 152, 88, 59, 174, '', '350', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(997, 'AMLOPIN ', 23, 136, 88, 158, 181, '', '251', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(998, 'AMLOPIN ', 23, 136, 88, 59, 159, '', '211', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(999, 'AMLOSIN-5 ', 23, 149, 88, 158, 159, '', '102', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1000, 'AMLOTAB', 23, 124, 88, 158, 174, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1001, 'AMLOVAS ', 23, 183, 88, 158, 174, '', '175', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1002, 'AMLOWIDE ', 23, 143, 88, 158, 181, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1003, 'AMO ', 23, 148, 88, 158, 174, '', '150', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1004, 'AMOCAL ', 23, 179, 88, 158, 113, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1005, 'AMOCAL ', 23, 179, 88, 59, 113, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1006, 'AMODIPIN ', 23, 148, 88, 158, 181, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1007, 'AMPRE ', 23, 165, 88, 158, 159, '', '150', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1008, 'AMPRE ', 23, 135, 88, 158, 156, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1009, 'AMPRE ', 23, 135, 88, 158, 174, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1010, 'CALCHEK ', 23, 156, 88, 158, 181, '', '251', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1011, 'CALPIN ', 23, 158, 88, 158, 181, '', '225', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1012, 'CALPRESS ', 23, 142, 88, 158, 181, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1013, 'CALPRESS ', 23, 142, 88, 59, 159, '', '210', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1014, 'CALVASC ', 23, 194, 88, 158, 156, '', '150', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1015, 'CALVASC ', 23, 194, 88, 59, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1016, 'CAMLODIN ', 23, 192, 88, 158, 189, '', '301', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1017, 'CAMLODIN ', 23, 192, 88, 59, 152, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1018, 'CANVAS-5 ', 23, 138, 88, 158, 156, '', '105', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1019, 'CARDIPIN ', 23, 185, 88, 158, 192, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1020, 'CARDOLAB 5 ', 23, 166, 88, 158, 174, '', '251', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1021, 'CARDOLAB 6', 23, 181, 88, 158, 181, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1022, 'CORDIL ', 23, 193, 88, 158, 159, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1023, 'CVNOR-5 ', 23, 173, 88, 158, 156, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1024, 'DIPLOR ', 23, 160, 88, 36, 156, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1025, 'DIPLOR ', 23, 160, 88, 59, 156, '', '210', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1026, 'DOPIN ', 23, 170, 88, 158, 159, '', '150', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1027, 'EMLON ', 23, 146, 88, 158, 181, '', '250', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1028, 'LOCARD ', 23, 164, 88, 158, 181, '', '153', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1029, 'LODICAL ', 23, 189, 88, 158, 156, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1030, 'LODIPIN ', 23, 141, 88, 158, 189, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1031, 'LOPIN ', 23, 154, 88, 38, 159, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1032, 'SIDOPIN ', 23, 155, 88, 158, 174, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1033, 'XELCARD ', 23, 159, 88, 158, 156, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1034, 'XELCARD ', 23, 159, 88, 59, 156, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1035, 'ACUDIPIN PLUS ', 24, 147, 88, 173, 159, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1036, 'AMDIN PLUS ', 24, 137, 88, 173, 174, '', '225', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1037, 'AMDOCAL PLUS ', 24, 145, 88, 173, 156, '', '158', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1038, 'AMDOCAL PLUS ', 24, 145, 88, 171, 189, '', '360', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1039, 'AMLOCARD PLUS ', 24, 152, 88, 173, 179, '', '339', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1040, 'AMLOCARD PLUS ', 24, 152, 88, 171, 174, '', '225', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1041, 'AMLOCOM ', 24, 143, 88, 173, 181, '', '226', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1042, 'AMLOSIN PLUS ', 24, 149, 88, 173, 159, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1043, 'AMLOTEN ', 24, 136, 88, 173, 181, '', '263', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1044, 'AMLOTEN ', 24, 136, 88, 171, 159, '', '158', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1045, 'AMLOVAS AT ', 24, 183, 88, 173, 174, '', '300', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1046, 'AMOCAL-AT ', 24, 179, 88, 173, 113, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1047, 'AMOCAL-AT ', 24, 179, 88, 171, 113, '', '158', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1048, 'AMPRE PLUS ', 24, 165, 88, 173, 159, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1049, 'ANGICAL ', 24, 138, 88, 171, 159, '', '105', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1050, 'ANGICAL ', 24, 138, 88, 173, 156, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1051, 'BETACAL ', 24, 181, 88, 173, 181, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1052, 'BETANOL-A ', 24, 187, 88, 173, 181, '', '301', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1053, 'BPNOL-PLUS ', 24, 148, 88, 173, 156, '', '120', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1054, 'CALBETA ', 24, 194, 88, 173, 159, '', '180', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1055, 'CALCHEK PLUS ', 24, 156, 88, 173, 159, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1056, 'CALPIN PLUS ', 24, 158, 88, 167, 159, '', '135', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1057, 'CAMLODIN PLUS ', 24, 192, 88, 171, 159, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1058, 'CAMLODIN PLUS ', 24, 192, 88, 173, 181, '', '301', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1059, 'CARDIPIN PLUS ', 24, 185, 88, 173, 192, '', '360', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1060, 'COMBICARD ', 24, 159, 88, 173, 156, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1061, 'CVNOR-A ', 24, 173, 88, 173, 156, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1062, 'DIPLOR PLUS ', 24, 160, 88, 171, 156, '', '105', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1063, 'DIPLOR PLUS ', 24, 160, 88, 173, 156, '', '135', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1064, 'EMLON PLUS ', 24, 146, 88, 173, 156, '', '180', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1065, 'FIXOCARD ', 24, 162, 88, 171, 174, '', '263', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1066, 'FIXOCARD ', 24, 162, 88, 173, 174, '', '300', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1067, 'IMPED PLUS', 24, 130, 88, 171, 108, '', '400', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1068, 'IMPED PLUS', 24, 186, 88, 173, 108, '', '500', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1069, 'LOCARD PLUS ', 24, 164, 88, 173, 159, '', '91', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1070, 'LODICAL PLUS ', 24, 190, 88, 173, 156, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1071, 'LODICARD ', 24, 141, 40, 173, 189, '', '360', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1072, 'LOPIN PLUS ', 24, 154, 88, 173, 159, '', '135', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1073, 'SIDOPLUS ', 24, 155, 53, 171, 162, '', '210', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1074, 'SIDOPLUS ', 24, 155, 53, 173, 162, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1075, 'TENOCAB ', 24, 135, 88, 171, 174, '', '263', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1076, 'TENOCAB ', 24, 135, 88, 173, 174, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1077, 'TENODIN ', 24, 142, 88, 171, 159, '', '126', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1078, 'TENODIN ', 24, 142, 88, 173, 159, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1079, 'AMDOVA ', 25, 145, 88, 167, 156, '', '330', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1080, 'AMITOR ', 25, 179, 88, 167, 113, '', '330', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1081, 'AMLIP ', 25, 155, 88, 167, 156, '', '330', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1082, 'AMOVAST ', 25, 143, 88, 167, 150, '', '221', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1083, 'ATV PLUS ', 25, 148, 52, 167, 102, '', '80', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1084, 'CAMLOTOR ', 25, 192, 88, 167, 159, '', '331', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1085, 'CARDUAL ', 25, 135, 88, 167, 159, '', '331', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1086, 'DIVASTIN PLUS ', 25, 152, 88, 167, 156, '', '330', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1087, 'TROVASTIN ', 25, 185, 88, 167, 160, '', '330', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1088, 'AMDOPRIL ', 26, 145, 43, 170, 156, '', '240', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1089, 'AMDOPRIL ', 26, 145, 43, 64, 156, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1090, 'AMDOPRIL ', 26, 145, 43, 93, 189, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1091, 'AMDOPRIL ', 26, 145, 43, 167, 189, '', '360', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1092, 'AMLOZEP-1O ', 26, 143, 43, 167, 159, '', '181', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1093, 'AMOCAL-BZ 5/10 ', 26, 179, 43, 167, 113, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1094, 'AMOCAL-BZ 2.5/10 ', 26, 179, 43, 89, 113, '', '121', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1095, 'AMOCAL-BZ 5/20 ', 26, 179, 43, 170, 112, '', '161', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1096, 'BENADIP 10/2.5', 26, 124, 43, 89, 148, '', '112', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1097, 'BENADIP 10/5 ', 26, 162, 43, 167, 148, '', '168', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1098, 'BENADIP 20/5 ', 26, 162, 43, 170, 148, '', '224', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1099, 'BENADIP 20/10', 26, 124, 43, 64, 148, '', '280', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1100, 'CACETOR-10/2.5 ', 26, 135, 43, 89, 145, '', '96', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1101, 'CACETOR-10/5 ', 26, 135, 43, 167, 145, '', '144', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1102, 'CACETOR-20/5 ', 26, 135, 43, 170, 145, '', '192', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1103, 'CAMLOPRIL ', 26, 192, 43, 170, 188, '', '241', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1104, 'CAMLOPRIL ', 26, 192, 43, 167, 188, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1105, 'LODIBEN ', 26, 155, 43, 170, 169, '', '128', 0, 1, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1106, 'LODIBEN ', 26, 155, 43, 167, 171, '', '144', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1107, 'LODIBEN ', 26, 155, 43, 92, 193, '', '144', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1108, 'ANOL ', 27, 170, 88, 150, 108, '', '80', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1109, 'ATEBIT ', 27, 142, 88, 150, 108, '', '77', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1110, 'ATEBIT ', 27, 142, 88, 54, 108, '', '138', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1111, 'ATIN ', 27, 164, 88, 150, 99, '', '76', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1112, 'BETANOL ', 27, 187, 88, 111, 143, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1113, 'BETANOL ', 27, 187, 88, 150, 143, '', '154', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1114, 'BETANOL ', 27, 187, 88, 54, 108, '', '137', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1115, 'BETASEC ', 27, 179, 88, 150, 108, '', '77', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1116, 'BPNOL ', 27, 148, 88, 150, 99, '', '76', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1117, 'CARDILOCK ', 27, 137, 88, 150, 99, '', '77', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1118, 'CARDIPRO ', 27, 192, 88, 150, 108, '', '77', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1119, 'ENOL ', 27, 154, 88, 150, 108, '', '77', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1120, 'ETNOL ', 27, 146, 88, 150, 108, '', '77', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1121, 'LOPRES 50 ', 27, 181, 88, 150, 108, '', '70', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1122, 'NORMATEN ', 27, 173, 88, 150, 99, '', '76', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1123, 'PRECINOL ', 27, 149, 88, 150, 99, '', '73', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1124, 'TENOCARD ', 27, 141, 88, 150, 99, '', '75', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1125, 'TENOLOC ', 27, 136, 88, 150, 99, '', '77', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1126, 'TENOLOC ', 27, 136, 88, 54, 99, '', '137', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1127, 'TENOREN ', 27, 135, 88, 111, 174, '', '23', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1128, 'TENOREN ', 27, 135, 88, 150, 99, '', '77', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1129, 'TENOREN ', 27, 135, 88, 150, 124, '', '116', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1130, 'TENOREN ', 27, 135, 88, 54, 99, '', '138', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1131, 'TENORMIN INJ ', 27, 135, 56, 49, 102, '', '916', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1132, 'ACUBIS ', 28, 147, 88, 87, 159, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1133, 'ACUBIS ', 28, 147, 88, 158, 159, '', '301', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1134, 'ANCOR ', 28, 141, 88, 87, 156, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1);
INSERT INTO `mims_brandinformation` (`ID`, `Name`, `GenericID`, `ManufacturerID`, `DosageFormID`, `StrengthID`, `PackSizeID`, `ImagePath`, `PriceInBDT`, `IsHighlighted`, `IsNewProduct`, `IsNewBrand`, `IsNewPresentation`, `CreateDate`, `LastUpdate`, `CreatedBy`, `IsActive`) VALUES
(1135, 'ANCOR ', 28, 141, 88, 158, 156, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1136, 'ANCOR ', 28, 141, 88, 59, 102, '', '160', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1137, 'BETABIS ', 28, 136, 88, 87, 159, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1138, 'BETABIS ', 28, 136, 88, 158, 159, '', '301', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1139, 'BETACOR ', 28, 183, 88, 87, 156, '', '180', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1140, 'BETACOR ', 28, 183, 88, 158, 156, '', '300', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1141, 'BETAPRO ', 28, 145, 88, 87, 156, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1142, 'BETAPRO ', 28, 145, 88, 158, 156, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1143, 'BETAPRO ', 28, 145, 88, 59, 156, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1144, 'BETAPRO ', 28, 145, 88, 158, 156, '', '480', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1145, 'BISLOL ', 28, 179, 88, 87, 123, '', '253', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1146, 'BISLOL ', 28, 179, 88, 158, 123, '', '422', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1147, 'BISLOL ', 28, 179, 88, 59, 122, '', '450', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1148, 'BISOCOR ', 28, 192, 88, 87, 159, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1149, 'BISOCOR ', 28, 192, 88, 158, 159, '', '302', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1150, 'BISOCOR ', 28, 192, 88, 59, 134, '', '161', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1151, 'BISOLOC ', 28, 181, 88, 87, 159, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1152, 'BISOLOC ', 28, 181, 88, 158, 159, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1153, 'BISOPRESS ', 28, 174, 88, 87, 156, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1154, 'BISOPRESS ', 28, 174, 88, 158, 156, '', '301', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1155, 'BISOPRO ', 28, 162, 88, 87, 156, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1156, 'BISOPRO ', 28, 162, 88, 158, 156, '', '300', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1157, 'BISOREN ', 28, 185, 88, 87, 159, '', '180', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1158, 'BISOREN ', 28, 185, 88, 158, 159, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1159, 'CARDICOR ', 28, 194, 88, 87, 156, '', '180', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1160, 'CARDICOR ', 28, 194, 88, 158, 156, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1161, 'CARDINOR ', 28, 167, 88, 87, 156, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1162, 'CARDINOR ', 28, 167, 88, 158, 156, '', '301', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1163, 'MYOCARD ', 28, 156, 88, 111, 159, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1164, 'MYOCARD ', 28, 156, 88, 158, 159, '', '301', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1165, 'MYOCOR ', 28, 146, 88, 87, 156, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1166, 'MYOCOR ', 28, 146, 88, 158, 156, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1167, 'ORABIS ', 28, 160, 88, 87, 156, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1168, 'ORABIS ', 28, 160, 88, 158, 156, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1169, 'PROBIS ', 28, 135, 88, 87, 156, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1170, 'PROBIS ', 28, 135, 88, 158, 156, '', '300', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1171, 'TABIS ', 28, 173, 88, 87, 156, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1172, 'TABIS ', 28, 173, 88, 158, 156, '', '301', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1173, 'TENOBIS ', 28, 152, 52, 87, 179, '', '339', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1174, 'TENOBIS ', 28, 152, 52, 158, 148, '', '281', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1175, 'ARB TAB ', 29, 192, 88, 193, 159, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1176, 'ARB TAB ', 29, 192, 88, 81, 159, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1177, 'GIRAN ', 29, 141, 88, 193, 156, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1178, 'GIRAN ', 29, 141, 88, 81, 156, '', '330', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1179, 'GIRAN-H      ', 30, 141, 88, 194, 156, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1180, 'CARDEX ', 31, 179, 88, 120, 108, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1181, 'CARDEX ', 31, 179, 88, 178, 116, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1182, 'CARDEX ', 31, 179, 88, 71, 113, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1183, 'CARVED ', 31, 146, 88, 178, 156, '', '135', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1184, 'CARVIDA ', 31, 148, 88, 178, 156, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1185, 'CARVIDA ', 31, 148, 88, 71, 156, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1186, 'CARVIPRESS ', 31, 136, 88, 111, 159, '', '242', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1187, 'CARVISTA ', 31, 162, 52, 178, 99, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1188, 'CARVISTA ', 31, 162, 52, 71, 174, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1189, 'CARVISTA ', 31, 162, 52, 111, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1190, 'CAVELON ', 31, 152, 88, 178, 174, '', '150', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1191, 'CAVELON ', 31, 152, 88, 71, 174, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1192, 'DILAPRESS ', 31, 145, 88, 178, 156, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1193, 'DILAPRESS ', 31, 145, 88, 71, 156, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1194, 'DILGARD ', 31, 156, 88, 178, 159, '', '91', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1195, 'DILGARD ', 31, 156, 88, 71, 159, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1196, 'DILGARD ', 31, 156, 88, 111, 159, '', '242', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1197, 'DIOLA ', 31, 175, 88, 178, 156, '', '188', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1198, 'DUROL ', 31, 192, 52, 178, 159, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1199, 'DUROL ', 31, 192, 52, 71, 159, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1200, 'DUROL-CR ', 31, 192, 43, 59, 159, '', '270', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1201, 'DUROL-CR ', 31, 192, 43, 98, 159, '', '450', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1202, 'EXEPRESS ', 31, 179, 88, 120, 108, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1203, 'EXEPRESS ', 31, 179, 88, 178, 116, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1204, 'EXEPRESS ', 31, 179, 88, 71, 113, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1205, 'EXEPRESS ', 31, 179, 88, 111, 112, '', '161', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1206, 'KARVEDIL ', 31, 135, 88, 178, 156, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1207, 'KARVEDIL ', 31, 135, 88, 178, 174, '', '151', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1208, 'KARVEDIL ', 31, 135, 88, 71, 156, '', '121', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1209, 'KARVEDIL ', 31, 135, 88, 111, 156, '', '241', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1210, 'REVODIL ', 31, 160, 88, 178, 168, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1211, 'ROVEDILOL ', 31, 159, 88, 178, 156, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1212, 'ROVEDILOL ', 31, 159, 88, 71, 156, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1213, 'UCARDOL ', 31, 194, 88, 178, 159, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1214, 'UCARDOL ', 31, 194, 88, 71, 156, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1215, 'UCARDOL ', 31, 194, 88, 111, 159, '', '270', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1216, 'VEDILOL ', 31, 155, 88, 178, 162, '', '120', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1217, 'VEDILOL ', 31, 155, 88, 71, 162, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1218, 'VEDILOL ', 31, 155, 88, 111, 141, '', '160', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1219, 'CARDIL ', 32, 160, 88, 132, 99, '', '202', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1220, 'CARDIL ', 32, 160, 88, 181, 99, '', '385', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1221, 'CARDIZEM ', 32, 152, 88, 132, 99, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1222, 'CARDIZEM ', 32, 152, 88, 181, 99, '', '380', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1223, 'CARDIZEM-SR ', 32, 152, 43, 195, 174, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1224, 'CARDIZEM-SR ', 32, 152, 43, 72, 174, '', '400', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1225, 'DILCONTIN XL 90 ', 32, 172, 45, 195, 159, '', '480', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1226, 'DILTI-SR ', 32, 154, 43, 195, 159, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1227, 'DILTIZEM ', 32, 192, 84, 195, 168, '', '225', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1228, 'EVASCON ', 32, 185, 52, 132, 108, '', '202', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1229, 'EVASCON ', 32, 185, 52, 181, 108, '', '385', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1230, 'LITIZEM ', 32, 162, 88, 132, 174, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1231, 'LITIZEM ', 32, 162, 88, 181, 156, '', '114', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1232, 'TIZEM ', 32, 148, 88, 132, 99, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1233, 'TIZEM ', 32, 148, 88, 181, 174, '', '190', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1234, 'ANAPRIL ', 33, 155, 88, 158, 99, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1235, 'ANAPRIL ', 33, 155, 88, 59, 99, '', '270', 0, 1, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1236, 'ENARIL ', 33, 145, 88, 158, 99, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1237, 'MINIPRIL ', 33, 185, 88, 158, 108, '', '152', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1238, 'MINIPRIL ', 33, 185, 88, 59, 108, '', '202', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1239, 'VASOPRIL ', 33, 192, 88, 158, 108, '', '125', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1240, 'VASOPRIL ', 33, 192, 88, 59, 181, '', '114', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1241, 'FRUSIN ', 34, 179, 88, 138, 108, '', '53', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1242, 'FRUSIN ', 34, 179, 70, 145, 191, '', '85', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1243, 'FRUSIN ', 34, 179, 56, 108, 187, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1244, 'FRUSIN ', 34, 179, 56, 107, 92, '', '80', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1245, 'FUSID ', 34, 192, 88, 138, 111, '', '128', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1246, 'FUSID ', 34, 192, 54, 106, 154, '', '80', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1247, 'LASIX ', 34, 187, 88, 138, 108, '', '64', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1248, 'LASIX ', 34, 187, 56, 106, 187, '', '201', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1249, 'URETIC TAB ', 34, 149, 88, 138, 108, '', '52', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1250, 'DILUP ', 35, 135, 88, 105, 156, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1251, 'DILUP ', 35, 135, 88, 142, 156, '', '241', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1252, 'DIRETIC ', 35, 153, 88, 105, 174, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1253, 'DIRETIC-DS ', 35, 152, 88, 142, 179, '', '451', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1254, 'DIRUSID-PLUS ', 35, 148, 88, 105, 156, '', '180', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1255, 'EDELOSS ', 35, 162, 52, 105, 174, '', '400', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1256, 'EDELOSS PLUS', 35, 162, 88, 142, 174, '', '500', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1257, 'EDEMIDE ', 35, 136, 88, 105, 159, '', '241', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1258, 'EDEMIDE ', 35, 136, 88, 142, 159, '', '301', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1259, 'EDENIL ', 35, 155, 88, 105, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1260, 'EDENIL ', 35, 155, 88, 142, 156, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1261, 'FRULAC ', 35, 181, 88, 105, 181, '', '400', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1262, 'FRULAC ', 35, 181, 88, 142, 159, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1263, 'FRUSELAC ', 35, 141, 88, 105, 156, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1264, 'FRUSELAC ', 35, 141, 88, 142, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1265, 'FRUSIN PLUS ', 35, 179, 88, 105, 113, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1266, 'FRUSIN PLUS ', 35, 179, 88, 142, 113, '', '241', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1267, 'FRUSITON ', 35, 158, 88, 105, 159, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1268, 'FRUSITON ', 35, 158, 88, 142, 159, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1269, 'FRUSON 20 ', 35, 160, 88, 105, 156, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1270, 'FURO PLUS ', 35, 143, 88, 105, 159, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1271, 'FUSID PLUS ', 35, 192, 88, 105, 162, '', '320', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1272, 'FUSID PLUS ', 35, 192, 88, 142, 153, '', '400', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1273, 'LACITONE ', 35, 156, 88, 105, 159, '', '181', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1274, 'LASILACTONE ', 35, 187, 88, 105, 181, '', '302', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1275, 'LAXUR ', 35, 159, 88, 105, 156, '', '0', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1276, 'RESITONE ', 35, 145, 88, 105, 156, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1277, 'RESITONE ', 35, 145, 88, 142, 156, '', '241', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1278, 'SPIROCARD PLUS ', 35, 183, 88, 105, 156, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1279, 'URITONE ', 35, 185, 88, 105, 159, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1280, 'URITONE ', 35, 185, 88, 142, 159, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1281, 'UROSPIN ', 35, 146, 88, 105, 156, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1282, 'L-CARDIN ', 36, 152, 52, 116, 181, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1283, 'L-CARDIN ', 36, 152, 52, 147, 159, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1284, 'LACICARD ', 36, 141, 88, 116, 189, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1285, 'LACICARD ', 36, 141, 88, 147, 156, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1286, 'LACIDIP ', 36, 162, 88, 116, 174, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1287, 'LACIDIP ', 36, 162, 88, 147, 156, '', '180', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1288, 'LACITAB ', 36, 136, 88, 116, 181, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1289, 'LACITAB ', 36, 136, 88, 147, 159, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1290, 'CANIDER ', 37, 135, 88, 59, 156, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1291, 'LARCADIP ', 37, 162, 88, 59, 156, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1292, 'LARCAN ', 37, 179, 88, 59, 113, '', '150', 0, 0, 1, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1293, 'ACUSAN 50 ', 38, 147, 88, 150, 159, '', '241', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1294, 'ANGILOCK ', 38, 192, 88, 111, 181, '', '226', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1295, 'ANGILOCK ', 38, 192, 88, 150, 181, '', '402', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1296, 'ANGILOCK ', 38, 192, 88, 54, 159, '', '361', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1297, 'ANIN ', 38, 148, 88, 150, 159, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1298, 'ANREB ', 38, 156, 88, 111, 181, '', '226', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1299, 'ANREB ', 38, 156, 88, 150, 159, '', '241', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1300, 'ARATEN ', 38, 194, 88, 150, 159, '', '240', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1301, 'ARBIUM ', 38, 142, 88, 111, 181, '', '175', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1302, 'ARBIUM ', 38, 142, 88, 150, 181, '', '400', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1303, 'ARBIUM ', 38, 142, 88, 54, 159, '', '360', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1304, 'CARDISAN ', 38, 143, 88, 150, 159, '', '241', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1305, 'CARDON ', 38, 155, 53, 111, 156, '', '135', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1306, 'CARDON ', 38, 155, 53, 150, 162, '', '320', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1307, 'ETAN ', 38, 154, 88, 150, 159, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1308, 'GITOX ', 38, 138, 88, 111, 156, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1309, 'GITOX ', 38, 138, 88, 150, 156, '', '0', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1310, 'LARB ', 38, 179, 88, 111, 113, '', '135', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1311, 'LARB ', 38, 179, 88, 150, 113, '', '240', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1312, 'LARB ', 38, 179, 88, 54, 113, '', '360', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1313, 'LOK 50 ', 38, 158, 88, 150, 159, '', '240', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1314, 'LOPASS ', 38, 175, 88, 111, 148, '', '168', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1315, 'LOPASS ', 38, 175, 88, 150, 148, '', '280', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1316, 'LOPO ', 38, 146, 52, 111, 156, '', '135', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1317, 'LOPO ', 38, 146, 52, 150, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1318, 'LOSA ', 38, 137, 88, 111, 156, '', '105', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1319, 'LOSA ', 38, 137, 88, 150, 156, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1320, 'LOSACOR ', 38, 159, 88, 150, 156, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1321, 'LOSAN ', 38, 181, 52, 111, 159, '', '135', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1322, 'LOSAN ', 38, 181, 52, 150, 159, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1323, 'LOSANIL ', 38, 170, 88, 150, 159, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1324, 'LOSAP-50 ', 38, 150, 52, 150, 156, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1325, 'LOSAPOT ', 38, 190, 88, 150, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1326, 'LOSARDIL ', 38, 152, 88, 111, 179, '', '255', 0, 1, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1327, 'LOSARDIL ', 38, 152, 88, 150, 148, '', '225', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1328, 'LOSARDIL ', 38, 152, 88, 54, 141, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1329, 'LOSARPEX ', 38, 138, 88, 111, 159, '', '105', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1330, 'LOSARPEX ', 38, 138, 88, 150, 159, '', '180', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1331, 'LOSART ', 38, 136, 88, 111, 159, '', '135', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1332, 'LOSART ', 38, 136, 88, 150, 181, '', '400', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1333, 'LOSART ', 38, 136, 88, 54, 159, '', '361', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1334, 'LOSARVA ', 38, 174, 88, 111, 174, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1335, 'LOSARVA ', 38, 174, 88, 35, 174, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1336, 'LOSATAN ', 38, 183, 88, 111, 156, '', '135', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1337, 'LOSATAN ', 38, 183, 88, 150, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1338, 'LOSIUM ', 38, 161, 88, 111, 156, '', '105', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1339, 'LOSIUM ', 38, 161, 88, 150, 156, '', '180', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1340, 'LOSPRE ', 38, 165, 88, 150, 159, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1341, 'OSARTAN ', 38, 141, 88, 111, 189, '', '270', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1342, 'OSARTAN ', 38, 141, 88, 150, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1343, 'OSARTIL', 38, 124, 52, 111, 174, '', '225', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1344, 'OSARTIL', 38, 162, 52, 150, 174, '', '400', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1345, 'OSARTIL', 38, 162, 52, 54, 156, '', '360', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1346, 'OSTAN ', 38, 185, 52, 111, 159, '', '135', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1347, 'OSTAN ', 38, 185, 52, 150, 181, '', '400', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1348, 'PARTEN ', 38, 164, 88, 150, 159, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1349, 'PERTILOS ', 38, 173, 88, 150, 156, '', '241', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1350, 'PRESLO-L', 38, 126, 88, 111, 174, '', '226', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1351, 'PRESLO-L', 38, 166, 88, 150, 174, '', '401', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1352, 'PROSAN ', 38, 145, 52, 111, 189, '', '270', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1353, 'PROSAN ', 38, 145, 52, 150, 189, '', '400', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1354, 'ROSATAN ', 38, 135, 88, 111, 156, '', '105', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1355, 'ROSATAN ', 38, 135, 88, 150, 156, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1356, 'VASOTAN ', 38, 173, 88, 111, 156, '', '105', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1357, 'VASOTAN ', 38, 173, 88, 150, 156, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1358, 'ACUSAN PLUS ', 39, 147, 88, 151, 159, '', '241', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1359, 'ANGILOCK PLUS ', 39, 192, 88, 55, 159, '', '331', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1360, 'ANGILOCK PLUS ', 39, 192, 88, 56, 159, '', '361', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1361, 'ANGILOCK PLUS ', 39, 192, 88, 151, 181, '', '400', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1362, 'ANIN PLUS ', 39, 148, 88, 151, 150, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1363, 'ANREB PLUS ', 39, 156, 88, 55, 150, '', '241', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1364, 'ANREB PLUS ', 39, 156, 88, 151, 159, '', '241', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1365, 'ARATEN PLUS ', 39, 194, 88, 151, 159, '', '240', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1366, 'ARBIUM PLUS ', 39, 142, 40, 55, 159, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1367, 'ARBIUM PLUS ', 39, 142, 88, 56, 159, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1368, 'ARBIUM PLUS ', 39, 142, 88, 151, 181, '', '400', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1369, 'CARDISAN PLUS ', 39, 143, 88, 151, 159, '', '241', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1370, 'CARDOPLUS ', 39, 155, 53, 151, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1371, 'LARB PLUS ', 39, 179, 88, 56, 113, '', '360', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1372, 'LARB PLUS ', 39, 179, 88, 151, 113, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1373, 'LOK-50 PLUS ', 39, 158, 88, 151, 159, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1374, 'LOPASS PLUS ', 39, 175, 88, 151, 148, '', '280', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1375, 'LOPO PLUS ', 39, 146, 88, 113, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1376, 'LOSA 50 PLUS ', 39, 137, 88, 151, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1377, 'LOSACOR PLUS ', 39, 159, 88, 151, 156, '', '0', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1378, 'LOSAN-D ', 39, 181, 88, 151, 159, '', '240', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1379, 'LOSAPOT PLUS ', 39, 190, 88, 151, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1380, 'LOSAPOT PLUS ', 39, 190, 88, 55, 156, '', '360', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1381, 'LOSARDIL-100/12.5 ', 39, 152, 88, 55, 141, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1382, 'LOSARDIL-100/25 ', 39, 152, 88, 56, 141, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1383, 'LOSARDIL-25/12.5 ', 39, 152, 88, 113, 174, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1384, 'LOSARDIL-50/12.5 ', 39, 152, 88, 151, 91, '', '451', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1385, 'LOSART PLUS ', 39, 136, 88, 55, 159, '', '361', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1386, 'LOSART PLUS ', 39, 136, 88, 56, 159, '', '361', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1387, 'LOSART PLUS ', 39, 136, 88, 151, 159, '', '241', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1388, 'LOSATAN HZ ', 39, 183, 88, 151, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1389, 'LOSIUM PLUS ', 39, 160, 88, 151, 156, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1390, 'OSARTAN-HZ ', 39, 141, 88, 151, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1391, 'OSARTIL PLUS ', 39, 162, 52, 56, 156, '', '360', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1392, 'OSARTIL PLUS ', 39, 162, 88, 55, 156, '', '360', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1393, 'OSARTIL PLUS ', 39, 162, 88, 151, 174, '', '400', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1394, 'OSTAN PLUS ', 39, 185, 88, 151, 159, '', '240', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1395, 'OSTAN PLUS ', 39, 185, 88, 56, 159, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1396, 'PARTEN PLUS ', 39, 164, 88, 151, 159, '', '181', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1397, 'PERTILOS PLUS ', 39, 173, 88, 151, 156, '', '241', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1398, 'PRESLO-H ', 39, 166, 88, 151, 156, '', '241', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1399, 'PROSAN-HZ ', 39, 145, 88, 151, 189, '', '480', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1400, 'ROSATAN-H ', 39, 135, 88, 113, 174, '', '201', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1401, 'ROSATAN-H ', 39, 135, 88, 151, 174, '', '301', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1402, 'DOPAMET ', 40, 179, 88, 109, 116, '', '154', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1403, 'SARDOPA', 40, 124, 88, 32, 174, '', '154', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1404, 'ANGILAT ', 41, 135, 88, 111, 99, '', '150', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1405, 'ANGILAT ', 41, 135, 88, 150, 99, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1406, 'ANGILAT ', 41, 135, 56, 176, 180, '', '600', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1407, 'BETACARD ', 41, 141, 88, 150, 99, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1408, 'BETALOC ', 41, 152, 52, 111, 204, '', '152', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1409, 'BETALOC ', 41, 152, 88, 150, 204, '', '201', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1410, 'BETALOC-XR ', 41, 152, 88, 150, 99, '', '400', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1411, 'BETAONE ', 41, 136, 88, 111, 108, '', '151', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1412, 'BETAONE ', 41, 136, 88, 150, 108, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1413, 'METALOC ', 41, 185, 88, 150, 108, '', '131', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1414, 'METALOC ', 41, 185, 88, 54, 181, '', '126', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1415, 'METOCARD ', 41, 183, 56, 175, 180, '', '602', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1416, 'METOPROL XL ', 41, 145, 51, 150, 174, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1417, 'METOPROL XL ', 41, 145, 51, 54, 174, '', '250', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1418, 'PRELOC ', 41, 179, 88, 111, 108, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1419, 'PRELOC ', 41, 179, 88, 150, 116, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1420, 'PRESONIL ', 41, 162, 88, 150, 99, '', '130', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1421, 'SELOMET ', 41, 195, 88, 111, 159, '', '45', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1422, 'SELOMET ', 41, 195, 88, 150, 159, '', '60', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1423, 'SELOMET ', 41, 195, 82, 150, 159, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1424, 'TOPRESS ', 41, 155, 88, 150, 99, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1425, 'BIPINOR ', 42, 135, 88, 87, 156, '', '151', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1426, 'BIPINOR ', 42, 135, 88, 158, 156, '', '241', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1427, 'NEBICARD ', 42, 194, 88, 87, 148, '', '196', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1428, 'NEBICARD ', 42, 194, 88, 158, 148, '', '336', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1429, 'NEBILOL ', 42, 179, 88, 87, 113, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1430, 'NEBILOL ', 42, 179, 88, 87, 116, '', '241', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1431, 'NEBITA ', 42, 192, 88, 87, 159, '', '211', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1432, 'NEBITA ', 42, 192, 88, 158, 159, '', '301', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1433, 'NIDIPINE ', 43, 192, 84, 98, 108, '', '64', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1434, 'NIFECAP ', 43, 152, 77, 59, 156, '', '63', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1435, 'NIFIN ', 43, 136, 88, 59, 99, '', '34', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1436, 'NIDIPRO     ', 44, 192, 43, 105, 181, '', '135', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1437, 'CADNYL ', 45, 192, 88, 147, 159, '', '362', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1438, 'COVERSYL 4MG ', 45, 188, 88, 147, 156, '', '495', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1439, 'COVERSYL 8 MG ', 45, 188, 88, 193, 156, '', '750', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1440, 'PENDORIL ', 45, 185, 88, 116, 150, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1441, 'PENDORIL ', 45, 185, 88, 147, 134, '', '140', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1442, 'PENDORIL ', 45, 185, 88, 147, 150, '', '280', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1443, 'PENDORIL ', 45, 185, 88, 193, 134, '', '241', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1444, 'PERICARD ', 45, 142, 88, 116, 134, '', '70', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1445, 'PERICARD ', 45, 142, 88, 147, 134, '', '120', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1446, 'VERSIL ', 45, 136, 88, 147, 159, '', '362', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1447, 'COVERSYL PLUS ', 46, 188, 88, 148, 156, '', '630', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1448, 'INDAPA-PLUS ', 46, 152, 88, 117, 141, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1449, 'INDAPA-PLUS ', 46, 152, 88, 148, 102, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1450, 'INDAPRIL ', 46, 162, 88, 117, 156, '', '210', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1451, 'INDAPRIL ', 46, 162, 88, 148, 141, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1452, 'INDURIC PLUS ', 46, 145, 88, 117, 132, '', '7', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1453, 'INOPIL PLUS ', 46, 148, 88, 118, 102, '', '70', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1454, 'INOPIL PLUS ', 46, 148, 88, 117, 102, '', '50', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1455, 'INOPIL PLUS ', 46, 148, 88, 148, 141, '', '160', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1456, 'PENDORILPLUS ', 46, 185, 88, 148, 150, '', '300', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1457, 'PENDORILPLUS ', 46, 185, 88, 117, 150, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1458, 'PERICARD PLUS ', 46, 142, 88, 148, 134, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1459, 'PERICARD PLUS ', 46, 142, 88, 117, 159, '', '210', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1460, 'PERINDAL PLUS ', 46, 179, 88, 117, 113, '', '211', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1461, 'PERINDAL PLUS ', 46, 179, 88, 148, 112, '', '241', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1462, 'REPRES PLUS ', 46, 192, 88, 148, 150, '', '241', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1463, 'REPRES PLUS ', 46, 192, 88, 117, 159, '', '211', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1464, 'ALPHAPRESS ', 47, 185, 88, 83, 108, '', '400', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1465, 'ALPHAPRESS ', 47, 185, 88, 116, 108, '', '600', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1466, 'PRAZOPRESS ', 47, 194, 88, 83, 113, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1467, 'PRAZOPRESS ', 47, 194, 88, 116, 113, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1468, 'PRAZOPRESS ', 47, 194, 51, 87, 150, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1469, 'PRAZOPRESS ', 47, 194, 51, 158, 150, '', '300', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1470, 'INDEVER ', 48, 135, 88, 59, 99, '', '51', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1471, 'INDEVER ', 48, 135, 88, 138, 99, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1472, 'INDEVER SR ', 48, 135, 83, 138, 99, '', '92', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1473, 'INDEVER SR ', 48, 135, 83, 190, 99, '', '155', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1474, 'PROPRANOL ', 48, 179, 88, 59, 108, '', '102', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1475, 'PROPRANOL ', 48, 179, 88, 138, 108, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1476, 'ACECARD ', 49, 159, 88, 51, 156, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1477, 'ACECARD ', 49, 159, 88, 87, 156, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1478, 'ACECARD ', 49, 159, 88, 158, 156, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1479, 'GEPRIL ', 49, 158, 88, 158, 159, '', '240', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1480, 'HYPACE ', 49, 193, 43, 158, 159, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1481, 'MYPRIL ', 49, 155, 52, 87, 162, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1482, 'MYPRIL ', 49, 155, 52, 158, 162, '', '320', 0, 1, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1483, 'NUVACE ', 49, 181, 88, 87, 159, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1484, 'NUVACE ', 49, 181, 88, 158, 159, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1485, 'PIRAMIL ', 49, 175, 88, 87, 159, '', '210', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1486, 'PIRAMIL ', 49, 175, 88, 158, 159, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1487, 'PRIL ', 49, 138, 88, 87, 174, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1488, 'PRIL ', 49, 138, 88, 158, 174, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1489, 'PRIMACE ', 49, 145, 88, 87, 156, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1490, 'PRIMACE ', 49, 145, 88, 158, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1491, 'PROTACE ', 49, 194, 88, 87, 159, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1492, 'PROTACE ', 49, 194, 88, 158, 159, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1493, 'R-PIL ', 49, 146, 88, 51, 156, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1494, 'R-PIL ', 49, 146, 88, 87, 156, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1495, 'R-PIL ', 49, 179, 88, 158, 156, '', '241', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1496, 'RAMACE ', 49, 179, 88, 51, 116, '', '126', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1497, 'RAMACE ', 49, 179, 88, 87, 113, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1498, 'RAMACE ', 49, 179, 88, 158, 113, '', '241', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1499, 'RAMICARD ', 49, 152, 88, 51, 174, '', '126', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1500, 'RAMICARD ', 49, 152, 52, 87, 174, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1501, 'RAMICARD ', 49, 152, 52, 158, 174, '', '350', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1502, 'RAMIL ', 49, 183, 88, 51, 174, '', '125', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1503, 'RAMIL ', 49, 183, 88, 87, 174, '', '251', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1504, 'RAMIL ', 49, 183, 88, 158, 174, '', '402', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1505, 'RAMILOK ', 49, 141, 88, 87, 174, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1506, 'RAMILOK ', 49, 141, 88, 158, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1507, 'RAMIPRO ', 49, 156, 52, 87, 181, '', '252', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1508, 'RAMIPRO ', 49, 156, 52, 158, 159, '', '242', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1509, 'RAMORIL ', 49, 162, 52, 51, 174, '', '125', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1510, 'RAMORIL ', 49, 162, 52, 87, 174, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1511, 'RAMORIL ', 49, 162, 52, 158, 174, '', '400', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1512, 'RAMORIL ', 49, 162, 52, 59, 156, '', '360', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1513, 'RIPRIL ', 49, 192, 88, 51, 159, '', '76', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1514, 'RIPRIL ', 49, 192, 88, 87, 159, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1515, 'RIPRIL ', 49, 192, 88, 158, 159, '', '242', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1516, 'TRITACE ', 49, 187, 88, 87, 151, '', '267', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1517, 'TRITACE ', 49, 187, 88, 158, 151, '', '393', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1518, 'UNIPRIL ', 49, 136, 88, 51, 159, '', '75', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1519, 'UNIPRIL ', 49, 136, 88, 87, 159, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1520, 'UNIPRIL ', 49, 136, 88, 158, 159, '', '242', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1521, 'MYPRIL PLUS ', 50, 155, 52, 171, 141, '', '160', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1522, 'MYPRIL PLUS ', 50, 155, 52, 90, 162, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1523, 'PROTACE H ', 50, 194, 88, 91, 159, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1524, 'RAMICARD PLUS ', 50, 152, 52, 171, 159, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1525, 'RAMICARD PLUS ', 50, 152, 52, 91, 181, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1526, 'RAMORIL PLUS', 50, 162, 88, 90, 156, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1527, 'RAMORIL PLUS', 50, 162, 88, 168, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1528, 'RIPRIL PLUS ', 50, 192, 88, 90, 159, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1529, 'RIPRIL PLUS ', 50, 192, 88, 171, 159, '', '241', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1530, 'HYTRIN ', 51, 194, 88, 83, 156, '', '376', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1531, 'HYTRIN ', 51, 194, 88, 116, 156, '', '691', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1532, 'HYTRIN ', 51, 194, 88, 158, 156, '', '1600', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1533, 'PROSTOL ', 51, 152, 76, 83, 174, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1534, 'PROSTOL ', 51, 152, 76, 116, 174, '', '250', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1535, 'TERAZON ', 51, 162, 88, 116, 174, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1536, 'TERAZON ', 51, 162, 88, 158, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1537, 'DILAST 20 ', 52, 162, 88, 30, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1538, 'DYTOR ', 52, 194, 88, 87, 156, '', '168', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1539, 'DYTOR ', 52, 194, 88, 158, 156, '', '308', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1540, 'LURETIC ', 52, 152, 88, 87, 174, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1541, 'LURETIC ', 52, 152, 88, 158, 174, '', '175', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1542, 'EXFORGE    ', 53, 175, 88, 174, 151, '', '1414', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1543, 'EXFORGE    ', 53, 175, 88, 169, 151, '', '1981', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1544, 'EXFORGE    ', 53, 175, 88, 63, 151, '', '2', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1545, 'AROVAN ', 54, 141, 43, 190, 90, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1546, 'CARDIVAL ', 54, 152, 88, 190, 156, '', '210', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1547, 'DIOVAN ', 54, 175, 88, 190, 151, '', '1512', 0, 1, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1548, 'DIOVAN ', 54, 175, 88, 78, 151, '', '2072', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1549, 'DIOVAN ', 54, 175, 88, 133, 172, '', '1960', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1550, 'DISYS ', 54, 159, 88, 190, 156, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1551, 'DISYS ', 54, 159, 88, 78, 156, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1552, 'VALCAP ', 54, 145, 43, 190, 141, '', '196', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1553, 'VALCAP ', 54, 145, 43, 78, 141, '', '320', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1554, 'VALSARTIL ', 54, 162, 88, 138, 156, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1555, 'VALSARTIL ', 54, 162, 88, 190, 156, '', '270', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1556, 'VALSARTIL ', 54, 162, 88, 78, 156, '', '480', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1557, 'VALSET ', 54, 181, 39, 190, 159, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1558, 'VALTIN ', 54, 136, 88, 190, 159, '', '271', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1559, 'VALTIN ', 54, 136, 88, 78, 159, '', '481', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1560, 'VALOSAN ', 54, 147, 88, 190, 159, '', '210', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1561, 'EXFORGE    ', 53, 175, 88, 174, 151, '', '1414', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1);
INSERT INTO `mims_brandinformation` (`ID`, `Name`, `GenericID`, `ManufacturerID`, `DosageFormID`, `StrengthID`, `PackSizeID`, `ImagePath`, `PriceInBDT`, `IsHighlighted`, `IsNewProduct`, `IsNewBrand`, `IsNewPresentation`, `CreateDate`, `LastUpdate`, `CreatedBy`, `IsActive`) VALUES
(1562, 'EXFORGE    ', 53, 175, 88, 169, 151, '', '1981', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1563, 'EXFORGE    ', 53, 175, 88, 63, 151, '', '2', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1564, 'CARDIVAL PLUS ', 55, 152, 52, 79, 102, '', '160', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1565, 'CARDIVAL PLUS ', 55, 152, 52, 192, 150, '', '160', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1566, 'CO-DIOVAN ', 55, 175, 52, 79, 151, '', '1854', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1567, 'CO-DIOVAN ', 55, 175, 52, 80, 151, '', '1854', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1568, 'CO-DIOVAN ', 55, 175, 52, 192, 86, '', '1348', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1569, 'DISYS PLUS ', 55, 159, 88, 192, 156, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1570, 'VALSARTIL 160 PLUS ', 55, 162, 88, 80, 156, '', '480', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1571, 'VALSARTIL 160/12.5 ', 55, 162, 88, 79, 156, '', '480', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1572, 'VALSARTIL 80 PLUS ', 55, 162, 88, 192, 156, '', '270', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1573, 'VALZIDE ', 55, 185, 88, 79, 170, '', '320', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1574, 'VALZIDE 80 ', 55, 185, 88, 192, 170, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1575, 'VERACAL ', 56, 162, 88, 138, 156, '', '113', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1576, 'VERACAL-SR ', 56, 162, 88, 190, 156, '', '210', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1577, 'ANGICARD ', 57, 152, 88, 48, 99, '', '300', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1578, 'ANGIST SR ', 57, 136, 84, 94, 159, '', '121', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1579, 'ANRIL 0.5 ', 57, 192, 78, 48, 159, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1580, 'ANRIL INJ ', 57, 192, 56, 177, 167, '', '301', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1581, 'ANRIL SPRAY ', 57, 192, 72, 33, 138, '', '216', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1582, 'ANRIL-SR ', 57, 192, 88, 94, 174, '', '201', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1583, 'GTN 2.6 SR ', 57, 155, 88, 94, 174, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1584, 'NIDOCARD INJ ', 57, 152, 41, 177, 132, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1585, 'NIDOCARD RETARD ', 57, 152, 88, 94, 179, '', '227', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1586, 'NIDOCARD RETARD ', 57, 152, 88, 179, 174, '', '350', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1587, 'NIDOCARD SPRAY ', 57, 152, 72, 47, 132, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1588, 'NITRIN-SR ', 57, 159, 88, 94, 156, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1589, 'NITRIN-SR ', 57, 159, 43, 94, 189, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1590, 'NITRO-SR ', 57, 194, 88, 94, 156, '', '120', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1591, 'NITROCAP ', 57, 181, 81, 94, 159, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1592, 'NITROCARD ', 57, 141, 88, 94, 189, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1593, 'NITROCONTIN ', 57, 172, 45, 94, 147, '', '135', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1594, 'NITROCONTIN ', 57, 172, 45, 179, 147, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1595, 'NITROSOL ', 57, 145, 72, 137, 136, '', '225', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1596, 'NITROVAS SR ', 57, 183, 88, 94, 174, '', '201', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1597, 'PACTORIN ', 57, 135, 75, 94, 174, '', '201', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1598, 'TROCER 2.6 SR CAPSULE ', 57, 162, 83, 94, 156, '', '120', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1599, 'TROCER 2.6 SR TABLET ', 57, 162, 84, 94, 156, '', '120', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1600, 'ESORDIN ', 58, 192, 88, 59, 99, '', '35', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1601, 'A-CARD ', 59, 136, 88, 98, 108, '4448a324daf1b68063f3d1c69e3aa3af.png', '142', 1, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1602, 'ANGIFIX ', 59, 162, 88, 98, 174, '', '71', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1603, 'ESMO ', 59, 192, 88, 98, 108, '', '142', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1604, 'ESMO-LA ', 59, 192, 43, 150, 159, '', '211', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1605, 'IMOCARD ', 59, 194, 88, 98, 99, '', '142', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1606, 'ISM 20 ', 59, 141, 88, 98, 99, '', '143', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1607, 'MONATE ', 59, 145, 88, 98, 99, '', '142', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1608, 'MONITEN ', 59, 135, 88, 98, 99, '', '142', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1609, 'MONITEN ', 59, 135, 88, 138, 99, '', '233', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1610, 'MONOCARD ', 59, 152, 88, 98, 99, '', '142', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1611, 'MONOCARD-SR ', 59, 152, 43, 150, 174, '', '354', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1612, 'TAB MONIT ', 59, 179, 88, 98, 108, '', '140', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1613, 'ANGIMET ', 60, 181, 52, 98, 181, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1614, 'ANGIMET-MR ', 60, 181, 88, 134, 159, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1615, 'ANGINOX ', 60, 156, 88, 98, 159, '', '90', 0, 0, 1, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1616, 'ANGIRID-MR ', 60, 136, 88, 134, 159, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1617, 'ANGIVAS 20 MG ', 60, 183, 88, 98, 174, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1618, 'ANGIVAS MR ', 60, 183, 88, 134, 156, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1619, 'ANGIVENT-MR ', 60, 192, 88, 134, 159, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1620, 'ANTORIS-MR ', 60, 179, 88, 134, 129, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1621, 'CARDIMET ', 60, 155, 64, 134, 156, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1622, 'FEELNOR ', 60, 162, 52, 98, 156, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1623, 'FEELNOR-MR ', 60, 162, 88, 134, 156, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1624, 'METACARD-MR ', 60, 141, 88, 134, 189, '', '360', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1625, 'METAVAS MR ', 60, 174, 88, 134, 156, '', '151', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1626, 'METAZINE MR ', 60, 145, 88, 134, 156, '', '180', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1627, 'TRANGIT MR ', 60, 175, 88, 134, 163, '', '347', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1628, 'TRIMET ', 60, 152, 88, 98, 174, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1629, 'TRIMET-MR ', 60, 152, 88, 134, 148, '', '141', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1630, 'VASTAREL MR ', 60, 188, 65, 134, 156, '', '265', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1631, 'VESTAR-MR ', 60, 159, 88, 134, 156, '', '0', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1632, 'ADECARD ', 61, 183, 57, 84, 180, '', '750', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1633, 'OSIDEN ', 61, 192, 57, 185, 183, '', '200', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1634, 'CARDIRON ', 62, 152, 88, 97, 156, '', '210', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1635, 'PACET ', 62, 145, 88, 54, 156, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1636, 'PACET ', 62, 145, 88, 97, 156, '', '301', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1637, 'NORBIT', 63, 124, 43, 54, 156, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1638, 'JASOCAINE ', 64, 164, 41, 135, 149, '', '37', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1639, 'JASOCAINE ', 64, 164, 91, 50, 176, '', '23', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1640, 'JASOCAINE ', 64, 164, 91, 86, 176, '', '29', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1641, 'JASOCAINE JELLY ', 64, 164, 60, 86, 157, '', '90', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1642, 'LIDO ', 64, 192, 80, 68, 158, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1643, 'XYLOKEN ', 64, 179, 80, 70, 89, '', '450', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1644, 'XYLOKEN ', 64, 179, 80, 69, 89, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1645, 'SOTALEX-80 ', 65, 194, 88, 190, 159, '', '300', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1646, 'CILOSTA ', 66, 192, 88, 54, 159, '', '363', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1647, 'INCLAUD ', 66, 135, 88, 54, 141, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1648, 'PANCIL ', 66, 152, 88, 54, 148, '', '330', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1649, 'VASOCIL ', 66, 160, 88, 150, 156, '', '210', 0, 0, 1, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1650, 'VASOCIL ', 66, 160, 88, 54, 141, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1651, 'ZOCIL ', 66, 145, 88, 150, 156, '', '210', 0, 1, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1652, 'ZOCIL ', 66, 145, 88, 54, 141, '', '240', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1653, 'CINARON ', 67, 192, 88, 77, 143, '', '200', 0, 0, 0, 1, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1654, 'CINARYL ', 67, 179, 88, 77, 108, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1655, 'CINARZIN ', 67, 160, 88, 77, 99, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1656, 'CINAZIN ', 67, 136, 88, 77, 99, '', '70', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1657, 'SUZARON ', 67, 186, 88, 77, 108, '', '100', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1658, 'ZINCIN ', 67, 141, 88, 77, 146, '', '250', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1659, 'ARTIGO     ', 68, 135, 88, 104, 174, '', '101', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1660, 'CINAZIN PLUS     ', 68, 136, 88, 104, 181, '', '76', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1661, 'NIMOCAL ', 69, 192, 88, 132, 159, '', '151', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1),
(1662, 'NIMODI ', 69, 155, 88, 132, 156, '', '150', 0, 0, 0, 0, '2018-09-12 22:04:00', '2018-10-01 14:33:08', 1, 1);

-- --------------------------------------------------------

--
-- Table structure for table `mims_brandin_data`
--

CREATE TABLE `mims_brandin_data` (
  `ID` bigint(20) NOT NULL,
  `Name` varchar(100) DEFAULT NULL,
  `Generic` varchar(100) DEFAULT NULL,
  `Manufacturer` varchar(100) DEFAULT NULL,
  `DosageForm` varchar(100) DEFAULT NULL,
  `Strength` varchar(100) DEFAULT NULL,
  `PackSize` varchar(100) DEFAULT NULL,
  `ImagePath` varchar(300) DEFAULT NULL,
  `PriceInBDT` decimal(10,0) DEFAULT NULL,
  `IsHighlighted` tinyint(1) NOT NULL DEFAULT '0',
  `IsFeatureProduct` tinyint(1) NOT NULL DEFAULT '0',
  `CreateDate` datetime DEFAULT NULL,
  `LastUpdate` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `CreatedBy` varchar(100) NOT NULL,
  `IsActive` tinyint(1) NOT NULL DEFAULT '1'
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `mims_brandin_data`
--

INSERT INTO `mims_brandin_data` (`ID`, `Name`, `Generic`, `Manufacturer`, `DosageForm`, `Strength`, `PackSize`, `ImagePath`, `PriceInBDT`, `IsHighlighted`, `IsFeatureProduct`, `CreateDate`, `LastUpdate`, `CreatedBy`, `IsActive`) VALUES
(1, 'ALENIA ', 'Esomeprazole', 'Delta Pharma ', 'CAP ', '20mg ', '8x8?s ', '', '320', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(2, 'ALENIA ', 'Esomeprazole', 'Delta Pharma ', 'CAP ', '40mg ', '30?s ', '', '210', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(3, 'ALTON ', 'Esomeprazole', 'General Pharma ', 'TAB ', '20mg ', '3x10?s ', '', '150', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(4, 'ALTON ', 'Esomeprazole', 'General Pharma ', 'TAB ', '40mg ', '3x10?s ', '', '241', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(5, 'ALTON ', 'Esomeprazole', 'General Pharma ', 'INJ ', '40mg/vial ', '1?s ', '', '100', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(6, 'EMA ', 'Esomeprazole', 'Globe Pharma ', 'CAP ', '20mg ', '6x10?s ', '', '420', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(7, 'EMA ', 'Esomeprazole', 'Globe Pharma ', 'CAP ', '40mg ', '3x10?s ', '', '270', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(8, 'EMA ', 'Esomeprazole', 'Globe Pharma ', 'TAB ', '20mg ', '3x10?s ', '', '143', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(9, 'EMA ', 'Esomeprazole', 'Globe Pharma ', 'TAB ', '40mg ', '3x10?s ', '', '240', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(10, 'EMA ', 'Esomeprazole', 'Globe Pharma ', 'INJ ', '40mg/vial', '1?s ', '', '80', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(11, 'EMEP ', 'Esomeprazole', 'Aristo Pharma ', 'CAP ', '20mg ', '60?s ', '', '420', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(12, 'EMEP ', 'Esomeprazole', 'Aristo Pharma ', 'CAP ', '40mg ', '40?s ', '', '360', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(13, 'EMEP ', 'Esomeprazole', 'Aristo Pharma ', 'INJ ', '40mg ', '1?s ', '', '90', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(14, 'EMEP ', 'Esomeprazole', 'Aristo Pharma ', 'TAB ', '20mg ', '60?s ', '', '300', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(15, 'EPRAZOL ', 'Esomeprazole', 'Labaid Pharma ', 'CAP ', '20mg ', '60?s ', '', '421', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(16, 'EPRAZOL ', 'Esomeprazole', 'Labaid Pharma ', 'CAP ', '40mg ', '30?s ', '', '301', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(17, 'ESCAP 20MG ', 'Esomeprazole', 'Sanofi Bangladesh ', 'CAP ', '20mg ', '5x10?s ', '', '400', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(18, 'ESCAP 20MG ', 'Esomeprazole', 'Sanofi Bangladesh ', 'CAP ', '40mg ', '5x6?s ', '', '400', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(19, 'ESMAX ', 'Esomeprazole', 'Concord ', 'TAB ', '20mg ', '6x10?s ', '', '301', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(20, 'ESMAX ', 'Esomeprazole', 'Concord ', 'CAP ', '20mg ', '10x10?s ', '', '700', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(21, 'ESMAX ', 'Esomeprazole', 'Concord ', 'CAP ', '40mg ', '5x4s ', '', '160', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(22, 'ESMOSEC ', 'Esomeprazole', 'Techno Drugs ', 'TAB ', '20mg ', '4x10?s ', '', '160', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(23, 'ESO ', 'Esomeprazole', 'Asiatic Lab', 'TAB ', '20mg ', '10x10?s ', '', '500', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(24, 'ESO ', 'Esomeprazole', 'Asiatic Lab', 'TAB ', '40mg ', '3x10?s ', '', '240', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(25, 'ESOCARE ', 'Esomeprazole', 'Novelta', 'CAP ', '20mg ', '50?s ', '', '300', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(26, 'ESOCARE ', 'Esomeprazole', 'Novelta', 'CAP ', '40mg ', '10x3?s ', '', '270', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(27, 'ESOCON ', 'Esomeprazole', 'Bio-Pharma ', 'CAP ', '20mg ', '60?s ', '', '360', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(28, 'ESOCON ', 'Esomeprazole', 'Bio-Pharma ', 'CAP ', '20mg ', '100?s ', '', '600', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(29, 'ESOCON ', 'Esomeprazole', 'Bio-Pharma ', 'CAP ', '40mg ', '40?s ', '', '360', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(30, 'ESOCON ', 'Esomeprazole', 'Bio-Pharma ', 'IV-INJ ', '40mg ', '1?s ', '', '65', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(31, 'ESOGEL ', 'Esomeprazole', 'Organic Health Care ', 'CAP ', '20mg ', '100?s ', '', '602', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(32, 'ESOGEL ', 'Esomeprazole', 'Organic Health Care ', 'CAP', '40mg ', '28?s ', '', '225', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(33, 'ESOPROL  ', 'Esomeprazole', 'Ziska Pharma ', 'CAP ', '20mg ', '8x7?s ', '', '280', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(34, 'ESOPROL  ', 'Esomeprazole', 'Ziska Pharma ', 'CAP ', '40mg ', '4x7?s ', '', '224', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(35, 'ESOLOK ', 'Esomeprazole', 'IBN Sina ', 'TAB ', '20mg ', '30?s ', '', '120', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(36, 'ESOLOK ', 'Esomeprazole', 'IBN Sina ', 'TAB ', '40mg ', '30?s ', '', '210', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(37, 'ESOLOK ', 'Esomeprazole', 'IBN Sina ', 'CAP ', '20mg ', '60?s ', '', '390', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(38, 'ESOLOK ', 'Esomeprazole', 'IBN Sina ', 'CAP ', '40mg ', '48?s ', '', '384', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(39, 'ESOLOK ', 'Esomeprazole', 'IBN Sina ', 'INJ ', '40mg ', '1?s ', '', '100', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(40, 'ESOM E', 'Esomeprazole', 'Edruc ', 'TAB ', '20mg ', '3x10?s ', '', '150', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(41, 'ESOMEP ', 'Esomeprazole', 'ACI Limited ', 'TAB ', '20mg ', '30?s ', '', '121', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(42, 'ESOMEP ', 'Esomeprazole', 'ACI Limited ', 'TAB ', '20mg ', '50?s ', '', '250', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(43, 'ESOMEP ', 'Esomeprazole', 'ACI Limited ', 'TAB ', '40mg ', '30?s ', '', '240', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(44, 'ESOMEP ', 'Esomeprazole', 'ACI Limited ', 'CAP ', '20mg ', '50?s ', '', '350', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(45, 'ESOMEP ', 'Esomeprazole', 'ACI Limited ', 'CAP ', '40mg ', '40?s ', '', '360', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(46, 'ESOMEP ', 'Esomeprazole', 'ACI Limited ', 'IV-INJ ', '40mg ', '1?s ', '', '90', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(47, 'ESOMILOC', 'Esomeprazole', ' Kumudini Pharma ', 'TAB ', '20mg ', '5x10?s ', '', '250', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(48, 'ESOMILOC', 'Esomeprazole', 'Kumudini Pharma', 'TAB ', '40mg ', '3x10?s ', '', '240', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(49, 'ESOLIN ', 'Esomeprazole', 'Rephco Pharma ', 'TAB ', '20mg ', '5x10?s ', '', '250', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(50, 'ESOLIN ', 'Esomeprazole', 'Rephco Pharma ', 'TAB', ' 40mg ', '5x10?s ', '', '300', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(51, 'ESONIX ', 'Esomeprazole', 'Incepta ', 'TAB ', '20mg ', '50?s ', '', '250', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(52, 'ESONIX ', 'Esomeprazole', 'Incepta ', 'TAB ', '40mg ', '30?s ', '', '240', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(53, 'ESONIX ', 'Esomeprazole', 'Incepta ', 'CAP ', '20mg ', '56?s ', '', '392', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(54, 'ESONIX ', 'Esomeprazole', 'Incepta ', 'CAP ', '40mg ', '30?s ', '', '270', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(55, 'ESONIX ', 'Esomeprazole', 'Incepta ', 'INJ ', '40mg ', '1?s ', '', '90', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(56, 'ESONIX 20 DR', 'Esomeprazole', 'lncepta ', 'SUSP (sachet) ', '20mg ', '30?s ', '', '210', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(57, 'ESOPRA ', 'Esomeprazole', 'Alco Pharma ', 'TAB ', '20mg ', '30?s ', '', '180', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(58, 'ESOPRA ', 'Esomeprazole', 'Alco Pharma ', 'TAB ', '40mg ', '30?s ', '', '270', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(59, 'ESOPREX ', 'Esomeprazole', 'Beacon Pharma ', 'CAP ', '20mg ', '7x8?s ', '', '393', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(60, 'ESOPREX ', 'Esomeprazole', 'Beacon Pharma ', 'CAP ', '40mg ', '5x6?s ', '', '270', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(61, 'ESOPREX ', 'Esomeprazole', 'Beacon Pharma ', 'IV-INJ ', '40mg ', '1x1?s ', '', '100', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(62, 'ESORAL ', 'Esomeprazole', 'Eskayef', 'EC-TAB ', '20mg ', '100?s ', '', '500', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(63, 'ESORAL ', 'Esomeprazole', 'Eskayef', 'EC-TAB ', '40mg ', '30?s ', '', '240', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(64, 'ESORAL ', 'Esomeprazole', 'Eskayef', 'CAP ', '20mg ', '60?s ', '', '420', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(65, 'ESORAL ', 'Esomeprazole', 'Eskayef', 'CAP ', '40mg ', '30?s ', '', '270', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(66, 'ESORAL ', 'Esomeprazole', 'Eskayef', 'IV-INJ ', '40mg ', '1?s ', '', '90', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(67, 'ESOTAC ', 'Esomeprazole', 'Navana', 'TAB ', '20mg ', '60?s ', '', '300', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(68, 'ESOTAC ', 'Esomeprazole', 'Navana', 'TAB ', '40mg ', '30?s ', '', '210', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(69, 'ESOTAC ', 'Esomeprazole', 'Navana', 'CAP ', '20mg ', '60?s ', '', '361', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(70, 'ESOTAC ', 'Esomeprazole', 'Navana', 'CAP ', '40mg ', '30?s ', '', '241', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(71, 'ESOTID ', 'Esomeprazole', 'Opsonin Pharma ', 'TAB ', '20mg ', '10x5?s ', '', '251', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(72, 'ESOTID ', 'Esomeprazole', 'Opsonin Pharma ', 'TAB ', '40mg ', '10x5?s ', '', '400', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(73, 'ESOTID ', 'Esomeprazole', 'Opsonin Pharma ', 'CAP ', '20mg ', '10x9?s ', '', '542', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(74, 'ESOTID ', 'Esomeprazole', 'Opsonin Pharma ', 'CAP ', '40mg ', '10x3?s ', '', '270', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(75, 'ESOTID ', 'Esomeprazole', 'Opsonin Pharma ', 'INJ ', '40mg ', '1?s ', '', '90', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(76, 'ESOTOR ', 'Esomeprazole', 'NIPRO JMI Pharma ', 'TAB ', '20mg ', '50?s ', '', '251', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(77, 'ESOTOR ', 'Esomeprazole', 'NIPRO JMI Pharma ', 'TAB ', '40mg ', '30?s ', '', '241', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(78, 'ESOTRON-20 ', 'Esomeprazole', 'Jayson Pharma ', 'TAB ', '20mg ', '3x10?s ', '', '150', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(79, 'ESOTRON-40 ', 'Esomeprazole', 'Jayson Pharma ', 'TAB ', '40mg ', '3x10?s ', '', '240', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(80, 'ESOZOL ', 'Esomeprazole', 'Medicon ', 'CAP ', '20mg ', '5x10?s ', '', '300', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(81, 'ESRU ', 'Esomeprazole', 'Doctor?s ', 'TAB ', '20mg ', '5x10?s ', '', '200', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(82, 'EXIUM ', 'Esomeprazole', 'Radiant Pharma ', 'CAP ', '20mg ', '100?s ', '', '752', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(83, 'EXIUM ', 'Esomeprazole', 'Radiant Pharma ', 'CAP ', '40mg ', '60?s ', '', '572', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(84, 'EXOR ', 'Esomeprazole', 'Orion ', 'CAP ', '20mg ', '10x10?s ', '', '700', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(85, 'EXOR ', 'Esomeprazole', 'Orion ', 'CAP ', '40mg ', '3x10?s ', '', '270', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(86, 'EXOR ', 'Esomeprazole', 'Orion ', 'IV-INJ ', '40mg ', '1?s ', '', '100', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(87, 'MAXIMA ', 'Esomeprazole', 'ACME Lab ', 'CAP ', '20mg ', '10x4?s ', '', '280', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(88, 'MAXIMA ', 'Esomeprazole', 'ACME Lab ', 'CAP ', '40mg ', '5x4?s ', '', '181', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(89, 'MAXIMA ', 'Esomeprazole', 'ACME Lab ', 'TAB ', '20mg ', '10x10?s ', '', '500', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(90, 'MAXIMA ', 'Esomeprazole', 'ACME Lab ', 'TAB ', '40mg ', '4x10?s ', '', '320', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(91, 'MAXIMA ', 'Esomeprazole', 'ACME Lab ', 'IV-INJ ', '40mg ', '1?s', '', '90', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(92, 'MAXPRO ', 'Esomeprazole', 'Renata ', 'EC-TAB ', '20mg', '10x10?s ', '', '700', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(93, 'MAXPRO ', 'Esomeprazole', 'Renata ', 'EC-TAB ', '40mg ', '3x10?s ', '', '240', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(94, 'MAXPRO ', 'Esomeprazole', 'Renata ', 'EC-CAP ', '20mg ', '16x6?s ', '', '672', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(95, 'MAXPRO ', 'Esomeprazole', 'Renata ', 'BC-CAP ', '40mg ', '10x6?s', '', '600', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(96, 'MAXPRO ', 'Esomeprazole', 'Renata ', 'IV-VIAL ', '40mg ', '1?s ', '', '90', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(97, 'NEPTOR ', 'Esomeprazole', 'Novartis ', 'CAP ', '20mg ', '8x10?s ', '', '648', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(98, 'NEPTOR ', 'Esomeprazole', 'Novartis ', 'CAP ', '40mg ', '10x4?s ', '', '480', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(99, 'NEXCAP ', 'Esomeprazole', 'UniMed & UniHealth ', 'DR-CAP ', '20mg ', '4x7?s ', '', '196', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(100, 'NEXCAP ', 'Esomeprazole', 'UniMed & UniHealth ', 'DR-CAP ', '40mg ', '4x7?s ', '', '252', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(101, 'NEXE ', 'Esomeprazole', 'Apex Pharma ', 'TAB ', '20mg ', '30?s ', '', '150', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(102, 'NEXE ', 'Esomeprazole', 'Apex Pharma ', 'TAB ', '20mg ', '50?s ', '', '250', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(103, 'NEXE-40 ', 'Esomeprazole', 'Apex Pharma ', 'TAB ', '40mg ', '30?s ', '', '240', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(104, 'NEXPRO ', 'Esomeprazole', 'UniMed & UniHealth ', 'TAB ', '20mg ', '30?s ', '', '120', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(105, 'NEXPRO ', 'Esomeprazole', 'UniMed & UniHealth ', 'TAB ', '40mg ', '30?s ', '', '240', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(106, 'NEXUM ', 'Esomeprazole', 'Square Pharma ', 'EC-TAB ', '20mg ', '5x10?s ', '', '251', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(107, 'NEXUM ', 'Esomeprazole', 'Square Pharma ', 'EC-TAB ', '40mg ', '3x10?s ', '', '241', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(108, 'NEXUM ', 'Esomeprazole', 'Square Pharma ', 'IV-VIAL ', '40mg ', '10?s ', '', '90', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(109, 'NEXUM CAP ', 'Esomeprazole', 'Square Pharma ', 'CAP ', '20mg ', '60?s ', '', '361', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(110, 'NEXUM CAP ', 'Esomeprazole', 'Square Pharma ', 'CAP ', '40mg ', '5x6?s ', '', '270', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(111, 'OPTON ', 'Esomeprazole', 'Beximco  Pharma ', 'CAP ', '20mg ', '60?s ', '', '420', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(112, 'OPTON ', 'Esomeprazole', 'Beximco  Pharma ', 'CAP ', '40mg ', '30?s ', '', '300', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(113, 'OPTON ', 'Esomeprazole', 'Beximco  Pharma ', 'EC-TAB ', '20mg ', '60?s ', '', '300', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(114, 'OPTON ', 'Esomeprazole', 'Beximco  Pharma ', 'EC-TAB ', '40mg ', '30?s ', '', '240', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(115, 'OPTON ', 'Esomeprazole', 'Beximco  Pharma ', 'IV-INJ ', '40mg ', '1?s ', '', '110', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(116, 'PROGUT ', 'Esomeprazole', 'Popular Pharma ', 'TAB ', '20mg ', '50?s ', '', '250', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(117, 'PROGUT ', 'Esomeprazole', 'Popular Pharma ', 'TAB ', '40mg ', '30?s ', '', '240', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(118, 'PROGUT ', 'Esomeprazole', 'Popular Pharma ', 'CAP ', '20 mg ', '100?s ', '', '700', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(119, 'PROGUT ', 'Esomeprazole', 'Popular Pharma ', 'CAP ', '40 mg ', '50?s ', '', '450', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(120, 'PROGUT ', 'Esomeprazole', 'Popular Pharma ', 'INJ ', '40mg ', '1?s ', '', '90', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(121, 'PRONEX ', 'Esomeprazole', 'Drug International ', 'TAB ', '20mg ', '56?s ', '', '283', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(122, 'PRONEX ', 'Esomeprazole', 'Drug International ', 'TAB ', '40mg ', '100?s ', '', '600', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(123, 'PRONEX ', 'Esomeprazole', 'Drug International ', 'CAP ', '20 mg ', '50?s ', '', '300', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(124, 'PRONEX ', 'Esomeprazole', 'Drug International ', 'CAP ', '40 mg ', '28?s ', '', '224', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(125, 'PRONEX ', 'Esomeprazole', 'Drug International ', 'lV-INJ ', '40mg ', '1?s ', '', '90', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(126, 'S-OME ', 'Esomeprazole', 'Somatec Pharma ', 'TAB ', '20mg ', '50?s ', '', '250', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(127, 'S-OME ', 'Esomeprazole', 'Somatec Pharma ', 'TAB ', '40mg ', '30?s ', '', '240', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(128, 'S-OME ', 'Esomeprazole', 'Somatec Pharma ', 'CAP ', '20mg ', '40?s ', '', '280', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(129, 'SERGEL ', 'Esomeprazole', 'Healthcare Pharma ', 'TAB ', '20mg ', '100?s ', '', '0', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(130, 'SERGEL ', 'Esomeprazole', 'Healthcare Pharma ', 'TAB ', '40mg ', '30?s ', '', '0', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(131, 'SERGEL ', 'Esomeprazole', 'Healthcare Pharma ', 'CAP ', '20mg ', '60?s ', '', '0', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(132, 'SERGEL ', 'Esomeprazole', 'Healthcare Pharma ', 'CAP ', '40mg ', '30?s ', '', '0', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1),
(133, 'SERGEL ', 'Esomeprazole', 'Healthcare Pharma ', 'INJ ', '40mg ', '1?s ', '', '0', 0, 0, '0000-00-00 00:00:00', '0000-00-00 00:00:00', '1', 1);

-- --------------------------------------------------------

--
-- Table structure for table `mims_city`
--

CREATE TABLE `mims_city` (
  `ID` int(11) NOT NULL,
  `Name` varchar(100) NOT NULL,
  `StateID` int(11) NOT NULL,
  `CreatedBY` bigint(20) NOT NULL,
  `LastUpdate` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `IsActive` tinyint(1) NOT NULL DEFAULT '1'
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `mims_city`
--

INSERT INTO `mims_city` (`ID`, `Name`, `StateID`, `CreatedBY`, `LastUpdate`, `IsActive`) VALUES
(1, 'Barisal', 1, 1, '2018-09-13 16:53:35', 1),
(2, 'Bogra', 5, 1, '2018-09-13 16:53:35', 1),
(3, 'Brahmanbaria', 2, 1, '2018-09-13 16:53:35', 1),
(4, 'Chittagong', 2, 1, '2018-09-13 16:53:35', 1),
(5, 'Comilla', 2, 1, '2018-09-13 16:53:35', 1),
(6, 'Dhaka', 3, 1, '2018-09-13 16:53:35', 1),
(7, 'Dinajpur', 5, 1, '2018-09-13 16:53:35', 1),
(8, 'Gazipur', 3, 1, '2018-09-13 16:53:35', 1),
(9, 'Jamalpur', 3, 1, '2018-09-13 16:53:35', 1),
(10, 'Jessore', 4, 1, '2018-09-13 16:53:35', 1),
(11, 'Khulna', 4, 1, '2018-09-13 16:53:35', 1),
(12, 'Mymensingh', 3, 1, '2018-09-13 16:53:35', 1),
(13, 'Naogaon', 5, 1, '2018-09-13 16:53:35', 1),
(14, 'Narayanganj', 3, 1, '2018-09-13 16:53:35', 1),
(15, 'Narsinghdi', 3, 1, '2018-09-13 16:53:35', 1),
(16, 'Nawabganj', 5, 1, '2018-09-13 16:53:35', 1),
(17, 'Pabna', 5, 1, '2018-09-13 16:53:35', 1),
(18, 'Rajshahi', 5, 1, '2018-09-13 16:53:35', 1),
(19, 'Rangpur', 5, 1, '2018-09-13 16:53:35', 1),
(20, 'Saidpur', 5, 1, '2018-09-13 16:53:35', 1),
(21, 'Sirajganj', 5, 1, '2018-09-13 16:53:35', 1),
(22, 'Sylhet', 6, 1, '2018-09-13 16:53:35', 1),
(23, 'Tangail', 3, 1, '2018-09-13 16:53:35', 1),
(24, 'Tungi', 3, 1, '2018-09-13 16:53:35', 1);

-- --------------------------------------------------------

--
-- Table structure for table `mims_country`
--

CREATE TABLE `mims_country` (
  `ID` int(11) NOT NULL,
  `Name` varchar(100) NOT NULL,
  `CreatedBY` bigint(20) NOT NULL,
  `LastUpdate` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `IsActive` tinyint(1) NOT NULL DEFAULT '1'
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `mims_country`
--

INSERT INTO `mims_country` (`ID`, `Name`, `CreatedBY`, `LastUpdate`, `IsActive`) VALUES
(1, 'Bangladesh', 1, '2018-09-13 16:46:26', 1);

-- --------------------------------------------------------

--
-- Table structure for table `mims_doctorinformation`
--

CREATE TABLE `mims_doctorinformation` (
  `ID` bigint(20) NOT NULL,
  `Name` varchar(100) NOT NULL,
  `Specialization` varchar(100) NOT NULL,
  `ProfessionDegree` varchar(100) NOT NULL,
  `Gender` tinyint(4) NOT NULL DEFAULT '1' COMMENT '1=Male, 2=Female',
  `ImagePath` varchar(100) DEFAULT NULL,
  `HomeAddressID` bigint(20) DEFAULT NULL,
  `ChamberAddressID` bigint(20) DEFAULT NULL,
  `PhoneNo` varchar(100) DEFAULT NULL,
  `MobileNo1` varchar(100) DEFAULT NULL,
  `MobileNo2` varchar(50) DEFAULT NULL,
  `MobileNo3` varchar(50) DEFAULT NULL,
  `Hotline` varchar(20) DEFAULT NULL,
  `CreatedBy` bigint(20) NOT NULL,
  `LastUpdate` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `IsActive` tinyint(1) NOT NULL DEFAULT '1'
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `mims_doctorinformation`
--

INSERT INTO `mims_doctorinformation` (`ID`, `Name`, `Specialization`, `ProfessionDegree`, `Gender`, `ImagePath`, `HomeAddressID`, `ChamberAddressID`, `PhoneNo`, `MobileNo1`, `MobileNo2`, `MobileNo3`, `Hotline`, `CreatedBy`, `LastUpdate`, `IsActive`) VALUES
(1, 'Prof. ( Brig. Gen. ) M H M Delowar Hossain', 'anesthesiologist', 'MBBS, DA, MCPS, FCPS, Professor, Combined Military Hospital ( CMH ), Dhaka', 1, '', 1, 1, '+880-2-9128835-7, 9126625-6', '880 1717351631, +880 1913568759 ', '', '', '', 1, '0000-00-00 00:00:00', 1),
(2, 'Prof. Dr. Kazi Mesbahuddin lqbal', 'Anesthesiology?Specialist', 'MBBS, DA, FFARCS (Ireland), FRCA (USA), Coordinator & Senior Consultant\nApollo Hospitals Dhaka\n', 1, '', 1, 1, '+880-2-8401661, 8845242', '+880 1841276556', '', '', '10678', 1, '0000-00-00 00:00:00', 1),
(3, 'Prof. Dr. Md. Ahsanul Habib', 'Anesthesiology?Specialist', 'MBBS, FCPS, Consultant, Square Hospitals Ltd.', 0, '', 1, 1, '+880-2-8159457, 8142431, 8141522, 8144400, 8142333', '1713141447', '', '', '', 1, '0000-00-00 00:00:00', 1),
(4, 'Prof. Dr. Md. Khalilur Rahman', 'Anesthesiology?Specialist', 'MBBS, MCPS, FCPS, DA (UK), FFARCS (Ireland), Consultant, SQUARE Hospitals Ltd.', 0, '', 1, 1, '+880-2-8159457, 8142431, 8141522, 8144400, 8142333', '1713141447', '', '', '', 1, '0000-00-00 00:00:00', 1),
(5, 'Prof. Dr. Salim Mohammad Jahangir', 'Anesthesiology?Specialist', 'MBBS, FCPS (Anaesthesia), Senior Consultant, Apollo Hospitals Dhaka', 1, '', 1, 1, '+880-2-8401661, 8845242', '+880 1841276556', '', '', 'Hotline: 10678', 1, '0000-00-00 00:00:00', 1),
(6, 'Prof. Dr. Wahiuddin Mahmood', 'Anesthesiology?Specialist', 'MBBS, FCPS, Consultant, SQUARE Hospitals Ltd.', 1, '', 1, 1, '+880-2-8159457, 8142431, 8141522, 8144400, 8142333', '1713141447', '', '', '', 1, '0000-00-00 00:00:00', 1),
(7, 'Prof. Dr. S.N. Samad Chowdhury', 'Anesthesiology?Specialist', 'Prof. of Anaesthesiology, DMC, Chief Consultant of Analgesia (Pain Relief Center)', 1, '', 1, 1, '9670210-3', '01911-342810', '', '', '', 1, '0000-00-00 00:00:00', 1),
(8, 'Dr. Lutful Aziz', 'Anesthesiology?Specialist', 'Assoc. Prof., BSMMU', 1, '', 1, 1, '+880-2-9670210-3, 9354641', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(9, 'Dr. Rafiqul Alam', 'Anesthesiology?Specialist', 'Associate Professor, BSMMU (P.G. Hospital)', 1, '', 1, 1, '+880-2-8610793-8, 8614545-49', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(10, 'Dr. Md. Mozaffer Hossain', 'Anesthesiology?Specialist', 'DA, FCPS ( Anaesthesiology ), Assistant Professor, Dhaka Medical College & Hospital', 1, '', 1, 1, '+880-2-8143312, 8143437, 8143913, 8143166, 9124436 ( Chmaber )', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(11, 'Dr. Dilip Kumar Saha', 'Anesthesiology?Specialist', 'Associate Professor and Head, National Institute of ENT, Tejgaon,?Dhaka', 1, '', 1, 1, 'Tel: +880-2-8878183', 'Cell:?+880 1724665568, 01552382218', '', '', '', 1, '0000-00-00 00:00:00', 1),
(12, 'Dr. (Maj) Mujibur Rahman (Retd)', 'Anesthesiology?Specialist', 'MBBS, FCPS, STNA, STPT (China), Asst. Prof. Sikder Medical', 0, '', 1, 1, 'Tel: +880-2-8115951, 9660966', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(13, 'Dr. Humayun Kabir', 'Anesthesiology?Specialist', 'Asst. Prof., Dept of Anaesthesiology', 1, '', 1, 1, 'Tel: +880-2-8618405, 01711-528079', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(14, 'Dr. Md. Naimul Haque', 'Anesthesiology?Specialist', 'Asst. Pro. Dept. of Anesthesiology', 1, '', 1, 1, 'Tel: +880-2-9552403, 9110105', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(15, 'Dr. Tahmina Banu', 'Anesthesiology?Specialist', 'MBBS, MD, Consutlant - Anesthesiology ? Neuro, SQUARE Hospitals Ltd', 2, '', 1, 1, 'Tel: +880-2-8159457, 8142431, 8141522, 8144400, 8142333', 'Mobile: 01713141447', '', '', '', 1, '0000-00-00 00:00:00', 1),
(16, 'Dr. Ahsanul Habib', 'Anesthesiology?Specialist', 'MBBS, FCPS, Consultant Anesthesiology, National Institute of Cardio Vascular Diseases', 1, '', 1, 1, 'Phone: +880-2-8311778', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(17, 'Dr. Sunil Kumar Sarkar', 'Anesthesiology?Specialist', '', 1, '', 1, 1, 'Tel: +880-2-8610793-8', 'Cell: 01713-005013', '', '', '', 1, '0000-00-00 00:00:00', 1),
(18, 'Dr. Lutful Aziz', 'Anesthesiology?Specialist', 'MBBS, PhD (Japan), FCPS, Consultant, Apollo Hospitals Dhaka', 1, '', 1, 1, 'Phone: +880-2-8401661, 8845242', 'Cell: +880 1841276556', '', '', 'Hotline: 10678', 1, '0000-00-00 00:00:00', 1),
(19, 'Dr. Md. Azharul Islam', 'Anesthesiology?Specialist', 'MBBS, FCPS, Consultant - Anesthesiology ? Cardiac, SQUARE Hospitals Ltd', 1, '', 1, 1, 'Phone: +880-2-8159457, 8142431, 8141522, 8144400, 8142333', 'Cell: 01713141447', '', '', '', 1, '0000-00-00 00:00:00', 1),
(20, 'Dr. Md. Azharul Islam', 'Anesthesiology?Specialist', 'MBBS, FCPS ( Anaesthesia), Senior Consultant, Apollo Hospital, Dhaka', 1, '', 1, 1, 'Phone: +880-2-8401661, 8845242', 'Cell: +880 1841276556', '', '', 'Hotline: 10678', 1, '0000-00-00 00:00:00', 1),
(21, 'Dr. Ranadhir Kumar Kundu', 'Anesthesiology?Specialist', 'MBBS, MD, Consultant, SQUARE Hospitals Ltd.', 1, '', 1, 1, 'Phone: +880-2-8159457, 8142431, 8141522, 8144400, 8142333', 'Cell: 01713141447', '', '', '', 1, '0000-00-00 00:00:00', 1),
(22, 'Dr. Shah Muhammad Ali', 'Anesthesiology?Specialist', 'MBBS, FCPS, Consultant, SQUARE Hospitals Ltd.', 1, '', 1, 1, 'Phone: +880-2-8159457, 8142431, 8141522, 8144400, 8142333', 'Cell: 01713141447', '', '', '', 1, '0000-00-00 00:00:00', 1),
(23, 'Dr. Syed Serajul Karim', 'Breast Surgery Specialist', 'MBBS, FCPS, FICS, Thyroid, Breast, Endocrine, Laparoscopic Surgeon, General Surgeon and Breast Surge', 1, '', 1, 1, 'Phone: +880-2-9669480, 9661491-3', ', Mobile : +880 1553341060-1', '', '', '', 1, '0000-00-00 00:00:00', 1),
(24, 'Dr. TasmiaTahmid', 'Breast Surgery Specialist', 'MBBS, MRCS ( Edin ), Consultant, United Hospital Limited', 2, '', 1, 1, 'Phone: +880-2-8836000, 8836444', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(25, 'Prof. Dr. Md. Abdul Kalam', 'Burn & Plastic Surgery Specialist', 'MBBS, FCPS (Surgery), Professor & Head, Dept. of Plastic & Reconstructive Surgery, Expertise : Plast', 1, '', 1, 1, 'Phone: +880-2-8142749, 9131901', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(26, 'Prof. Dr. Shafquat Hussain Khundker', 'Burn & Plastic Surgery Specialist', 'MBBS, FCPS, FICS, Head, Department of Plastic Surgery, Expertise : Plastic & Cosmetic Surgeon, Dhaka', 1, '', 1, 1, 'Phone: +880-2-8124990 (Master Line), 8129667, 8124380', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(27, 'Prof. Dr. Shafquat Hussain Khundker', 'Burn & Plastic Surgery Specialist', 'MBBS, FCPS, FICS, Head, Department of Plastic Surgery, Expertise : Plastic & Cosmetic Surgeon, Dhaka', 1, '', 1, 1, 'Phone: + 880-2-9676356, 8610793-8', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(28, 'Dr. A.K.M Fazlul Haque', 'Burn & Plastic Surgery Specialist', 'MBBS, FRCS (UK), Burn & Plastic Surgery Specialist, Coordinator & Consultant, Apollo Hospitals Dhaka', 1, '', 1, 1, 'Phone: +880-2-8401661', '', '', '', 'Hotline - 10678?', 1, '0000-00-00 00:00:00', 1),
(29, 'Dr. Abdullah Al Tariq', 'Burn & Plastic Surgery Specialist', 'MBBS, FCPS, Burn & Plastic Surgery Specialist, Consultant, Dhaka Medical College Hospital', 1, '', 1, 1, 'Phone: +880-2-831-8135, 831-9802?', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(30, 'Dr. kawser Ahmed', 'Burn & Plastic Surgery Specialist', 'MBBS, MD ( HK ) , MAPBA, Specialist Surgeon, Rushmono General Hospital', 1, '', 1, 1, 'Phone: +880-2-8317819, 8317606?', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(31, 'Dr. Kishore Kumar Das', 'Burn & Plastic Surgery Specialist', 'MBBS (DMC), FCPS (Surgery), M.S. Plastic Surgery Final Part student, Assistant Registrar, Dhaka Medi', 1, '', 1, 1, 'Phone: +880 1732200645?', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(32, 'Dr. Liman Kumar Dhar', 'Burn & Plastic Surgery Specialist', 'MBBS, FCPS - Part-ll trainee (Plastic & Reconstructive Surgery), Burn & Plastic Surgery Specialist, ', 1, '', 1, 1, 'Phone: +880 1735198433', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(33, 'Dr. Md. Abdul Mabin', 'Burn & Plastic Surgery Specialist', 'MBBS, DSS (Vienna), Cosmetic & Plastic Surgeon, United Hospital Limited', 1, '', 1, 1, 'Phone: +880-2-8836000, 8836444', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(34, 'Prof. (Dr). Saumen Basu', 'Cancer - Oncology Specialist', 'MBBS (Calcutta University), MD (Radiation Oncology), Diplomate National Board(DNB) (RT)  Visiting Fe', 1, '', 1, 1, 'Tel: +88 02 8836444, +88 02 8836000?', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(35, 'Prof. Dr. Syed Md. Akram Hossain', 'Cancer - Oncology Specialist', 'MBBS, MPH, FCPS , Fellow WHO ( Medical Oncology ), Professor & Ex-Chairman, Oncology Department, (BS', 1, '', 1, 1, 'Phone: +880-2-8610793-8, 9670210-3, 8631177', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(36, 'Prof. Dr. Sarwar Alam', 'Cancer - Oncology Specialist', 'MBBS, DIH ( DU ), MPhil (Oncology), Professor & Chairman, Oncology Department, Bangabandhu Sheikh Mu', 1, '', 1, 1, 'Phone: +880-2-9145786, 9137076, 01819494530 (Chamber)', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(37, 'Prof. Dr. Lt. Col. Md. Mofazzel Hossain', 'Cancer - Oncology Specialist', 'MBBS, FCPS ( Med. ), FACP ( USA ), FRCP ( Edin ), Professor & Head, Department of Oncology, Banglade', 1, '', 1, 1, 'Phone: + 880-2-9676356, 8610793-8', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(38, 'Prof. Dr. Parveen Shahida Akhter', 'Cancer - Oncology Specialist', 'MBBS, FCPS, Professor, National Institute of Cancer Research & Hospital', 2, '', 1, 1, 'Phone: +880-2-8143312, 8143437, 8143166, 8143167, 9124436', 'Mobile - 01711622788?', '', '', '', 1, '0000-00-00 00:00:00', 1),
(39, 'Prof. Dr. A.B.M.F.  Karim', 'Cancer - Oncology Specialist', 'MBBS, FRCR, PhD, Professor & Chairman, Oncology Club & Editorial Board of Cancer Control Journal', 1, '', 1, 1, 'Phone: +880-2-9672277, 9676161, 9664028, 9664029', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(40, 'Dr. Zafor Md. Masud', 'Cancer - Oncology Specialist', 'MBBS, M.Phil, FCPS, Associate Professor, Bangladesh Medical College & Hospital', 1, '', 1, 1, 'Phone: +880-2-9128835-7, 9126625-6', 'Cell: +880 1717351631, +880 1913568759 ', '', '', '', 1, '0000-00-00 00:00:00', 1),
(41, 'Dr. Masuda Begum', 'Cancer - Oncology Specialist', 'MBBS, FCPS, Associate professor, Department of Hematology, Bangabandhu Sheikh Mujib Medical Universi', 2, '', 1, 1, 'Phone: + 880-2-9660016-19, 8624514-18 ( Chamber )?', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(42, 'Dr. M A Hashem', 'Cancer - Oncology Specialist', 'MBBS, FCPS, Associate Professor, Sir Salimullah Medical College & Hospital', 1, '', 1, 1, 'Phone: +880 1711106136, +880-2-8610313?', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(43, 'Dr. A K M Hamidur Rahman', 'Cancer - Oncology Specialist', 'MBBS, DMRT, Associate Professor, IbnSina Diagnostic & Imaging Center', 1, '', 1, 1, 'Phone: +880-2-9128835-7, 9126625-6', 'Cell: +880 1717351631', '', '', '', 1, '0000-00-00 00:00:00', 1),
(44, 'Dr. Zebunnesa Yasmin', 'Cancer - Oncology Specialist', 'MBBS, M Phil(Radiotherapy), ?Assistant Professor, Delta Medical College & Hospital', 2, '', 1, 1, 'Phone: +880-2-8017151-52, 8031378-79?', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(45, 'Dr. Tarit Kumar Samadder', 'Cancer - Oncology Specialist', 'MBBS, DMRT, TSF Fellow ( Japan ), Assistant Professor, National Institute of Cancer Research and Hos', 1, '', 1, 1, 'Phone: +880 1715517621?', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(46, 'Dr. Naheed Rukhsana', 'Cancer - Oncology Specialist', 'MBBS, FCPS ( Radiotherapy), Assistant Professor, Delta Medical College & Hospital', 2, '', 1, 1, 'Phone: +880-2-8017151-52, 8031378-79?', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(47, 'Dr. Md. Ehteshamul Huq', 'Cancer - Oncology Specialist', 'MBBS, M.Phil, Assistant Professor, City Hospital Ltd.', 1, '', 1, 1, 'Phone: +880-2-8143166, 8143312, 8143437 ', 'Mobile - 01552406812', '', '', '', 1, '0000-00-00 00:00:00', 1),
(48, 'Dr. Md. Abul Ahsan ( Didar )', 'Cancer - Oncology Specialist', 'MBBS, MPH, MD (Radiotheraphy), Assistant Professor, National Cancer Institute & Hospital, Dhaka, Ban', 1, '', 1, 1, 'Phone: +880-2-9672277, 9676161, 9664028, 9664029?', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(49, 'Dr. Lutfun Naher', 'Cancer - Oncology Specialist', 'MBBS, M Phil(Radiotherapy), Assistant Professor, Delta Medical College & Hospital', 2, '', 1, 1, 'Phone: +880-2-8017151-52, 8031378-79?', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(50, 'Dr. Ishtiak Ahmed Shamim', 'Cancer - Oncology Specialist', 'MBBS(Dhaka),Ph.D(Japan) Assistant Professor, Bangabandhu Sheikh Mujib Medical University (BSMMU)', 1, '', 1, 1, 'Phone: +880-2-8143312, 8143437, 8143166, 8143167, 9124436', 'Mobile - 01911340179', '', '', '', 1, '0000-00-00 00:00:00', 1),
(51, 'Dr. A F M Anowar Hossain', 'Cancer - Oncology Specialist', 'MBBS, FCPS, MS, Assistant Professor, National Cancer Institute & Hospital', 1, '', 1, 1, 'Phone: +880-2-9126625, 9128835-7', 'Cell: +880 1717351631', '', '', '', 1, '0000-00-00 00:00:00', 1),
(52, 'Lt. Col. (Dr.) Shormin Ara Ferdousi', 'Cancer - Oncology Specialist', 'MBBS, DCH, FCPS (Ped), OJT-Ped. Oncology (Tata Medical Center, India)', 2, '', 1, 1, 'Phone: 01712933451', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(53, 'Dr. Md. Rezaul Sharif', 'Cancer - Oncology Specialist', 'MBBS, M Phil (Radiotherapy), Consultant, Delta Medical College & Hospital', 1, '', 1, 1, 'Phone: +880-2-8017151-52, 8031378-79?', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(54, 'Dr. Md. Ehteshamul Hoque', 'Cancer - Oncology Specialist', 'MBBS, M.Phil ( Radiotherapy ) Consultant ( Visiting ), United Hospital Limited', 1, '', 1, 1, 'Phone: +880 2 8836000, 8836444', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(55, 'Dr. Qamruzzaman Chowdhury', 'Cancer - Oncology Specialist', 'MBBS, FCPS, DMRT, Consultant, SQUARE Hospitals Ltd.', 1, '', 1, 1, 'Phone: +880-2-8159457, 8142431, 8141522, 8144400, 8142333', 'Mobile: 01713377773?', '', '', '', 1, '0000-00-00 00:00:00', 1),
(56, 'Dr. Parvin Akhter Banu', 'Cancer - Oncology Specialist', 'MBBS, Consultant, Delta Medical College & Hospital', 2, '', 1, 1, 'Phone: +880-2-8017151-52, 8031378-79?', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(57, 'Dr. Muhammad Tawfique', 'Cancer - Oncology Specialist', 'MBBS (DMC), MD (Ped.) MD (Ped. Haematology &  Oncology), Consultant - SQUARE Hospitals Ltd.', 1, '', 1, 1, 'Phone: +880-2-8159457, 8142431, 8141522, 8144400, 8142333', 'Mobile: 01713377773?', '', '', '', 1, '0000-00-00 00:00:00', 1),
(58, 'Dr. Md. Salim Reza', 'Cancer - Oncology Specialist', 'MBBS ( CU) , DMRT, FCPS ( Radiotheraphy), Consultant, Ahsania Mission Cancer Hospital', 1, '', 1, 1, 'Phone: +880-2-9008919, 9665544?', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(59, 'Dr. Md. Moarraf Hossain', 'Cancer - Oncology Specialist', 'MBBS, FCPS, DMRT, Cancer Specialist, National Institute of Cancer Research and Hospital', 1, '', 1, 1, 'Phone: + 880-2-8610793-8, 9670210-3 ', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(60, 'Dr.(Lt. Col) M S Sarwar Alam', 'Cancer - Oncology Specialist', 'MBBS, DMRT, FCPS, OJT-LiNAC(German), Consultant, Delta Medical College & Hospital', 1, '', 1, 1, 'Phone: +880-2-8017151-52, 8031378-79?', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(61, 'Dr. Ehteshamul Haque', 'Cancer - Oncology Specialist', 'MBBS, BCS ( Health ), M.Phil(Radiotherapy) , Cancer Specialist, Ahsania Mission Cancer & General Hos', 1, '', 1, 1, 'Phone: +880-2-8113010, 8118522', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(62, 'Professor Dr. Abu Azam', 'Cardiology Specialist', 'MBBS, MD, FRCP ( UK ), FACC (USA), Professor & Head, Department of Nuclear Cardiology', 1, '', 1, 1, 'Phone: +880-2-9101641, 8123865 ', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(63, 'Dr. Md. Rois Uddin', 'Cardiology Specialist', 'MBBS, MD (Cardiology), Associate Professor, Medicine & Cardiology, Rajshahi Medical College & Hospit', 1, '', 1, 1, 'Phone: +880-2- 9111911 (Chamber)', 'Cell: 01553341660 ( Chamber ), Cell: 01822494969', '', '', '', 1, '0000-00-00 00:00:00', 1),
(64, 'Dr. Md. Mohsin Hossain', 'Cardiology Specialist', 'MBBS, MD ( Medicine ), FCPS (Cardiology), Assistant Professor, Cardiology, National Institute of Car', 1, '', 1, 1, 'Phone: +880-2-8610420, 966497, 9663289, 8618262 ', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(65, 'Dr. A.K.M Monwarul Islam', 'Cardiology Specialist', 'MBBS, FCPS, MD, Designation : Consultant, Organization: National Institute of Cardiovascular Disease', 1, '', 1, 1, 'Phone: +880-2- 9111911', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(66, 'Dr. Md. Kamrul Islam', 'Cardiology Specialist', 'MBBS, FCPS, D.Card, CCD, Consultant, Bangabandhu Sheikh Mujib Medical Univeristy (BSMMU)', 1, '', 1, 1, 'Phone: +880 1713209137, +880 1715101796 ( Chamber )', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(67, 'Prof. Dr. A.K.M. Mostofa Hossain', 'Chest Specialist', 'MBBS, DTCD, MD(Chest), FCP(USA), Chest, Asthma & Medicine Specialist, Director, National Institute o', 1, '', 1, 1, 'Phone: +880-2-8333811-3', '', '', '', '', 1, '0000-00-00 00:00:00', 1),
(68, 'Prof. Dr. Mirza Mohammad Hiron', '', 'FCPS (medicine), MD (Chest), FCCP (USA), FRCP (Ireland), FRCP (Edin), FRCP (Glasgow)', 1, '', 1, 1, '', '', '', '', '', 1, '0000-00-00 00:00:00', 1);

-- --------------------------------------------------------

--
-- Table structure for table `mims_dosageforminformation`
--

CREATE TABLE `mims_dosageforminformation` (
  `ID` int(11) NOT NULL,
  `Name` varchar(100) NOT NULL,
  `LastUpdate` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `CreatedBy` bigint(20) NOT NULL,
  `IsActive` tinyint(1) NOT NULL DEFAULT '1'
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `mims_dosageforminformation`
--

INSERT INTO `mims_dosageforminformation` (`ID`, `Name`, `LastUpdate`, `CreatedBy`, `IsActive`) VALUES
(39, ' TAB ', '2018-10-01 14:30:58', 1, 1),
(40, '(TAB ', '2018-10-01 14:30:58', 1, 1),
(41, 'AMP ', '2018-10-01 14:30:58', 1, 1),
(42, 'BC-CAP ', '2018-10-01 14:30:58', 1, 1),
(43, 'CAP ', '2018-10-01 14:30:58', 1, 1),
(44, 'CHW-TAB ', '2018-10-01 14:30:58', 1, 1),
(45, 'CR-TAB ', '2018-10-01 14:30:58', 1, 1),
(46, 'DIS-TAB ', '2018-10-01 14:30:58', 1, 1),
(47, 'DR-CAP ', '2018-10-01 14:30:58', 1, 1),
(48, 'DR-TAB ', '2018-10-01 14:30:58', 1, 1),
(49, 'EC-CAP ', '2018-10-01 14:30:58', 1, 1),
(50, 'EC-TAB ', '2018-10-01 14:30:58', 1, 1),
(51, 'ER-TAB ', '2018-10-01 14:30:58', 1, 1),
(52, 'FC-TAB ', '2018-10-01 14:30:58', 1, 1),
(53, 'FC:TAB ', '2018-10-01 14:30:58', 1, 1),
(54, 'IM/IV-AMP ', '2018-10-01 14:30:58', 1, 1),
(55, 'INF ', '2018-10-01 14:30:58', 1, 1),
(56, 'INJ ', '2018-10-01 14:30:58', 1, 1),
(57, 'IV-INJ ', '2018-10-01 14:30:58', 1, 1),
(58, 'IV-VIAL ', '2018-10-01 14:30:58', 1, 1),
(59, 'IV:INJ ', '2018-10-01 14:30:58', 1, 1),
(60, 'JELLY ', '2018-10-01 14:30:58', 1, 1),
(61, 'lM/IV-INJ ', '2018-10-01 14:30:58', 1, 1),
(62, 'lV-INJ ', '2018-10-01 14:30:58', 1, 1),
(63, 'lV-VIAL ', '2018-10-01 14:30:58', 1, 1),
(64, 'MR TAB ', '2018-10-01 14:30:58', 1, 1),
(65, 'MR-TAB ', '2018-10-01 14:30:58', 1, 1),
(66, 'O-SPY', '2018-10-01 14:30:58', 1, 1),
(67, 'O:DPS ', '2018-10-01 14:30:58', 1, 1),
(68, 'O:LIQ ', '2018-10-01 14:30:58', 1, 1),
(69, 'O:PWD ', '2018-10-01 14:30:58', 1, 1),
(70, 'O:SOL ', '2018-10-01 14:30:58', 1, 1),
(71, 'O:SUSP ', '2018-10-01 14:30:58', 1, 1),
(72, 'OM:SPY    ', '2018-10-01 14:30:58', 1, 1),
(73, 'P-O:DPS ', '2018-10-01 14:30:58', 1, 1),
(74, 'P-O:SUSP', '2018-10-01 14:30:58', 1, 1),
(75, 'RETD-TAB ', '2018-10-01 14:30:58', 1, 1),
(76, 'SG-CAP ', '2018-10-01 14:30:58', 1, 1),
(77, 'SG:CAP ', '2018-10-01 14:30:58', 1, 1),
(78, 'SL:TAB ', '2018-10-01 14:30:58', 1, 1),
(79, 'SOLN ', '2018-10-01 14:30:58', 1, 1),
(80, 'SPY', '2018-10-01 14:30:58', 1, 1),
(81, 'SR CAP ', '2018-10-01 14:30:58', 1, 1),
(82, 'SR TAB ', '2018-10-01 14:30:58', 1, 1),
(83, 'SR-CAP ', '2018-10-01 14:30:58', 1, 1),
(84, 'SR-TAB ', '2018-10-01 14:30:58', 1, 1),
(85, 'SUPP ', '2018-10-01 14:30:58', 1, 1),
(86, 'SUSP (sachet) ', '2018-10-01 14:30:58', 1, 1),
(87, 'SYR ', '2018-10-01 14:30:58', 1, 1),
(88, 'TAB ', '2018-10-01 14:30:58', 1, 1),
(89, 'TR-CAP ', '2018-10-01 14:30:58', 1, 1),
(90, 'V-AMP ', '2018-10-01 14:30:58', 1, 1),
(91, 'VIAL ', '2018-10-01 14:30:58', 1, 1);

-- --------------------------------------------------------

--
-- Table structure for table `mims_genericinformation`
--

CREATE TABLE `mims_genericinformation` (
  `ID` bigint(20) NOT NULL,
  `Name` varchar(100) NOT NULL,
  `Classification` varchar(100) DEFAULT NULL,
  `SafetyRemark` varchar(100) DEFAULT NULL,
  `Indication` text,
  `IndicationTags` varchar(300) DEFAULT NULL,
  `DosageAdministration` text,
  `ContraindicationPrecaution` text,
  `SideEffect` text,
  `PregnancyLactation` text,
  `LastUpdate` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `CreatedBy` bigint(20) NOT NULL,
  `IsActive` tinyint(1) NOT NULL DEFAULT '1'
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `mims_genericinformation`
--

INSERT INTO `mims_genericinformation` (`ID`, `Name`, `Classification`, `SafetyRemark`, `Indication`, `IndicationTags`, `DosageAdministration`, `ContraindicationPrecaution`, `SideEffect`, `PregnancyLactation`, `LastUpdate`, `CreatedBy`, `IsActive`) VALUES
(1, 'Esomeprazole', 'Proton Pump Inhibitor', 'P? L? Food * Lab *', 'It is indicated for the treatment of - Gastroesophageal Reflux Disease (GERD), Healing of Erosive Esophagitis, Maintenance of healing of Erosive Esophagitis, Symptomatic Gastroesophageal Reflux Disease (GERD), Risk Reduction of NSAID associated gastric ulcer & H. pylori eradication (Triple therapy).', 'GERD, Acidity', 'Adult : PO Erosive oesophagitis 40 mg once daily for 4 wk, up to another 4 wk if needed. Maintenance: 20 mg once daily. GERD 40 mg once daily for 4 wk, up to another 4 wk if needed. Maintenance or GERD w/o erosive oesophagitis: 20 mg once daily. Peptic ulcer 20 mg bid for 7 days or 40 mg once daily for 10 days as triple therapy w/ amoxicillin and clarithromycin. Prophylaxis of NSAID-induced ulcers 20 or 40 mg/day. NSAID-associated ulceration 20 mg once daily for 4-8 wk. Zollinger-Ellison syndrome Initial: 40 mg bid. Usual range: 80-160 mg/day. Daily doses >80 mg should be given in 2 divided doses. IV GERD 20 or 40 mg by inj over at least 3 min or infusion over 10-30 min once daily for ?10 days until PO can be resumed. NSAID-associated ulceration 20 mg/day by inj over at least 3 min or infusion over 10-30 min until PO can be resumed. Gastric and duodenal ulcers 80 mg infusion over 30 min followed by continuous infusion 8 mg/hr over 72 hr, until PO can be resumed given as 40 mg once daily for 4 wk. Delayed-Release Cap: Should be taken on an empty stomach. Take 1 hr before meals.\r\nTab: May be taken with or without food.', 'Esomeprazole is contraindicated in those patients who have known hypersensitivity to any other components of the formulation. Exclude the possibility of malignancy when gastric ulcer is suspected & before treatment for dyspepsia.', 'Side Effects reported with Esomeprazole include headache, diarrhea & abdominal pain.', 'This drug should be used during regnancy only if clearly needed. Because Esomeprazole is likely to be excreted in human milk, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.', '0000-00-00 00:00:00', 1, 1),
(2, 'Domperidone', 'Dopamine Antagonist', 'P? L? Food *', '1. Dyspeptic symptom complex: Often\nassociated with delayed gastric emptying,\ngastroesophageal reflux and esophagitis.\nepigastric sense of fullness, feeling of\nabdominal distension, upper abdominal pain,\neructation, early satiety, heartburn with or\nwithout regurgitations of gastric contents in\nthe mouth, diabetic gastroparesis, non ulcer\ndyspepsia.\n2. Nausea & vomiting: Acute nausea & vomiting\nof functional, organic, infectious, dietetic origin\nor induced by radiotherapy or drug therapy or\ninduced in migraine.\n3. Parkinson?s disease: In dopamine-agonist\ninduced nausea and vomiting.\n4. Radiological studies: Speading barium transit\nin follow through radiological studies.', '', '1-2 tablet or 10-20 ml suspension every 6-8\nhours daily before meals. Children: 2 ml-4 ml\nsuspension/10 kg or 0.4 ml-0.8 ml Paed. drops/\n10 kg 6-8 hours daily.', 'Known hypersensitivity, gastro-intestinal\nstimulation, gastro-intestinal hemorrhage, mechanical obstruction or perforation,\nprolactinoma, increased risk of extra-pyramidal\nreactions, should be used with caution in\npatient with hepatic impairment.', 'Hyperprolactinemia, galactorrhea, breast\nenlargement, & soreness & reduced libido.\nDry mouth, thirst, headache, nervousness,\ndrowsiness, diarrhea, skin rash & itching.', 'Not recommended during pregnancy. It\nis secreted in breast milk but in very small\nquantities insufficient to be considered\nharmful.', '0000-00-00 00:00:00', 1, 1),
(3, 'Famotidine', 'H2-receptor Antagonist ', 'P? L?', 'Duodenal ulcer, Gastric ulcer, Gastrooesophageal\nreflux dis', '', '20 mg twice daily or 40 mg at night. Maintenance therapy as Famotack 20 one tablet at night.', 'Hypersensitivity', 'Headache, dizziness, constipation & diarrhoea,\nnausea and/or vomiting, abdominal discomfort\nor distention, anorexia, fatigue, rash.', 'Should be prescribed only if clearly needed. It is best avoided by nursing mothers.', '0000-00-00 00:00:00', 1, 1),
(4, 'Lansoprazole', 'Proton Pump Inhibitor; Antiulcer', 'P? L? ', 'Duodenal ulcer, gastric ulcers, erosive\nesophagitis, Zollinger-Ellison Syndrome, H.\npylori eradication.', '', '30 mg daily dose.', 'Known hypersensitivity.', 'Gastrointestinal disturbances, headache,\ndizziness, malaise, dry or sour mouth or throat.', 'USFDA Pregnancy category B.', '0000-00-00 00:00:00', 1, 1),
(5, 'METOCLOPRAMIDE', 'Antiemetics / GIT Regulators, Antiflatulents & Anti-Inflammatories', 'P? L? Lab *', '', '', 'Adult : PO GERD 10-15 mg 4 times/day. If symptoms are intermittent, may give single doses of 20 mg prior to provoking situation. Max duration: 12 wk. Diabetic gastric stasis 10 mg 4 times/day for 2-8 wk. Nausea and vomiting associated w/ cancer chemotherapy or radiotherapy 10 mg, up to tid. Max duration: 5 days. IM/IV Diabetic gastric stasis 10 mg 4 times/day by IM inj or slow IV inj over 1-2 min for up to 10 days. Convert to oral admin when symptoms subside sufficiently. Prophylaxis of post-op nausea and vomiting 10 mg as a single dose by IM or slow IV inj over at least 3 min. IV Prophylaxis of chemotherapy-induced nausea and vomiting For highly emetogenic drugs/regimens: Initial: 2 mg/kg by slow inj over at least 15 min, 30 min before chemotherapy. Repeat 2 hrly for 2 doses, then 3 hrly for 3 doses. For less emetogenic drugs/regimens: 1 mg/kg may be used. Max duration: 5 days. Intubation of the small intestine; Premedication for radiologic examination of the upper GI tract 10 mg as a single dose by slow inj over 1-2 min.  Should be taken on an empty stomach. Take ? hr before meals.', '', '', 'Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters).', '0000-00-00 00:00:00', 1, 1),
(6, 'MISOPROSTOL', 'Drugs Acting on the Uterus / Antacids, Antireflux Agents & Antiulcerants', 'P? L? ', 'Labor induction (in unfavorable cervical\nconditions) & in the prevention & treatment of\nPost Partum Hemorrhage (PPH)', '', 'Induction of Labor: 25 mcg vaginally 6 hourly\nor, 50 mcg orally 4 hourly.\nPostpartum Hemorrhage (PPH) prophylaxis:\n400 mcg to 600 mcg orally or rectally immediately following delivery of the child.\nPostpartum Hemorrhage (PPH) treatment:\n1000 mcg rectally or, 200 mcg orally with 400\nmcg sublingually.', 'Precaution should be taken in conditions\nwhere hypertension might precipitate\nsevere complications (e.g. Cerebrovascular &\ncardiovascular disease).', 'Spotting, cramps, hypermenorrhea, menstrual\ndisorder & dysmenorrhea. Postmenopausal\nvaginal bleeding may be related to Misoprostol\nadministration.', 'Because of the abortifacient property of the\nMisoprostol component, it is contraindicated\nin women who are pregnant.', '0000-00-00 00:00:00', 1, 1),
(7, 'OMEPRAZOLE', 'Proton Pump Inhibitor; Antacid, Antiulcer', 'P? L? Food * Lab *', 'Omeprazole indicated for gastroesophageal reflux disease including reflux esophagitis,\r\nacid reflux disease, duodenal & benign gastric ulcers, Helicobacter pylori eradication regimens in\r\npeptic ulcer disease, prophylaxis of acid aspiration, Zollinger-Ellison Syndrome & for the treatment\r\nof NSAID-associated gastric ulcers, duodenal ulcers or gastroduodenal erosions.\r\nSeclo IV is indicated primarily for the treatment of Zollinger-Ellison syndrome, & may also be used\r\nfor the treatment of gastric ulcer, duodenal ulcer & reflux esophagitis.', 'gastroesophageal reflux disease , GERD, reflux esophagitis, acid reflux disease, peptic ulcer disease ', 'Omeprazole should be taken 30 minutes before meal.', 'There are no known contraindications to\r\nthe use of Omeprazole. When gastric ulcer\r\nis suspected, the possibility of malignancy\r\nshould be excluded before treatment with\r\nOmeprazole is instituted as treatment may\r\nalleviate symptoms & delay diagnosis.', 'Omeprazole is well tolerated. Nausea, diarrhoea, abdominal colic, paresthesia,\r\ndizziness & headache have been stated to be\r\ngenerally mild & transient & not requiring a\r\nreduction in dosage.', 'US FDA pregnancy category C. Omeprazole is excreted in breast milk but is not likely to influence the child when therapeutic doses are used.', '0000-00-00 00:00:00', 1, 1),
(8, 'PANTOPRAZOLE', 'Proton Pump Inhibitor', 'P? L? Food * Lab*', 'Trupan is indicated for the treatment of - Benign\r\ngastric ulcer, duodenal ulcer, gastroesophageal\r\nreflux disease (GERD), NSAID-induced peptic\r\nulcer, acid hypersecretory conditions including\r\nZollinger-Ellison Syndrome, eradication of\r\nHelicobacter pylori (in combination with\r\nAntibiotics), ulcer resistant to H2 receptor\r\nantagonists.', 'GERD', 'Adult : PO GERD 20-40 mg for 4 wk, up to 8 wk if needed. Maintenance: 20-40 mg/day. Erosive oesophagitis 20-40 mg for up to 16 wk if needed. Peptic ulcer 40 mg for 2-4 wk (duodenal ulcer) or 4-8 wk for (benign gastric ulceration). Prophylaxis of NSAID-induced ulcers 20 mg. Zollinger-Ellison syndrome Initial: 80 mg. Max: 240 mg/day. Daily doses >80 mg should be given in 2 divided doses. All doses to be taken once daily in the morning. H.pylori infection 40 mg bid w/ clarithromycin and either amoxicillin or metronidazole. IV Zollinger-Ellison syndrome 80 mg once or twice daily until PO can be resumed. Max: 240 mg/day in divided doses. GERD; Peptic ulcer 40 mg/day until PO can be resumed.', 'Pantoprazole is contraindicated in patients\r\nwith known hypersensitivity to the active drug\r\nor any other components of the formulation.\r\nPatients should be cautioned that Pantoprazole\r\ntablet should not be split, crushed or chewed.', 'Pantoprazole is well tolerated in both short\r\nterm & long term treatment. Headache &\r\ndiarrhoea are the most common side effects\r\n& rarely included abdominal pain, flatulence,\r\nrash, insomnia & hyperglycemia.', 'USFDA Pregnancy category B. Pantoprazole should\r\nbe used during pregnancy only if clearly needed. A\r\ndecision should be made whether to discontinue\r\nnursing or to discontinue the drug, taking into\r\naccount the benefit of the drug to the mother.', '0000-00-00 00:00:00', 1, 1),
(9, 'RABEPRAZOLE', 'Proton Pump Inhibitor', 'P? Food *', 'Short-term treatment in healing & symptomatic\nrelief of duodenal ulcers & erosive or ulcerative\nGastroesophageal Reflux Disease (GERD).\nMaintaining healing & reducing relapse rates\nof heartburn symptoms in patients with GERD.\nTreatment of daytime & nighttime heartburn &\nother symptoms associated with GERD. Longterm\ntreatment of pathological hypersecretory\nconditions, including Zollinger-Ellison\nSyndrome. In combination with Amoxicillin &\nClarithromycin to eradicate Helicobacter pylori.', '', 'Can be taken with or without food. Healing of\nErosive or Ulcerative Gastroesophageal Reflux\nDisease (GERD): 20 mg to be taken once daily\nfor 4 to 8 weeks. For those patients who have\nnot healed after 8 weeks of treatment, an\nadditional 8 week course may be considered.\nMaintenance of Healing of Erosive or Ulcerative\nGastroesophageal Reflux Disease (GERD\nMaintenance): The recommended adult oral\ndose is 20 mg once daily.\nTreatment of Symptomatic Gastroesophageal\nReflux Disease (GERD): The recommended\nadult oral dose is 20 mg once daily for 4 weeks.\nIf symptoms do not resolve completely after 4\nweeks, an additional course of treatment may\nbe considered.\nHealing of Duodenal Ulcers: The recommended\nadult oral dose is 20 mg once daily after the\nmorning meal for a period up to four weeks.\nMost patients with Duodenal Ulcer heal\nwithin four weeks. A few patients may require\nadditional therapy to achieve healing.\nHelicobacter pylori Eradication to Reduce\nthe Risk of Duodenal Ulcer Recurrence:\nRabeprazole Sodium 20 mg Twice Daily for\n7 Days Amoxicillin 1000 mg Twice Daily for 7\nDays Clarithromycin 500 mg Twice Daily for\n7 Days. All three medications should be taken\ntwice daily with the morning & evening meals.\nIt is important that patients comply with the\nfull 7-day regimen.  Treatment of Pathological Hypersecretory\nConditions Including Zollinger-Ellison\nSyndrome: The dosage of Rabeprazole Sodium\nin patients with pathologic hypersecretory\nconditions varies with the individual patient.\nThe recommended adult oral starting dose is\n60 mg once a day. Doses should be adjusted\nto individual patient needs & should continue\nfor as long as clinically indicated. Some patients\nmay require divided doses. Doses up to 100 mg\nQD & 60 mg BID have been administered. Some\npatients with Zollinger-Ellision syndrome have\nbeen treated continuously with Rabeprazole\nSodium for up to one year.', 'Rabeprazole Sodium is contraindicated\nin patient with known hypersensitivity to\nRabeprazole or to any component in the\nproduct. Administration of Rabeprazole Sodium to patients with mild to moderate liver impairment resulted in increased exposure & decreased elimination. Caution should be exercised in patients with severe hepatic impairment.', '', 'Rabeprazole is USFDA Pregnancy Category\nC. No data is available on administration of Rabeprazole to pregnant women. However this drug should be used during pregnancy, only if clearly needed. There are no data on the excretion of Rabeprazole into the breast milk. A decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the benefit of the drug to\nthe mother.', '0000-00-00 00:00:00', 1, 1),
(10, 'RANITIDIN', 'H2-receptor Antagonist', 'P? L?', 'Duodenal ulcer, Gastric ulcer, Reflux\noesophagitis, Zollinger-Ellison syndrome, post\noperative ulcer, Mendelson?s syndrome', '', '150 mg twice daily. Maintenance therapy: 150\nmg at night. Injection: 50 mg, slow IV every\nsix to eight hourly. Children: 2 mg/kg-4 mg/\nkg twice daily to a maximum 300 mg/day.\nInjection is not indicated for children.', 'Hypersensitivity.', 'Infrequent Rash, mental confusion & hallucination.', 'Should be prescribed only if clearly needed. It is best avoided by nursing mothers.', '0000-00-00 00:00:00', 1, 1),
(11, 'SUCRALFATE', 'Chelating complex', 'P? L?', 'For the treatment of duodenal ulcer, gastric ulcer and chronic gastritis.', '', 'Adult: Usual dose 1 gm 4 times daily to be taken 1 hour before meals and at bed time. Maximum daily dose is 8 gm. Four to six weeks treatment is usually needed for ulcer healing but upto twelve weeks may be necessary in resistant cases. Antacids may be used as required for relief of pain, but should not be taken half an hour before or after Gastalfet.\n\nElderly: There are no special dosage requirements for elderly patients but as with all medicines the lowest effective dose should be used. \n\nchildren: Safety and efficacy in children have not been established', 'There are no known contraindications', 'The incidence and severity of side effects from sucralfate are very low. Mild side effect like constipation has been reported in some patients.', 'Although animal studies show no evidence of foetal malformation, safety in pregnant women has not been established and Sucralfate should be used in pregnancy only if clearly needed. \n\nIt is not known whether this drug is excreted in human milk. Caution should be exercised when sucralfate is administered to nursing mothers.', '0000-00-00 00:00:00', 1, 1),
(12, 'DICYCLOVERINE HYDROCHLORIDE', 'Anticholinergic; Antispasmodic Agent ', 'P? L?', 'Irritable bowel syndrome, Infantile colic,\nGIT spasm, Diverticulitis, Abdominal colic,\nDiarrhoea, Dysentery.', '', 'Adults : 10 to 20 mg three to four times a day.\nMaximum recommended oral dose is 160 mg\ndaily in divided dose. Children : Children over\n6 months of age- 5 to 10 mg three times a day.', 'Obstructive uropathy, Obstruction disorder\nin GIT, Severe ulcerative colitis, Unstable\ncardiovascular status in acute hemorrhage,\nGlucoma, Myasthenia gravis, Patients with\nhypersensitivity to dicycloverine hydrochloride.', 'Insomnia, headache, weakness, confusion,\nincreased ocular tension, urinary hesitancy,\npalpitations etc.', 'Pregnancy Category B. Dicycloverine should be used during pregnancy only if clearly needed. Dicycloverine should not be used in case of lactating mother.', '0000-00-00 00:00:00', 1, 1),
(13, 'DROTAVERINE', 'soquinolone; \nAntispasmodic Agent ', 'P? L?', 'Spastic conditions of the gastrointestinal tract, irritable bowel syndrome-\nBiliary colics and spastic conditions of the biliary tract: Cholecystolithiasis, cholecystitis, cholangitis.\nRenal colics and spastic conditions of the urogenital tract: Nephrolithiasis, ureterolithiasis, pyelitis, cystitis.\nSpastic conditions of the uterus: Dysmenorrhea, imminent abortion, uterine tetanus.', '', 'Oral-\nAdults: 1 to 2 tablets, 3 times daily\nChildren (over 6 years): 1/2 to 1 tablet, 1-2 times daily.\nChildren (1-6 years): 1/4 to 1/2 tablet, 1-2 times daily.\nInjection-\nAdults: 1 to 2 ampoules, intramuscularly or subcutaneously, 1-3 times daily.\nFor the management of acute stone colics: 1 or 2 ampoules by slow intravenous injection.', 'Drotaverine is contraindicated in patients with known hypersensitivity to the products and its constituents.\n\nCaution should be taken for patients suffering from liver and kidney disease.', 'The common side effects are headache, dizziness, rhinitis, sinusitis, gastrointestinal upset, nausea, pharyngitis, edema and fatigue.', 'As with most drugs, the use of Drotaverine Hydrochloride should be avoided during pregnancy and lactation unless essential.', '0000-00-00 00:00:00', 1, 1),
(14, 'HYOSCINE', 'Anticholinergic; Antispasmodic Agent', 'P? L?', 'Hyoscine butylbromide is an antispasmodic medicine which is taken to relieve cramps in the stomach, intestines or bladder. In particular, it helps to ease bloating and the spasm-type pain that can be associated with irritable bowel syndrome and diverticular disease. It works by relaxing some of the muscles in your gastrointestinal and urinary systems.\r\n\r\nHyoscine butylbromide is available on prescription. You can also buy it from a pharmacy, without a prescription, to relieve the symptoms of irritable bowel syndrome, providing your symptoms have previously been diagnosed by a doctor.\r\n\r\nThere is also a medicine called hyoscine which is taken to prevent travel sickness. There is more information about this in a separate medicine leaflet called Hyoscine for travel sickness.', 'antispasmodic, cramps in the stomach, cramps in the intestines, cramps in the bladder', 'Tablets: The usual dose of Hyoscine tablets is 10 to 20 mg tablets per day. If you need to take this medication regularly, then the usual dose is 10 mg tablet 3 to 5 times a day. The maximum dose is 6 tablets per day.\r\n\r\nInjection: The usual dose of Hyoscine Injection is 10 mg to 20 mg given by intramuscular (into a muscle), intravenous (into a vein), or subcutaneous (under the skin) injection. The maximum daily dose is 100 mg.\r\n\r\nMany things can affect the dose of medication that a person needs, such as body weight, other medical conditions, and other medications. If your doctor has recommended a dose different from the ones listed here,do not change the way that you are using the medication without consulting your doctor.\r\n\r\nSwallow the tablets whole with a glass of water. Do not crush or chew the tablets.\r\n\r\nIt is important to use this medication exactly as prescribed by your doctor. If you miss a dose, skip the missed dose and continue with your regular dosing schedule. Do not use a double dose to make up for a missed one. If you are not sure what to do after missing a dose, contact your doctor or pharmacist for advice.', 'Some medicines are not suitable for people with certain conditions, and sometimes a medicine may only be used if extra care is taken. For these reasons, before you start taking hyoscine butylbromide it is important that your doctor or pharmacist knows:\r\nIf you are pregnant or breast-feeding.\r\nIf you have prostate problems.\r\nIf you have any other digestive system problems, such as reflux disease, diarrhoea, ulcerative colitis, or severe constipation.\r\nIf you have high blood pressure, or if you have recently had a heart attack.\r\nIf you have glaucoma. This is a condition where the pressure in your eyes is raised.\r\nIf you have been told by a doctor that you have a fast heart rate.\r\nIf you have Down\\\\\\\'s syndrome.\r\nIf you are less than 12 years old or over 65 years old.\r\nIf you have been told you have nerve damage, a condition called autonomic neuropathy.\r\nIf you have a condition that causes muscle weakness, called myasthenia gravis.\r\nIf you are taking any other medicines. This includes any medicines you are taking which are available to buy without a prescription, as well as herbal and complementary medicines.\r\nIf you have ever had an allergic reaction to a medicine.', 'Hyoscine butylbromide side-effects (these affect less than 1 in 100 people) are Dry mouth, Dry skin, sweating, Itchy skin rash', '', '0000-00-00 00:00:00', 1, 1),
(15, 'MEBEVERINE', 'Anticholinergic; Antispasmodic Agent', 'P? L?', '? Symptomatic treatment of IBS\n? Chronic irritable colon\n? Spastic constipation\n? Mucous colitis\n? Colicky abdominal pain\n? Persistent non-specific diarrhoea', '', 'Dosage & Administration\nAdults, elderly & children over 10 years: MevinTM\nTablet: 1 tablet three times daily. MevinTM 200\nSR Capsule: 1 capsule 2 times daily. MevinTM is\nmost effective when taken 20 minutes before\nmeals. After several weeks when the desired\neffect has been obtained, the dosage may be\ngradually reduced.', 'Caution should be exercised in porphyria or\nallergic reaction to this or any other medicine\nof this group.', 'Generally Mebeverine is well tolerated.\nHowever, few side-effects like skin rash,\nurticaria & angioedema may appear.', 'No teratogenicity has been shown in animal experiments. However, the usual precautions concerning the administration of any drug during pregnancy should be exercised.\nMebeverine does not excrete in the breast milk after administering the therapeutic dose.', '0000-00-00 00:00:00', 1, 1),
(16, 'OXYPHENONIUM', 'Anticholinergic; Antispasmodic Agent ', 'P? L?', 'Abdominal pain, Colic, Gastrointestinal tract spasm, Peptic ulcer disease, Visceral spasms', '', 'Adult: 1-2 tablets 3-4 times daily\nChildren: ?- 1 tablets 1-3 times daily', 'Urinary outflow obstruction, paralytic ileus, myasthenia gravis. \n\nChildren; elderly; benign prostatic hyperplasia; acute MI, cardiac failure, hypertension, thyrotoxicosis; pregnancy and lactation; fever; angle-closure glaucoma.', 'Dryness of mouth, difficulty in talking/swallowing; reduced bronchial secretions; blurring of vision, photophobia; bradycardia followed by tachycardia and arrhythmias; urinary retention, constipation, vomiting, nausea; confusion and giddiness.', 'Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.', '0000-00-00 00:00:00', 1, 1),
(17, 'TRIMEBUTINE', 'Synthetic anticholinergic agent ', 'P? L?', 'Treatment & relief of symptoms associated\nwith irritable bowel syndrome (spastic colon)\nPostoperative paralytic ileus in order to\naccelerate the resumption of the intestinal\ntransit following abdominal surgery.', '', 'For adults: 100mg-200mg, 3 times per day\nbefore meals.', 'Patients with known hypersensitivity to\ntrimebutine maleate or any excipient.', '', 'The use of trimebutine maleate in pregnant women is recommended. It is not known if trimebutine maleate passes into breast milk. This medication should be used while breast feeding only if the potential benefits outweigh risks to the nursing infants.', '0000-00-00 00:00:00', 1, 1),
(18, 'LACTULOSE', 'Synthetic Disaccharide; Osmotic Laxative', '', 'Constipation, hepatic encephalopathy.', '', 'Constipation: Initially Osmolax solution may be given twice daily. In due course the dose\nshould be adjusted according to the needs of\nthe individual, but the following serves as a guide line:-\nStarting dose: Adults: (including the elderly) - 15 ml twice daily. Children: 5 to 10 years - 10 ml twice daily.\nChildren under 5 years - 5 ml twice daily. Children under 1 year - 2.5 ml twice daily.\nOsmolax solution may, if necessary, be taken    with water, fruit juice etc.\nHepatic encephalopathy: Adults (including the\nelderly): Initially 30-50 ml three times a day.\nSubsequently adjust the dose to produce two\nor three soft stools each day.\nChildren: No dosage recommended for this\nindication.\nBecause of Lactulose?s physiological mode of\naction it may take up to 48 hours before Effects\nare obtained. However, clinical experience\nhas shown that this medicament does exhibit\na ?carry-over? Effect, which may enable the\npatient to reduce the dose gradually over a\nperiod of time. A maintenance dose of 15 ml per\nday provides only 14 kilocalories & is therefore,\nunlikely to adversely affect diabetic patients.', 'Galactosaemia. gastro-intestinal obstruction,\nlactose intolerance.', 'Meteorism & increased flatulence, diarrhoea.', 'If laxative therapy is needed in pregnancy, use of this drug is acceptable.', '0000-00-00 00:00:00', 1, 1),
(19, 'SULFASALAZINE', 'Drugs for Irritable Bowel Syndrome, Drugs used for Rheumatoid Arthritis, Ulcerative Colitis', '', 'Sulfasalazine is indicated in:\nRheumatoid arthritis & Juvenile arthritis: In the treatment of patients with rheumatoid arthritis and pediatiric patients with polyarticular-course juvenile rheumatoid arthritis, who have responded inadequately to salicylates or other non-steroidal anti-inflammatory drugs (NSAIDs).\nUlcerative colitis and Crohn\'s Disease: As adjunct in the treatment of ulcerative colitis with the usual supportive and dietary measures. In the treatment of active Crohn\'s disease, especially in patients with colonic involvement.', '', 'The dosage of Sulfasalazine tablets should be individually adjusted according to the patient\'s tolerance and response to the treatment and taken in evenly divided doses preferably after meals.\n\nAdult dose for crohn?s disease: 500 mg orally 2 to 4 times a day with food.\n\nPediatric use (6 years or older) for Ulcerative Colitis: The initial dose 40 to 60 mg/kg/day orally divided into 3 to 6 doses. \n\nAdult dose for rheumatoid arthritis: 2 g daily in two evenly divided doses. It is advisable to initiate therapy with a lower dosage e.g. 0.5 to 1.0 g daily, to reduce possible gastrointestinal intolerance. A suggested dosing schedule is given bellow:\nFirst week: One tablet in the evening\nSecond week: One tablet in the morning & One tablet in the evening\nThird week: One tablet in the morning & two tablet in the evening\nForth week: Two tablet in the morning & two tablet in the evening\nIn case of rheumatoid arthritis 6 years or older: initial dose 10 mg/kg/day orally in 2 equally divided doses.\n\nJuvenile rheumatoid arthritis-polyarticular course: Children 6 years of age and older: 30 to 50 mg/kg/day in two evenly divided doses. Typically the maximum dose is 2 g per day.\n\nFor other indications:\nInitial therapy: \nAdults: 3 to 4 g daily in divided doses with dosage intervals not exceeding eight hours. It may be advisable to initiate therapy with a lower dosage e.g. 1 to 2 g daily to reduce possible gastrointestinal intolerance.\nChildren 6 years of age and older: 40 to 60 mg/kg/day in to 3 to 6 divided doses.\nMaintenance therapy: \nAdults: 2 g daily.\nChildren 6 years of age and older: 30 mg/kg/day in 4 divided doses.', 'Hypersensitivity to Sulfasalazine, its metabolites, sulfonamides or salicylates, patients with intestinal or urinary obstruction and porphyria.\n\nHepatic/renal impairment, G6PD deficiency, allergic bronchial asthma, lactation.', 'The common adverse reactions are anorexia, headache, nausea, vomiting, gastric distress, dyspepsia, abdominal pain, dizziness, apparently reversible oligospermia etc.', 'Use in pregnancy: Pregnancy category B. This drug should be used during pregnancy only if clearly needed.\n\nUse in lactation: Caution should be exercised when sulfasalazine is administered to a nursing mother.', '0000-00-00 00:00:00', 1, 1),
(20, 'LOPERAMIDE', 'Antidiarrheals', '', 'Acute & chronic diarrhoea, IBS (Diarrhoea predominant).', '', 'Acute diarrhoea: The initial dose is 2 capsules for adults & 1 capsule for children older than eight; in addition 1 capsule should be taken at any subsequent loose stool. The daily dose, however should not exceed 8 capsules for adults, for children 4-6 capsules according to age. Chronic diarrhoea Initial dose: Adults: 2 capsules daily. Children: Older than eight: 1 capsule daily.', 'It should not be used in children less than 4 years of age.', 'Paralytic ileus, abdominal cramps & bloating urticaria, nausea, vomiting, constipation, tiredness, drowsiness, dizziness & dry mouth.', 'Although studies in animal did not demonstrate any teratogenic Effect of loperamide, it should not be administered during pregnancy. The fraction of loperamide secreted in the human milk is very low, but caution is advised if it is to be administered to nursing mothers.', '0000-00-00 00:00:00', 1, 1),
(21, 'URSODEOXYCHOLIC ACID', 'Cholagogues, Cholelitholytics & Hepatic Protectors', 'P? L?', 'Ursodeoxycholic Acid is indicated for the treatment of different hepatobiliary disorders like, Alcoholic Fatty Liver Disease, Dissolution of gallstones, Primary Billiary Cirrhosis (PBC), Primary Sclerosing Cholangitis (PSC), Non-alcoholic steato hepatitis (NASH), Cholestasis & viral hepatitis.', '', 'Dissolution of Gall stones: 8 - 12 mg/kg/day either as single night time dose or in divided doses; Primary Billiary irrhosis (PBC): 10- 15  mg/kg/day in 2-4 divided doses; Alcoholic Fatty Liver: 300 mg/day; Acute Viral Hepatitis: 600 mg/day; Primary Sclerosing Cholangitis (PSC): 25 - 30 mg/kg/day; Non-alcoholic steato hepatitis (NASH): 13 - 15 mg/kg/day', 'Non-functioning gall-bladder calcified and pigmented gallstones, inflammatory bowel disease. It should be used cautiously in those with liver disease.', 'Nausea, vomiting, diarrhea, gallstones calcification and pruritus.', 'Pregnancy category B. No evidence of harm has been reported in pregnancy. It has been effectively used for the reatment of cholestasis of pregnancy during the last trimester without any side effects. Problems have not been documented in humans regarding breast feeding.', '0000-00-00 00:00:00', 1, 1),
(22, 'AMILORIDE + HYDROCHLOROTHIAZIDE', 'Thiazide diuretics & related drugs', '', 'Treatment of hypertension or congestive heart failure in patients who develop hypokalemia when thiazide or other kaliuretic diuretics are used alone, or in patients in whom maintenance of normal serum potassium levels is clinically important (eg, digitalized patients); alone or as adjunctive treatment with other antihypertensive agents.', '', 'Adult: 1-2 tablets (5 mg amiloride & 50 mg hydrochlorothiazide) daily in single or divided doses, increasing if necessary to maximum 4 tablets.\n\nChildren: Safety and efficacy not established.', 'Hyperkalemia (serum potassium levels greater than 5.5 mEq/L); concurrently with other potassium-sparing diuretics (eg, spironolactone), potassium supplements (including potassium-rich diet) except in severe or refractory cases of hypokalemia; impaired renal function; sensitivity to any components of product.', 'Cardiovascular: Arrhythmia, tachycardia, palpitations (amiloride).\nCNS: Headache, fatigue, tiredness, weakness, dizziness, encephalopathy, tremors, decreased libido (amiloride); restlessness (hydrochlorothiazide).\nDermatologic: Mild skin rash, pruritus, alopecia (amiloride); urticaria, purpura (hydrochlorothiazide).\nEENT (eye, ear, nose, and throat): Increased ocular pressure, tinnitus (amiloride); transient blurred vision, xanthopsia (hydrochlorothiazide).\nGI: Nausea, anorexia, GI and abdominal pain, flatulence, activation of peptic ulcer, dyspepsia, heartburn, dry mouth (amiloride); pancreatitis, cramping, GI irritation, sialadenitis (hydrochlorothiazide).\nGenitourinary: Bladder spasm, polyuria, urinary frequency (amiloride); interstitial nephritis (hydrochlorothiazide).\nHematologic: Aplastic anemia, neutropenia (amiloride); agranulocytosis, leukopenia, hemolytic anemia, thrombocytopenia (hydrochlorothiazide).\nHepatic: Jaundice.\nMetabolic: Hyperkalemia, hyperglycemia, glucosuria, hyperuricemia (hydrochlorothiazide).\nRespiratory: Shortness of breath, cough (amiloride); respiratory distress, including pneumonitis and pulmonary edema (hydrochlorothiazide).', 'Pregnancy Category B \n\nLactation: \nAmiloride: undetermined\nhydrochlorothiazide: excreted in breast milk.', '0000-00-00 00:00:00', 1, 1),
(23, 'AMLODIPINE', 'Calcium-channel blockers', 'P? L?', 'Hypertension: Amlodipine is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.\n\nStable angina: Amlodipine is indicated for the treatment of chronic stable angina. It may be used alone or in combination with other antianginal agents.\n\nVasospastic angina: Amlodipine is indicated for the treatment of confirmed or suspected vasospastic angina. The drug may be used as single therapy or in combination with other antianginal drugs.', '', 'The dose should be individualized according to the goal of therapy and patient response. The usual initial oral dose for stable or vasospastic angina and hypertension is 5 mg once daily with a maximum dose of 10 mg once daily.', 'Amlodipine is contraindicated in patients with-\n\n1. Hypersensitivity to amlodipine, dihydropyridine derivatives or any of the excipients\n2. Shock (including cardiogenic shock)\n3. Obstruction of the outflow-tract of the left ventricle (e.g. high grade aortic stenosis)\n4. Unstable angina\n5. Hemodynamically unstable heart failure after acute myocardial infarction (during the first 28 days)\n6. Severe hypotension', 'Peripheral oedema may occasionally be severe but is fully reversible. As with other calcium antagonist drugs, peripheral oedema and skin erythema occur in a proportion of patients (5-10%) and facial flushing in 2-5% of patients. Complain of fatigue was also reported more frequently than in placebo treated patients. There is evidence that these effects are more common in patients treated with doses greater than 10 mg daily.', 'Pregnancy Category C. The safety of amlodipine in human pregnancy has not been established. In animal studies, reproductive toxicity was observed at high doses. Use in pregnancy is only recommended when there is no safer alternative and when the disease itself carries greater risk for the mother and fetus.\n\nLactation: It is not known whether amlodipine is excreted in breast milk. A decision on whether to continue/discontinue breast-feeding or to continue/discontinue therapy with amlodipine should be made taking into account the benefit of breast-feeding to the child and the benefit of amlodipine therapy to the mother.', '0000-00-00 00:00:00', 1, 1),
(24, 'AMLODIPINE + ATENOLOL', 'Beta-blocker + Calcium-channel blocker; \nAntihypertensive', 'P? L?', 'Hypertension not controlled by monotherapy, patients with angina pectoris & hypertension as co-existing diseases, Post MI, Refractory angina pectoris where nitrate therapy has failed.', '', 'Initiated with a single dose of Amlodipine 5 mg + Atenolol 50 mg. Depending upon the therapeutic response, titration of the dosage is recommended. In elderly patients, it is advisable to initiate the therapy with Amlodipine 5 mg + Atenolol 25 mg tablet. ', 'Hypersensitivity to any of the components. Bronchospasm: The combination should be used with caution in patients with airway obstruction. Renal Impairment: Caution may be necessary if the creatinine clearance is less\nthan 30ml/min. Hepatic impairment: Caution may be necessary in the use of the combination in patients with severe liver damage. Drug withdrawal: Any discontinuation should be gradual & under observation.\n', 'Well tolerated. Overall side effects include fatigue, headache, edema, nausea, drowsiness, anxiety & depression.', 'Pregnancy: The combination should be used during pregnancy only if the expected benefit outweighs the potential foetal risk. Lactation: Nursing mothers should not use the combination. If its use is considered necessary, breast feeding should be stopped.', '0000-00-00 00:00:00', 1, 1),
(25, 'AMLODIPINE + ATORVASTATIN', '', '', 'Amlodipine:\nHypertension\nChronic Stable Angina\nVasospastic Angina (Prinzmetal\'s or Variant Angina)\nAtorvastatin:\nHeterozygous Familial and Nonfamilial Hypercholesterolemia\nElevated Serum TG Levels\nPrimary Dysbetalipoproteinemia\nHomozygous Familial Hypercholesterolemia', '', '', '', '', '', '0000-00-00 00:00:00', 1, 1),
(26, 'AMLODIPINE + BENAZEPRIL ', '', '', 'Hypertension', '', 'Amlodipine is an effective treatment of hypertension in once-daily doses of 2.5-10 mg while Benazepril is effective in doses of 10-80 mg.', 'In patients who are hypersensitive to Benazepril, to any other ACE inhibitor, or to Amlodipine.\nImpaired Renal Function: Should be used with caution in patients with severe renal disease. Patients with Congestive Heart Failure: Calcium channel blockers should be used with caution in patients with heart failure. Patients with Hepatic Failure: In patients with impaired hepatic function, caution should be exercised when administering this combination.\n', 'Generally mild & transient. The most common reasons for discontinuation of therapy with this combination were cough. Body as a whole: Asthenia & fatigue. CNS: Insomnia, nervousness, anxiety, tremor & decreased\nlibido. Dermatologic: Flushing, hot flashes, rash, skin nodule & dermatitis. Digestive: Dry mouth, nausea, abdominal pain, constipation, diarrhea, dyspepsia & esophagitis. Metabolic & Nutritional: Hypokalemia. Musculoskeletal: Back pain, musculoskeletal pain, cramps & muscle cramps. Respiratory: Pharyngitis.\nUrogenital: Sexual problems such as impotence, & polyuria\n', 'Pregnancy Category C (first trimester) & D (second & third trimesters). Nursing Mothers: It is recommended that nursing should be discontinued while this combination is administered.', '0000-00-00 00:00:00', 1, 1),
(27, 'ATENOLOL', '', '', 'Hypertension, angina pectoris, cardiac arrhythmia, myocardial infarction.', '', '50 mg once daily, can be raised to 100- 200 mg.', 'Second & third degree heart block, Untreated heart failure, Cardiogenic shock.', 'Cold extremities, fatigue, vivid dreams, insomnia, diarrhoea, constipation, impotence & paraesthesia.', 'Recommended.', '0000-00-00 00:00:00', 1, 1),
(28, 'BISOPROLOL', 'Beta-blocker; Antihypertensive', 'P? L? Lab *', 'Bisoprolol is indicated in the management of hypertension & in the treatment of angina. It may be used alone or in combination with other antihypertensive agents.', '', 'The dose of Bisoprolol must be individualized to the needs of the patient. The usual starting dose Bisoprolol 5 mg once daily. In some patients Bisoprolol 2.5 mg may be an appropriate starting dose. If the antihypertensive Effect of Bisoprolol 5 mg is inadequate, the dose may be increased to Bisoprolol 10 mg & then, if necessary, to 20 mg once daily.', 'Bisoprolol is contraindicated in patients with cardiogenic shock, overt cardiac failure, second or third degree AV block, & marked sinus bradycardia. Impaired renal or hepatic function: Use caution in adjusting the dose of Bisoprolol in patients with renal or hepatic impairment. Risk of anaphylactic reaction: While taking beta-blockers, patients with a history of severe anaphylactic reaction to a variety of allergens may be more reactive torepeated challenge, accidental, diagnostic or therapeutic. Such patients may be unresponsive to the usual doses of epinephrine used to treat allergic reaction.', 'Fatigue, dizziness, headache, disturbances of the gut such as nausea, vomiting, diarrhoea, constipation or abdominal pain, cold or numb extremities, e.g. hands & feet, muscle weakness or cramps, slower than normal heart beat (bradycardia), worsening of heart failure, sleep disturbance, depression, breathing difficulties due to a narrowing of the airways (bronchospasm) in people with asthma or COPD.', 'Pregnancy: Bisoprolol should not be used during pregnancy unless clearly necessary. If treatment with Bisoprolol is considered necessary, the uteroplacental blood flow & the foetal growth should be monitored. Lactation: It is not known whether this drug is excreted in human milk. Therefore, breast-feeding is not recommended during administration of Bisoprolol. ', '0000-00-00 00:00:00', 1, 1),
(29, 'CANDESARTAN', '', '', 'Hypertension', '', '2-32 mg once or twice daily.', '', '', '', '0000-00-00 00:00:00', 1, 1),
(30, 'Candesartan + Hydrochlorothiazide ', '', '', 'Hypertension', '', '2-32 mg once or twice daily.', '', '', '', '0000-00-00 00:00:00', 1, 1),
(31, 'CARVEDILOL', '', '', 'Mild or moderate heart failure of ischemic or cardiomyopathic origin, in conjunction with digitalis, diuretics & ACE inhibitors, Hypertension: Monotherapy or in combination.', '', 'Heart failure: Start at 3.125 mg twice daily & increase to 6.25 & then 25 mg twice daily over intervals of at least 2 weeks. Maintain lower doses if higher doses are not tolerated. ? Left ventricular dysfunction following myocardial infarction: Start at 6.25 mg twice daily & increase to 12.5 mg then 25 mg twice daily after intervals of 3 to 10 days. A lower starting dose or slower titration may be used. ? Hypertension: Start at 6.25 mg twice daily & increase if needed for blood pressure control to 12.5 mg then 25 mg twice daily over intervals of 1 to 2 weeks.', 'Severe chronic cardiac failure requiring intravenous inotropic therapy, bronchial asthma or related bronchospastic conditions, second or third-degree AV block, sick sinus syndrome (unless a permanent pacemaker is in place), cardiogenic shock, or severe bradycardia, use in hepatic impairment is not recommended. Carvedilol is contraindicated in patients with hypersensitivity to the drug.', 'Postural hypotension, dizziness, headache, fatigue, gastro-intestinal disturbances, bradycardia, occasionally diminished peripheral circulation, peripheral oedema & painful extremities, dry mouth, dry eyes, eye irritation or disturbed vision, impotence, disturbances of micturition, influenza like symptoms, rarely angina.', 'Not recommended.', '0000-00-00 00:00:00', 1, 1),
(32, 'DILTIAZEM HYDROCHLORIDE', '', '', 'Angina pectoris, Hypertension with tachycardia.', '', '90 - 120 mg twice daily up to 240 mg.', 'Known hypersensitivity, sick sinus syndrome, second or third degree AV block, severe hypertension or acute myocardial infarction & pulmonary congestion.', 'Bradycardia, sino-atrial block, atrioventricular block, hypertension, malaise, headache, hot flushes, GIT disturbances, oedema, hepatitis & depression reported.', 'The drug should be used during pregnancy only when the potential benefits justify the possible risk to the fetus. Women receiving the drug should not breastfeed their infants.', '0000-00-00 00:00:00', 1, 1),
(33, 'ENALAPRIL', 'Angiotensin-converting enzyme (ACE) inhibitors', '', 'Enalapril is indicated in-\nAll grades of essential hypertension and renovascular hypertension either alone or in combination with other antihypertensive agents especially thiazide diuretics.\nPrevention of symptomatic heart failure.\nTreatment of congestive heart failure (adjunct), usually in combination with diuretics and digitalis.\nPrevention of coronary ischaemic events in patients with left ventricular dysfunction.\nEnalapril is also used either alone or as an adjunct in the treatment of angina, diabetic nephropathy and Raynaud\'s disease.', '', 'Hypertension: Initially 5 mg once daily if used alone or 2.5 mg daily if used in addition to diuretic, in elderly patients or in patients with renal impairment. Usual maintenance dose is 10-20 mg once daily. However, in severe hypertension it may be increased to a maximum of 40 mg once daily.\n\nHeart failure (adjunct) and asymptomatic left ventricular dysfunction: Initially 2.5 mg under close medical supervision. Usual maintenance dose is 20 mg daily in 1-2 divided doses', 'Aortic stenosis or outflow tract obstruction. Renovascular disease. Severe resistant HTN. Peripheral vascular disease or generalized atherosclerosis.\n\nAssess renal function; regular WBC counts in patient w/ collagen vascular disease eg SLE & scleroderma. Patient receiving immunosuppressive therapy; those prone to salt or water depletion. Pregnancy.', 'Dizziness and headache are more commonly reported side effects. Fatigue and asthenia were reported in 2-3% of patients. Other side effects occurred in less than 2% of patients and included hypotension, orthostatic hypotension, syncope, nausea, diarrhoea, muscle cramps, rash and cough.\n\nLess frequently renal dysfunction, renal failure and oliguria have been reported. Angioedema, hyperkalemia and hyponatremia have also been reported rarely', 'Category D: Contraindicated in pregnancy. The drug is excreted in trace amount in human milk and caution should be exercised if given to nursing mothers.', '0000-00-00 00:00:00', 1, 1),
(34, 'FUROSEMIDE', '', '', 'Cardiac, pulmonary, hepatic & renal oedema, peripheral oedema & hypertension.', '', 'Tablet : In mild cases, 20 mg daily or 40 mg on alternate days. In resistant cases, 80 mg/day. Children- 1 to 3 mg/kg/day, max. 40 mg/day. Injection : 20-50 mg/day IM/IV. Children- 0.5- 1.5 mg/kg/day. max. 20 mg/day.', 'Anuria, electrolyte deficiency & precomatose states associated with liver cirrhosis. Hypersensitivity to furosemide or sulphonamides.', 'Alkalosis, uric acid retention & may rarely produce acute gout. Fusid may provoke hyperglycemia & glycosuria.', 'Fusid should be cautiously used in cardiogenic shock complicated by pulmonary oedema & in the first trimester of pregnancy. Blood pressure & pulse during rapid diuresis should be monitored. Should be used with caution\nduring lactation.\n', '0000-00-00 00:00:00', 1, 1),
(35, 'FUROSEMIDE +  SPIRONOLATONE ', '', '', 'Essential hypertension, Chronic congestive heart failure, Hepatic cirrhosis with ascites, Swelling due to excess fluid retention (edema), Hyperaldosteronism, resistant edema associated with secondary hyperaldosteronism.', '', 'Fusid plus: 1 to 4 tablets daily, Fusid 40 plus: one to two tablets daily.', 'Anuria, acute renal insufficiency, rapidly deteriorating or severe impairment of renal function (creatinine clearance: < 30 ml/ min), hyperkalaemia, Addison?s disease, & in patients who are hypersensitive to spironolactone, furosemide or sulphonamides. Caution should be taken in patients liable to electrolyte deficiency. Used with caution in diabetes, enlarged prostate, hypotension & in hypovolemia.', 'Headache & drowsiness, gastrointestinal distress including cramp & diarrhoea, ataxia, mental confusion, skin rashes, gynaecomastia, hirsutism, deepening of the voice, menstrual irregularities, impotence, hyponatremia,\nhyperkalemia, dehydration & reduction in blood volume with circulatory collapse, cardiac arrhythmias.', 'Furosemide should only be used in women in child bearing age when appropriate contraceptive measures are taken or if the potential benefits justify the potential risks to the foetus.\n\nIf use of Spironolactone is considered essential, an alternative method of infant feeding should be instituted. Furosemide is excreted in breast milk & breast-feeding should be discontin', '0000-00-00 00:00:00', 1, 1),
(36, 'LACIDIPIN', 'Calcium-channel blockers', '', 'Lacidipine is indicated for the treatment of hypertension either alone or in combination with other antihypertensive agents, including ?-blockers, diuretics, ACE-inhibitors etc.', '', 'The recommended initial dose of Lacidipine is 2 mg once daily. The dose may be increased to 4 mg and then, if necessary, to 6 mg after 3 to 4 weeks. Lacidipine should be taken preferably in the morning.', 'Hypersensitivity to any ingredient of this product, cardiogenic shock, unstable angina, aortic stenosis, avoid within 1 month of myocardial infarction, impaired left ventricular function.\n\nCardiac conduction abnormalities, poor cardiac reserves, hepatic impairment, withdraw if ischemic pain occurs shortly after initiating treatment or if cardiogenic shock develops, avoid grape fruit juice.', 'Lacidipine is generally well tolerated. Some individuals may experience minor side effects like flushing, palpitation, edema, headache, dizziness, rarely gastro-intestinal disturbances, gum hyperplasia, mood disturbances, asthenia, polyuria, muscle cramps, skin rash etc.', 'Pregnancy: There are no data on the safety of Lacidipine in human pregnancy. Lacidipine provides no evidence of a teratogenic effect in animal study.\n\nLactation: Milk transfer studies in animals have shown that Lacidipine (or its metabolites) are likely to be excreted into breast milk. There is, however, no clinical experience of Lacidipine in pregnancy and lactation. Accordingly, Lacidipine should not be used during pregnancy or lactation.', '0000-00-00 00:00:00', 1, 1);
INSERT INTO `mims_genericinformation` (`ID`, `Name`, `Classification`, `SafetyRemark`, `Indication`, `IndicationTags`, `DosageAdministration`, `ContraindicationPrecaution`, `SideEffect`, `PregnancyLactation`, `LastUpdate`, `CreatedBy`, `IsActive`) VALUES
(37, 'LERCANIDIPINE', 'Calcium-channel blockers', '', 'Lercanidipine is indicated for the treatment of mild to moderate essential hypertension.', '', 'Use in elderly: The recommended dosage is 10 mg orally once a day at least 15 minutes before meals; the dose may be increased to 20 mg depending on the individual patient\'s response. It may take about 2 weeks before the maximal anti-hypertensive effect is apparent. Some individuals, not adequately controlled on a single antihypertensive agent, may benefit from the addition of Lercanidipine to therapy with a beta-adrenoceptor blocking drug (atenolol), a diuretic (hydrochlorothiazide) or an ACE inhibitor (ramipril).\n\nUse in children: Since there is no clinical data in patients under the age of 18 years, use in children is not currently recommended.\n\nUse in renal or hepatic dysfunction: Special care should be exercised in patients with mild to moderate renal or hepatic dysfunction. Dosage above 20 mg daily must be approached with caution. Lercanidipine is not recommended for use in patients with severe hepatic or renal dysfunction.\n\nAdministration\nShould be taken on an empty stomach. Take at least 15 min before meals.', 'Lercanidipine is contraindicated in patients with left ventricular outflow tract obstruction, untreated congestive cardiac failure, unstable angina pectoris, within 1 month of a myocardial infarction and known hypersensitivity to any dihydropyridine. Lercanidipine should not be taken with grapefruit juice.\n\nSpecial care should be exercised when Lercanidipine is used in patients with sick sinus syndrome, left ventricular dysfunction and ischaemic heart disease.', 'Treatment with Lercanidipine is generally well tolerated. The most common side effects are related to the vasodilatory properties of Lercanidipine such as flushing, peripheral edema, headache, dizziness and asthenia. Other side effects, which occurred in less than 1% of patients include fatigue; GI disturbances such as dyspepsia, nausea, vomiting, epigastric pain and diarrhea, polyurea, rash, somnolence and myalgia.', 'Pregnancy Category C. There is no clinical experience with lercanidipine in pregnancy, but other dihydropyridine compounds have been found to cause irreversible malformations in animals. Therefore, lercanidipine should not be administered during pregnancy or to women with child-bearing potential unless effective contraception is used.\n\nUse in lactation: There is no clinical experience with lercanidipine in lactation. Distribution into milk may be expected, due to the high lipophilicity of lercanidipine. Therefore, lercanidipine should not be administered to lactating women.', '0000-00-00 00:00:00', 1, 1),
(38, 'LOSARTAN', '', '', 'Hypertension: Losartan indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents, including diuretics. Hypertensive patients with Left Ventricular Hypertrophy Losartan is indicated to reduce the risk of stroke in patients with hypertension & left ventricular hypertrophy. Nephropathy in Type 2 Diabetic Patients: Losartan is indicated for the treatment of diabetic nephropathy with an elevated serum creatinine & proteinuria (urinary albumin to creatinine ratio ?300 mg/g) in patients with type 2 diabetes & a history of hypertension.', '', 'Adult hypertensive patients: The usual starting dose of Losartan is 50 mg once daily. 25 mg used in patients with possible depletion of intravascular volume (e.g., patients treated with diuretics) & patients with a history of hepatic Impairment. Losartan can be administered once or twice daily with total daily doses ranging from 25 mg to 100 mg. The effect of Losartan is substantially present within one week but in some studies the maximal effect occurred in 3-6 weeks. No initial dosage adjustment is necessary for elderly patients or for patients with renal impairment, including patients on dialysis. A lower dose should be considered for patients with a history of hepatic impairment. There is no therapeutic experience in patients with severe hepatic impairment. Therefore,\nLosartan is contraindicated in patients with severe hepatic impairment. Pediatric hypertensive patients ? 6 years of age: The usual recommended starting dose is 0.7 mg/kg once daily (up to 50 mg total) administered as a tablet or a suspension. Dosage should be adjusted according to blood pressure response. Doses above 1.4 mg/kg\n(or in excess of 100 mg) daily have not been studied in pediatric patients. Losartan is not recommended in pediatric patients less than 6 years of age or in pediatric patients with glomerular filtration rate less than 30 mL/\nmin/1.73 ml. Hypertensive patients with Left Ventricular Hypertrophy: The usual starting dose is 50 mgof Losartan once daily. Hydrochlorothiazide 12.5 mg daily should be added and/or the dose of Losartan should be increased to 100 mg once daily followed by an increase in Hydrochlorothiazide to 25 mg once daily based\non blood pressure response. Nephropathy in Type 2 Diabetic Patients: The usual starting dose is 50 mg once daily. The dose should be increased to 100 mg once daily based on blood pressure response. Losartan may be administered with insulin & other commonly used hypoglycemic agents (e.g., sulfonylureas, glitazones & glucosidase inhibitors). Losartan may be administered with other antihypertensive agents & with or without food.\n', 'Losartan is contraindicated in patients who are hypersensitive to any component of this product. Do not co-administer aliskiren with Losartan in patients with diabetes. It is also contraindicated in severe hepatic impairment. In patients who are intravenously volume depleted (e.g. those treated with high-dose diuretics), symptomatic hypotension may occur. These conditions should be corrected prior to the administration of Losartan or a lower starting dose should be used. A lower dose should be considered for patients with a history of hepatic impairment. Losartan should not be used with Potassium-sparing diuretics.', 'Dizziness, rash, angioedema involving swelling of the face, lips and/or tongue & serious hypotension (particularly on initiating treatment in salt-depleted patients) or renal failure (mainly in patients with renal artery stenosis) may be encountered during Losartan potassium treatment.', 'Pregnancy Catagory D. Losartan Potassium should not be used in pregnancy & if pregnancy is detected Losartan potassium should be discontinued as soon as possible. Losartan Potassium should not be used in lactating mother.', '0000-00-00 00:00:00', 1, 1),
(39, 'LOSARTAN +  HYDROCHLOROTHIAZIDE', '', '', 'Hypertension: Indicated for the treatment of hypertension. This fixed dose combination is not indicated for initial therapy of hypertension, except when the hypertension is severe enough that the value of achieving prompt blood pressure control exceeds the risk of initiating combination therapy in these patients. Hypertensive patients with Left Ventricular Hypertrophy: Indicated to reduce the risk of stroke in patients with hypertension & left ventricular hypertrophy.', '', 'Hypertension: The usual starting dose is 50/12.5 one tablet once daily. More than two tablets 50/12.5 or one tablet 100/25 once daily is not recommended. Maximum antihypertensive effect is attained about three weeks after initiation of therapy. Patients whose blood pressure is not adequately controlled with Losartan or Hydrochlorothiazide monotherapy, may be switched  50/12.5 once daily. If blood pressure remains uncontrolled after about three weeks of therapy, the dose may be increased to one tablet 100/12.5 or two tablets 50/12.5 or 100/25 once daily. Patients whose blood pressure is not adequately controlled with Losartan 100 mg monotherapy, may be switched to 100/12.5 once daily. If blood pressure remains uncontrolled after about three weeks of therapy, the dose may be increased to 2 tablets 50/12.5 or 100/25 once daily.', 'This combination is contraindicated in patients who are hypersensitive to any component of this product. Because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs. Do not coadminister Aliskiren with this combination in patients with diabetes. Periodic determination of serum electrolytes to detect possible electrolyte imbalance should be performed at appropriate intervals. All patients receiving thiazide therapy should be observed for\nclinical signs of fluid or electrolyte imbalance. Serum & urine electrolyte determinations are particularly important when the patient is vomiting excessively or receiving parenteral fluids. Hyperuricemia may occur or frank gout may be precipitated in certain patients receiving thiazide therapy. Because Losartan decreases uric acid, Losartan in combination with Hydrochlorothiazide attenuates the diuretic-induced hyperuricemia. In diabetic\npatients, dosage adjustments of Insulin or oral hypoglycemic agents may be required. Hyperglycemia may occur with thiazide diuretics. Thus latent diabetes mellitus may become manifest during thiazide therapy.\n', 'Abdominal pain, edema/swelling, palpitation, back pain, dizziness, cough, sinusitis, upper\nrespiratory infection, rash.\n', 'Pregnancy Catagory D . Because of the potential for adverse Effects on the nursing infant, a decision should be made whether to discontinue nursing or discontinue the drug,taking into account the importance of the drug to the mother.', '0000-00-00 00:00:00', 1, 1),
(40, 'METHYLDOPA', 'Centrally acting antihypertensive drugs (central sympatholytic)', '', 'Methyldopa is indicated in Hypertension', '', 'Adults-\nInitiation of Therapy: The usual starting dosage of Methyldopa is 250 mg two or three times a day in the first 48 hours. The daily dosage then may be increased or decreased, preferably at intervals of not less than two days, until an adequate response is achieved. To minimize the sedation, start dosage increases in the evening. When Methyldopa is given to patients on other antihypertensives, the dose of these agents may need to be adjusted to effect a smooth transition. When Methyldopa is given with antihypertensives other than thiazides, the initial dosage of Methyldopa should be limited to 500 mg daily in divided doses; when Methyldopa is added to a thiazide, the dosage of thiazide need not to be changed. \n\nMaintenance Therapy: The usual daily dosage of Methyldopa is 500 mg to 2 g in two to four doses. Although occasional patients have responded to higher doses, the maximum recommended daily dosage is 3 gm. Occasionally tolerance may occur, usually between the second and third month of therapy. Adding a diuretic or increasing the dosage of Methyldopa frequently will restore effective control of blood pressure. A thiazide may be added at any time during Methyldopa therapy and is recommended if therapy has not been started with a thiazide or if effective control of blood pressure cannot be maintained on 2 gm of Methyldopa daily. Methyldopa is largely excreted by the kidney and patients with impaired renal function may respond to smaller doses. Syncope in older patients may be related to an increased sensitivity and advanced arteriosclerotic vascular disease. This may be avoided by lower doses. \n\nPediatric Use-\nInitial dosage is based on 10 mg/kg of body weight daily in two to four doses. The daily dosage then is increased or decreased until an adequate response is achieved. The maximum dosage is 65 mg/kg or 3 gm daily, whichever is less.', 'Methyldopa is contraindicated in patients with: \nactive hepatic disease, such as acute hepatitis and active cirrhosis.\nliver disorders previously associated with Methyldopa therapy.\nhypersensitivity to any component of these products.\nOn therapy with monoamine oxidase (MAO) inhibitors.', 'Sedation, usually transient, may occur during the initial period of therapy or whenever the dose is increased. Headache, asthenia, or weakness may be noted as early and transient symptoms. The following systemic side effects may rarely occurs with the use of Methyldopa - angina pectoris, congestive heart failure, orthostatic hypotension, edema or weight gain, bradycardia, pancreatitis, colitis, vomiting, diarrhea, nausea, constipation, dryness of mouth, hyperprolactinemia, bone marrow depression, leukopenia, granulocytopenia, thrombocytopenia, hemolytic anemia; rheumatoid factor, hepatitis, jaundice, myocarditis, pericarditis, vasculitis, eosinophilia, parkinsonism, bell\'s palsy, nightmares and reversible mild psychoses or depression, dizziness, lightheadedness, paresthesias, arthralgia, myalgia, nasal stuffiness, rash, amenorrhea, gynecomastia, lactation, impotence. However, significant adverse effects due to Methyldopa have been infrequent and this agent usually is well tolerated.', 'Pregnancy Category B. Methyldopa appears in breast milk. Therefore, caution should be exercised when Methyldopa is given to a nursing woman.', '0000-00-00 00:00:00', 1, 1),
(41, 'METOPROLOL', 'Beta-adrenoceptor blocking drugs, Beta-blockers', '', 'ln the management of hypertension and angina pectoris. Cardiac arrhythmias, especially supraventricular tachyarrhythmias. Adjunct to the treatment of hyperthyroidism. Early intervention with Metoprolol in acute myocardial infarction reduces infarct size and the incidence of ventricular fibrillation. Pain relief may also decrease the need for opiate analgesics. Metoprolol has been shown to reduce mortality when administered to patients with acute myocardial infarction.', '', 'Oral-\nHypertension: Total daily dosage Metoprolol 100-400 mg to be given as a single or twice daily dose. The starting dose is 100 mg (two Metoprolol-50 tablets) per day. This may be increased by 100 mg per day at weekly intervals. lf full control is not achieved using a single daily dose, a b.i.d. regimen should be initiated. Combination therapy with a diuretic or other anti-hypertensive agent may also be considered.\n\nAngina: Usually Metoprolol 50 mg (one Metoprolol-50 tablet) to 100 mg (two Metoprolol-50 tablets) twice or three times daily.\n\nCardiac arrhythmias: Metoprolol 50 mg (one Metoprolol-50 tablet) b.i.d or t.i.d should usually control the condition. It necessary the dose can be increased up to 300 mg per day in divided doses. Following the treatment of an acute arrhythmia with Metoprolol injection, continuation therapy with Metoprolol tablets should be initiated 4-6 hours later. The initial oral dose should not exceed 50 mg t.i.d.\n\nHyperthyroidism: Metoprolol 50 mg (one Metoprolol-50 tablet) four times a day.The dose should be reduced as the euthyroid state is achieved.\n\nMyocardial infarction: Orally, therapy should commence 15 minutes after the last injection with 50 mg every 6 hours for 48 hours. Patients who fail to tolerate the full intravenous dose should be given half the suggested oral dose. Maintenance ? The usual maintenance dose is 200 mg daily given in divided doses. Elderly? There are no special dosage requirements in otherwise healthy elderly patients. Signidcant hepatic dysfunction: A reduction in dosage may be necessary.\n\nInjection-\nArrhythmias: By intravenous injection, up to 5 mg at a rate of 1-2 mg/minute, repeated after 5 minutes if necessary, total dose 10-15 mg. \n\nIn surgery: By slow intravenous injection 2-4 mg at induction or to control arrhythmias developing during anaesthesia; 2 mg doses may be repeated to a maximum of 10 mg. \n\nMyocardial Infarction: Early intervention within 12 hours of infarction, by intravenous injection 5 mg every 2 minutes to a maximum of 15 mg, followed after 15 minutes by 50 mg by mouth every 6 hours for 48 hours; maintenance 200 mg daily in divided doses.\n\nImpaired Renal Function: Dose adjustment is not needed in patients with impaired renal function. \n\nImpaired Hepatic Function: Dose adjustment is not normally needed in patients suffering from liver cirrhosis because Metoprolol has low protein binding (5-10%). When there are signs of serious impairment of liver function (e.g. shunt-operated patients), a reduction in dose should be considered. \n\nElderly: Dose adjustment is not needed.', '2nd or 3rd degree AV block, sick sinus syndrome, hypotension, decompensated heart failure, sinus bradycardia, severe peripheral arterial circulatory disorders, cardiogenic shock, severe asthma and bronchospasm, untreated phaeochromocytoma, Prinzmetal\'s angina, metabolic acidosis.  The second or third dose should not be given if the heart rate is <40 beats/minute, the P-R interval is > 0.26 seconds and the systolic blood pressure is <90 mmHg or if there is any aggravation of dyspnoea or cold sweating. Intravenous administration of calcium antagonists of the Verapamil-type should not be given to patients treated with beta-blockers. When treating patients with suspected or definite myocardial infarction, the haemodynamic status of the patient should be carefully monitored after each of the three 5 mg intravenous doses. Use in Pregnancy: As with most medicines, Metoprolol should not be given during pregnancy and lactation unless its use is considered essential. As with all antihypertensive agents, beta-blockers may cause side effects (e.g. bradycardia) in the foetus and in the newborn and breast-fed infant. Use in Lactation: The amount of Metoprolol ingested via breast-milk seems to be negligible as regards beta-blocking effect in the infant if the mother is treated with Metoprolol doses within the normal therapeutic range.', 'Bradycardia, bronchospasm, hypotension, headache, fatigue, sleep & gastro-intestinal disturbances, dizziness, vertigo, visual disturbances etc.', 'Metoprolol should not be used in pregnancy or lactating mothers unless the physician considers that the benefit outweighs the possible hazard to the fetus or infant.', '0000-00-00 00:00:00', 1, 1),
(42, 'NEBIVOLOL', '', '', 'Hypertension, Heart Failure Dosage & administration: Heat Failure: Initially 1.25 mg once daily, then if tolerated increased at intervals of 1?2 weeks to 2.5 mg once daily, then to 5 mg once daily, then to max. 10 mg once daily. Hypertension: Starting dose is 5 mg once daily. The dose can be increased at 2 weeks interval up to 40 mg once daily.\n\n', '', '', 'Nebivolol is contraindicated in the following conditions: severe bradycardia, heart block greater than first degree, patients with cardiogenic shock, decompensated cardiac failure, sick sinus syndrome, patients with severe hepatic impairment, patients who are hypersensitive to any component of this product.', 'The most common side effects are headache, nausea & bradycardia.', '?-blockers may cause intra-uterine growth restriction, neonatal hypoglycaemia, & bradycardia; the risk is greater in severe hypertension. If beta-blockers are used close to delivery, infants should be monitored for signs of ?-blockade. Nebivolol is advised to avoid during breast-feeding due to possible risk of toxicity due to ?-blockade. ', '0000-00-00 00:00:00', 1, 1),
(43, 'NIFEDIPINE', '', '', 'Hypertension, Angina.', '', '20 mg twice daily with food.', 'Cardiogenic shock, advanced aortic stenosis, nursing mothers, GI obstruction, inflammatory bowel disease, hypotension, should be swallowed whole & should not be bitten, chewed or broken up. It should be used with caution in patient whose cardiac reserve is poor.', 'Headache, flushing, lethargy, gravitational oedema, rash, nausea, increased frequency of micturition, eye pain, gum hyperplasia, depression, tremor, photosensitivity & few cases of jaundice have been reported.', 'It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.', '0000-00-00 00:00:00', 1, 1),
(44, 'Nifedipine+ Atenolol ', '', '', 'Management of hypertension & chronic stable  angina pectoris where therapy with either a calcium channel blocker or a beta-blocking drug proves inadequate.', '', 'Adult: Hypertension: One capsule daily  swallowed with water. If necessary, the dosage may be increased to 1 capsule every 12 hours. Angina: One capsule every 12 hours swallowed with water. Where additional efficacy is necessary, prophylactic nitrate therapy or additional nifedipine may be of benefit. Elderly: Dosage should not exceed 1 capsule daily in hypertension or 1 capsule twice daily in angina.', 'Known hypersensitivity to either active component or any other excipient or other dihydropyridines. Bradyca dia; cardiogenic shock; hypotension; metabolic acidosis; severe peripheral arterial circulatory disturbances; second or third degree heart block; sick sinus syndrome; untreated pheochromocytoma; uncontrolled heart failure; women capable of childbearing or during pregnancy or during lactation; patients with clinically signif cant aortic stenosis; patients with marked renal impairment, secondary prevention of myocardial infarction, patients with Prinzmetal?s angina & first degree heart block.', 'Flushing, edema, dizziness, headache, gastrointestinal disturbance, purpura, impotence, fatigue.', 'Contraindicated in women capable of childbearing or during pregnancy or during lactation.', '0000-00-00 00:00:00', 1, 1),
(45, 'PERINDOPRIL', 'Angiotensin-converting enzyme (ACE) inhibitors, Direct Renin Inhibitors', '', 'Perindopril is a long-acting ACE (Angiotensin Converting Enzyme) inhibitor and is indicated in Essential hypertension, Stable coronary artery disease, Congestive heart failure.', '', 'Hypertension: One Perindopril 4 tablet once daily preferably in the morning. If necessary, the dose may be increased to 8 mg after 1 month of treatment. Perindopril should be taken before food.\n\nStable coronary artery disease: Perindopril 4 once daily for two weeks, then increased to 8 mg once daily, depending on renal function and provided that the 4 mg dose is well tolerated. Elderly patients should receive Perindopril 2 mg once daily for one week, then Perindopril 4 once daily the next week, before increasing the dose up to 8 mg once daily, depending on renal, function. The dose should be increased only if the previous lower dose is well tolerated.\n\nCongestive heart failure: Perindopril should be started under close medical supervision at a starting dose of 2 mg in the morning. If necessary dose may be increased to 4 mg. \n\nElderly patients: Start treatment at Perindopril 2 mg daily.', 'Perindopril is contraindicated in patients with a history of hypersensitivity to Perindopril. This drug is contraindicated in case of management of hypertension of Children, during Pregnancy & Lactation.', 'Rare and mild: usually at the start of treatment cough, fatigue, asthenia, headache, disturbances of mood and/or sleep have been reported.\n\nLess often: Taste impairment, epigastric discomfort, nausea, abdominal pain and rash. Reversible increase in blood urea and creatinine may be observed. Proteinuria has occurred in some patients.\n\nRarely: Angioneurotic edema and decrease in hemoglobin, red cells and platelets have been reported.', '', '0000-00-00 00:00:00', 1, 1),
(46, 'PERINDOPRIL + INDAPAMIDE', 'Combined antihypertensive preparations', '', 'Indapamide & Perindopril combination is indicated in essential hypertension.', '', 'Adult: One tablet daily, preferably to be taken in the morning and before a meal.\n\nElderly patients: Normal dosage.\n\nRenal failure: \nCreatinine clearance (CrCl) >30 ml/min: No dosage modification. \nCreatinine clearance (CrCl) <30 ml/min: Treatment contraindicated.', 'Absolute: Known allergy to perindopril Erbumine, indapamide, or sulfonamides; history of Quincke\'s edema linked to previous ACE inhibitor therapy; severe renal failure; serious liver disorder; hypokalemia; pregnancy; lactation. \n\nRelative: Combination therapy with lithium, potassium salts, potassium-sparing diuretics, and certain medicines which can cause heart rhythm disorders.', 'Asthenia, dizziness, headache, mood swings and/or sleep disturbances, cramps, hypotension, allergic reactions, skin rashes, gastrointestinal disorders, dry cough, dry mouth, risk of dehydration in the elderly and in patients suffering from heart failure; changes in blood test results may occur.', 'There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.\n\nAnimal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.', '0000-00-00 00:00:00', 1, 1),
(47, 'PRAZOSIN', 'Alpha adrenoceptor blocking drugs', '', 'Hypertension (Primary and Secondary Hypertension). Raynaud\'s phenomenon and Raynaud\'s disease, Congestive heart failure (Prazosin may be used alone or added to the therapeutic regimen in those patients with congestive heart failure who are resistant or refractory to conventional therapy with diuretics and/or cardiac glycosides) & Benign prostatic hyperplasia (For the symptomatic treatment of urinary obstruction due to BPH and in patients awaiting prostatic surgery).', '', 'Hypertension:\nRecommended starting dose is 0.5 mg (in the evening), twice or thrice daily for 3 to 7 days. This dose should be increased to 1 mg twice or three times daily for a further 3 to 7 days. Thereafter, the daily dose should be increased gradually as determined by the patient\'s response to the blood pressure lowering effect. Most patients are likely to be maintained on a dosage regimen of Prazosin alone of up to 15 mg daily in divided doses.\nMaximum dose: 20 mg in divided doses.\nPatients receiving other antihypertensive therapy but with inadequate control: \nThe dosage of the other drug should be reduced to a maintenance level and Prazosin initiated at 0.5 mg in the evening, then continuing with 0.5 mg twice or three times daily.\nSubsequent dosage increases should be made gradually depending upon the patient\'s response.\nCongestive heart failure: \nThe recommended starting dose is 0.5 mg two, three or four times daily, increasing to 4 mg in divided doses. Dosage should be adjusted according to the patient\'s response, based on careful monitoring of cardiopulmonary signs and symptoms.\nUsual daily maintenance dosage: 4 mg to 20 mg in divided doses.\nRaynaud\'s disease: \nThe recommended starting dosage is 0.5 mg twice daily given for a period of 3 to 7 days and should be adjusted according to the patient\'s clinical response.\nUsual maintenance dosage is 1 mg or 2 mg twice daily.\nBenign prostatic hyperplasia: \nThe recommended dosage is 0.5 mg twice daily for a period of 3 to 7 days, with the initial dose administered in the evening. The dosage should then be adjusted according to clinical response.\nThe usual maintenance dosage is 2 mg twice daily.', 'Prazosin is contraindicated in patients with known sensitivity to Prazosin & other quinazolines or any of the excipients. In patients with benign prostatic hyperplasia: Prazosin is not recommended for patients with a history of micturition syncope. It should not normally be administered to patients already receiving another alpha-1-antagonist.\n\nIn patients with congestive heart failure: Prazosin is not recommended in the treatment of congestive cardiac failure due to mechanical obstruction such as aortic valve stenosis, mitral valve stenosis, pulmonary embolism and restrictive pericardial disease.\n\nIn patients with hypertension: Postural hypotension evidenced by dizziness and weakness, or rarely loss of consciousness, has been reported, particularly with the commencement of therapy', 'The most common side effects of Prazosin are allergic reaction, depression, nervousness, insomnia, Hallucinations, dizziness, drowsiness, headache, faintness, syncope, paraesthesia, worsening of pre-existing narcolepsy, blurred vision, eye pain, reddened sclera, vertigo, tinnitus, palpitations etc.', 'Pregnancy category C. It should be used only when, in the opinion of the physician, potential benefit outweighs potential risk. Prazosin has been shown to be excreted in small amounts in human milk. Caution should be exercised when Prazosin is administered to nursing mothers.', '0000-00-00 00:00:00', 1, 1),
(48, 'PROPRANOLOL', 'Beta-adrenoceptor blocking drugs, Beta-blockers', '', 'Propranolol is indicated in:\nessential and renal hypertension\nangina pectoris\nlong term prophylaxis after recovery from acyte myocardial infarction\ncardiac dysrhythmia\nprophylaxis of migraine\nessential tremor\nanxiety and anxiety tachycardia\nadjunctive management of thyrotoxicosis and thyrotoxic crisis\nhypertrophic obstructive cardiomyopathy\nphaeochromocytoma (with ?-blocker)', '', 'Dosage of Propranolol Tablet:\nAdults:\nHypertension: A starting dose of 80 mg twice a day may increased at weekly intervals according to response. The usual dose range is 160-320 mg per day. With concurrent diuretic or other antihypertensive drugs a further reduction of blood pressure is obtained.\nAngina, anxiety, migraine and essential tremor: A staring dose of 40 mg two or three times daily may be increased by the same amount at weekly intervals according to patients response. An adequate response in anxiety, migraine and essential tremor is usually seen in the range 80-160 mg/day and an angina in the range 120-240 mg/day.\nSituational and generalized anxiety: A dose of 40 mg daily may provide short term relief of acute situational anxiety. Generalized anxiety require long term therapy, usually responds adequately to 40 mg twice daily which ,which individual cases, may be increased to 40 mg three times daily. Treatment should be continued according to responses. Patients should reviewed after 6 to 12 months treatment.\nDysrhythmias, anxiety tachycardia, hypertrophic obstructive cardiomyopathy and thyrotoxicosis: A dosage range of 10-40 mg three or four times a day usually achieves the required response.\nPost myocardial infarction: Treatment should be started between days 5 and after 21 after myocardial infarction, with an initial dose of 40 mg four times a day for 2 or 3 days. In order to improve compliance the total daily doses three after be given as 80 mg twice a day. Phaeochromocytoma (Used only with an alpha receptor blocking drug).\nPre-operative: 60 mg daily for three days.\nNon-operable malignant cases: 30 mg daily.\nMigraine: Under 12 years: 20 mg two or three times daily. Over 12 years : The adult dose.\nChildren:\nSysrhythmias, Phaeochromocytoma, Thyrotoxicisis: Dosage should be individually determined and the following is only a guide 0.25-0.5 mg/kg three or four times daily as required.\n\nDosage of Propranolol Sustained Release Capsule:\nAdult:\nHypertension: The usual initial dose is 80mg Propranolol SR once daily, whether used alone or added to a diuretic. The usual maintenance dosage is 120 to 160 mg once daily.\nAngina pectoris: Starting with 80mg Propranolol SR once daily, dosage should be gradually increased three to seven day intervals until optimum response is obtained.\nMigraine: The initial oral dose is 80 mg Propranolol SR once daily. T he usual effective dose range is 160 to 240 mg once daily. It may be advisable to withdraw the drug gradually over a period of several weeks.\nHypertrophic subaortic stenosis: 80 mg Propranolol SR once daily', 'This product is contraindicated in patients with known Hypersensitivity to any component of the formulation. If there is a history of bronchial asthma of bronchospasm. Beta-adrenoceptor blocking drugs should be avoided in over heart failure. Propranolol modifies the tachycardia of hypoglycaemic therapy in diabetic patients. Propranolol may prolong the hypoglycaemic response to insulin.', 'Propranolol is usually well tolerated. Minor side effects such as cold extremities, nausea, diarrhea, sleep disturbances and lassitude are often transient. There have been reports of skin rashes and/or dry eyes associated with the use of beta-adrenergic blocking drugs.', 'There are no adequate and controlled studies in pregnant women. Propranolol is excreted in human milk. Caution should be exercised when propranolol is administered to a nursing mother.', '0000-00-00 00:00:00', 1, 1),
(49, 'RAMIPRIL', '', '', 'Mild to severe hypertension, Congestive heart failure.', '', 'Initial dose is 1.25-2.5 mg once daily. Maintenance dosage in adult is 2.5-20 mg daily as single or in 2 divided doses.', 'Hypersensitivity, angioedema.', 'Dizziness, headache, fatigue & asthenia, hypotension, cough, nausea, vomiting, diarrhoea, rash, urticaria, oliguria, anxiety, amnesia.', 'Not recommended.', '0000-00-00 00:00:00', 1, 1),
(50, 'RAMIPRIL +  HYDROCHLOROTHIAZIDE', 'Combined antihypertensive preparations', '', 'Indicated for the treatment of mild to moderate hypertension in patients (in whom combination therapy is appropriate) who have been stabilised on the individual components given in the same proportion.', '', 'Dose Titration Guided by Clinical Effect. A patient whose blood pressure is not adequately controlled with ramipril (or another ACE inhibitor) alone or with hydrochlorothiazide (or another thiazide diuretic) alone may be switched to combination therapy with Ramipril 2.5 mg + Hydrochlorothiazide 12.5 mg or Ramipril 5 mg + Hydrochlorothiazide 25 mg tablet.\n\nReplacement Therapy: For convenience, patients receiving ramipril and hydrochlorothiazide from separate tablets may instead wish to receive tablets of combination of Ramipril 2.5 mg + Hydrochlorothiazide 12.5 mg or Ramipril 5 mg + Hydrochlorothiazide 25 mg.\n\nIf necessary, the dose may be increased to two tablets of Ramipril 2.5 mg + Hydrochlorothiazide 12.5 mg or Ramipril 5 mg + Hydrochlorothiazide 25 mg once daily.\n\nMaximum daily dose: 10 mg ramipril and 50 mg hydrochlorothiazide (four tablets of Ramipril 2.5 mg + Hydrochlorothiazide 12.5 mg or two tablets of Ramipril 5 mg + Hydrochlorothiazide 25 mg).', 'This preparation must not be used in patients with hypersensitivity to ramipril, hydrochlorothiazide or other thiazide diuretics. History of hereditary angioneurotic oedema. Severe impairment of renal function. Haemodynamically relevant unilateral or bilateral renal artery stenosis, mitral stenosis, aortic stenosis, and in patients with low blood pressure (hypotensive patients) or in patients with an unstable circulatory situation (haemodynamically unstable patients) where there might be a risk of life-threatening fall in blood pressure and renal failure. Clinically relevant electrolyte disturbances e.g. hypokalemia, hyponatremia or hypercalcemia which may worsen following treatment. Treatment with Ramipril and Hydrochlorothiazide combination requires regular medical supervision. Generally dehydration, reduced blood volume (hypovolumia) or salt depletion should be corrected before initiating the treatment (in patients with concomitant heart failure, however, this must be carefully weighed against the risk of volume overload).\n\nSpecial caution is necessary during the treatment of: Patients with severe and particularly with malignant hypertension. Patients with concomitant and particularly with severe heart failure. Patients in whom fluid or salt deficiency exists or may develop (as a result of inadequate fluid or salt intake) or as a result of diarrhoea, vomiting or excessive sweating in cases where salt and fluid replacement is inadequate. Patients with haemodynamically relevant renal artery stenosis. In patients with pre-existing impairment of renal function or in kidney transplant patients. White blood cell count should be monitored (more frequent in the initial phase of the treatment) so that leucopenia can be detected. Insufficient experience has been gained concerning the use of Ramipril and Hydrochlorothiazide combination in children.', 'The combination of Ramipril and Hydrochlorothiazide is generally well tolerated. Side effects commonly reported include headache, dizziness, asthenia, nausea, vomiting, hypotension, cough, weakness, diarrhoea, fever, gastric irritation, pulmonary oedema, photosensitivity, electrolyte imbalance, hyperglycaemia, hyperuricaemia and vertigo.', 'ACE inhibitors can cause foetal and neonatal morbidity and death when administered to pregnant women. Also, thiazides cross the placental barrier and appear in cord blood. There is a risk of foetal or neonatal jaundice, thrombocytopenia, and possibly other adverse reactions that have occurred in adults. When pregnancy is detected, Ramipril and Hydrochlorothiazide combination should be discontinued as soon as possible. This product is excreted in breast milk. Because of the potential for serious adverse reactions in nursing infants, women receiving Ramipril and Hydrochlorothiazide combination should not breast feed.', '0000-00-00 00:00:00', 1, 1),
(51, 'TERAZOSIN', 'Alpha adrenoceptor blocking drugs, BPH/ Urinary retention/ Urinary incontinence', '', 'Terazosin Hydrochloride single therapy is used to relieve for signs and symptoms of benign prostatic hyperplasia (BPH), for the treatment of hypertension', '', 'Benign Prostatic Hyperplasia:\nInitial dose: 1 mg at bedtime is starting dose of all patients and this dose should not be exceeded.\nSubsequent dose: The dose slowly increases to achieve the desired response. The usual recommended dose range is 5-10 mg administered once a day.\nHypertension:\nInitial dose: 1 mg at bedtime is starting dose of all patients and this dose should not be exceeded.\nSubsequent dose: The dose slowly increases to achieve the desired response. The usual recommended dose range is 2-10 mg administered once a day.', 'Terazosin is contraindicated in patients known to be hypersensitive to Terazosin or its analogues. First dose may cause hypotension (within 30-90 minutes). Therefore should be taken on retiring to bed. Caution should be observed when Terazosin is administered with other antihypertensive agents; avoid the possibility of significant hypotension. When adding Terazosin to a diuretic or other antihypertensive agent, dosage reduction and retitration may be necessary. The patients should be cautioned to avoid situation such as driving and hazardous tasks where injury could result due to syncope after initiation of Terazosin therapy.', 'Postural hypertension is more commonly reported side effect. Dizziness, lack of energy, peripheral oedema; urinary frequency and priapism reported.', 'The safety of Terazosin during pregnancy has not been established so Terazosin is not recommended during pregnancy unless the potential benefit justifies the potential risk to moher and fetus. It is not known whether Terazosin is excreted in breast milk. Because many drugs are excreted in breast milk, caution should be exercised when Terazosn is administered to a nursing mother.', '0000-00-00 00:00:00', 1, 1),
(52, 'TORASEMIDE', 'Loop diuretics', '', 'Torasemide is indicated for the management of edema of cardiac, renal and hepatic origin.The management of hypertension, as a sole therapeutic agent or in combination with other classes of antihypertensive agents.', '', 'Congestive heart failure: The usual initial oral dose is 10 mg or 20 mg once daily. If the diuretic response is inadequate, the dose should be titrated upward by approximately doubling until the desired diuretic response is obtained. Single doses higher than 200 mg have not been adequately studied.\n\nChronic renal failure: The usual initial oral dose is 20 mg once daily. lf the diuretic response is inadequate, the dose should be titrated upward by approximately doubling until the desired diuretic response is obtained. Single doses higher than 200mg have not been adequately studied.\n\nHepatic cirrhosis: The usual initial oral dose is 5 mg or 10 mg once daily, administered together with an aldosterone antagonist or a potassium sparing diuretic. If the diuretic response is inadequate, the dose should be titrated upward by approximately doubling until the desired diuretic response is obtained. Single doses higher than 40 mg have not been adequately studied. Chronic use of any diuretic in hepatic disease has not been studied in adequate and well-controlled trials.\n\nHypertension: The usual initial oral dose is 2.5-5 mg once daily. If the 5 mg dose does not provide adequate reduction of blood pressure within 4 to 6 weeks, the dose may be increased to 10 mg once daily. If the response to 10 mg is insufficient, an additional antihypertensive should be added to the treatment regimen.', 'Torasemide is contraindicated in patients with known hypersensitivity to torasemide and other sulfonyl ureas. It is also contraindicated in patients who are anuric. Precautions should be taken while torasemide is administered in the conditions like diabetes, gout, hypotension and liver failure.', 'Usually torasemide is well tolerated. However, a few side effects like dry mouth, dizziness, tiredness, skin rash, diarrhea, constipation, nausea, vomiting, orthostatic hypotention and muscle cramp may occur. All side effects usually are mild and transient.', 'Pregnancy: Adequate and well controlled studies of torasemide have not been carried out in pregnant woman. Because animal reproduction studies are not always predictive of human response, torasemide can be used during pregnancy only if clearly needed.\n\nNursing Mother: lt is not known whether torasemide is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when torasemide is administered to a nursing mother.', '0000-00-00 00:00:00', 1, 1),
(53, 'AmIdipine besylate and Valsartan', 'Combined antihypertensive preparations', '', 'Amlodipine and Valsartan combination is indicated for the treatment of hypertension. This fixed combination drug is not indicated for the initial therapy of hypertension', '', 'Amlodipine is an effective treatment of hypertension in once daily doses of 2.5 mg-10 mg while Valsartan is effective in doses of 80 mg-320 mg. In clinical trials with Amlodipine and Valsartan combination using Amlodipine doses of 5 mg-10 mg and Valsartan doses of 160 mg-320 mg, the antihypertensive effects increased with increasing doses.', 'Amlodipine and Valsartan combination is contraindicated in patients who are hypersensitive to any compounds of this product. Amlosartan should be used with caution because there is a risk for fetal or neonatal morbidity, hypotension, myocardial infarction or increased angina.\n\nDose should be titrated slowly in patients with impaired hepatic or severely impaired renal function. In general, calcium channel blockers should be used with caution in patients with heart failure.', 'The most common side effects include peripheral edema, vertigo, nasopharyngitis, upper respiratory tract infection and dizziness.', 'Pregnancy: Amlodipine and Valsartan combination should not be used in 2nd and 3rd trimester because it can cause fetal death .\n\nNursing Mothers: It is not known whether Valsartan and Amlodipine are excreted in human milk. Because of the potential for adverse effects on the nursing infant, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.', '0000-00-00 00:00:00', 1, 1),
(54, 'VALSARTAN', 'Angiotensin-ll receptor blocker', '', 'Acute heart failure, Cardiomyopathy, Coronary artery disease, Diabetic nephropathy, Heart failure, Hypertension, Post myocardial infarction', '', 'Hypertension-\nAdult: Initially, 80 mg once daily, may be increased to 160 mg once daily if needed. Max: 320 mg once daily.\nChild: As tab: ?6 yr <35 kg: Initially, 40 mg once daily. Max: 80 mg once daily; 35-80 kg: Initially, 80 mg once daily. Max: 160 mg once daily; >80 kg: Initially, 80 mg once daily. Max: 320 mg once daily. As oral soln: Started at half the equivalent tab dose in valsartan-naive patients. If switching from tab to oral soln, the dose should be halved; if switching from soln to tab, same dose should be used initially. Dose should be titrated further according to response.\nElderly: No dosage adjustment needed.\nPost-myocardial infarction-\nAdult: Start as early as 12 hr after MI in stable patients at an initial dose of 20 mg bid, doubled at intervals over a few wk up to 160 mg bid if tolerated.\nElderly: No dosage adjustment needed.\nHeart failure-\nAdult: Initially, 40 mg bid, may be increased to 160 mg bid if tolerated.\nElderly: No dosage adjustment needed.', 'Hypersensivity to Valsartan or any of the components of the product. Patients with renal artery stenosis, heart failure, aortic or mitral stenosis, severe Na and/or volume depletion. Renal and mild to moderate hepatic impairment. Lactation.', 'The overall incidence of adverse experiences with Valsartan was similar to placebo. The common side effects are headache, dizziness, rhinitis, sinusitis, pharyngitis, nausea, gastrointestinal upset, oedema and fatigue. Dose related orthostatic effects were seen in less than 1% of patients. An increase in the incidence of dizziness was observed in patients treated with Valsartan 320 mg compared to 80-160 mg.', 'Pregnancy: Due to the mechanisms of action of angiotensin II antagonists, a risk for the foetus cannot be excluded. In utero exposure to angiotensin converting enzyme (ACE) inhibitors given to pregnant women during the 2nd and 3rd trimesters has been reported to cause foetal injury, including hypotension, neonatal skull hypoplasia, anuria, reversible or irreversible renal failure, and death. When pregnancy is detected, Valsartan should be discontinued as soon as possible.\n\nLactation: It is not known whether Valsartan is excreted in human milk. Valsartan was excreted in the milk of lactating rats. Thus, it is not advisable to use Valsartan in lactating mothers.', '0000-00-00 00:00:00', 1, 1),
(55, 'VALSARTAN+ HYDROCHLOROTHIAZIDE ', 'Combined antihypertensive preparations', '', 'Diabetic nephropathy, Heart failure, Hypertension', '', 'Per combination tablet contains valsartan/ hydrochlorothiazide: 80/12.5 mg; 160/12.5 mg; 160/25 mg; 320/12.5 mg; 320/25 mg: Initially, 80/12.5 mg once daily, titrate dose gradually according to response, up to 320/25 mg.', 'Hypersensitivity to valsartan, hydrochlorothiazide or sulphonamides. Severe hepatic impairment, creatinine clearance <30ml/min, anuria, cirrhosis, biliary obstruction, conditions where there is increased potassium loss (e.g. salt losing nephropathies and pre-renal impairment of kidney function), refractory hypokalaemia, hyponatraemia, hypercalcaemia, hyperuricaemia, history of gout and uric acid stones, untreated Addison\'s disease. Pregnancy and lactation.  \n\nDM, postsympathectomy patients. May exacerbate SLE. Monitor serum potassium regularly. Observe for signs of fluid or electrolyte imbalance. Discontinue before testing for parathyroid function. May affect ability to drive or operate machinery. Elderly.', 'Headache, asthenia, fatigue, dizziness, somnolence, insomnia, orthostatic hypotension, paraesthesia, nasopharyngitis, tachycardia, palpitations, tinnitus, vertigo, dyspepsia, diarrhoea, flatulence, dry mouth, nausea, vomiting, abdominal pain, peripheral oedema, pyrexia, increased BUN, elevated LFT, anxiety, erectile dysfunction, glucose intolerance, increased serum cholesterol, triglycerides, uric acid. Electrolyte imbalances e.g. hypomagnesaemia, hypercalcaemia, hyponatraemia, hypochloraemic alkalosis.', 'Category D: There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective).', '0000-00-00 00:00:00', 1, 1);
INSERT INTO `mims_genericinformation` (`ID`, `Name`, `Classification`, `SafetyRemark`, `Indication`, `IndicationTags`, `DosageAdministration`, `ContraindicationPrecaution`, `SideEffect`, `PregnancyLactation`, `LastUpdate`, `CreatedBy`, `IsActive`) VALUES
(56, 'VERAPAMIL', 'Calcium-channel blockers', '', 'Verapamil Tablet:\nEssential hypertension\nAngina pectoris and prevention of re-infarction\nSupraventricular arrhythmias\nVerapamil Injection:\nTachycardias such as: Paroxysmal supraventricular tachycardias\nAtrial fibrillation with rapid ventricular response (except WPWS)\nAtrial flutter with rapid conduction\nExtrasystoles\nAcute hypertension\nAcute coronary insufficiency\nFor the prophylaxis and / or therapy of ectopic arrhythmias (predominantly ventricular extrasystoles) in halothane anaesthesia and in the application of adrenaline in halothane anaesthesia respectively.', '', 'Intravenous-\nSupraventricular arrhythmias:\nAdult: Initially, 5-10 mg via slow inj over 2-3 min then 5 mg via inj over 5-10 min if needed.\nChild: ?1 yr 100-200 mcg; 1-15 yr 100-300 mcg/kg. All doses to be given over at least 2 min, repeat after 30 min if needed.\nOral-\nAngina pectoris:\nAdult: 120 mg tid or 80 mg tid in patients w/ angina of effort. As modified-release: Up to 480 mg daily.\nSupraventricular arrhythmias:\nAdult: 120-480 mg daily in 3-4 divided doses depending on patient\'s response and severity of the condition.\nChild: ?2 yr 20 mg 2-3 times daily; >2 yr 40-120 mg 2-3 times daily, depending on age and response.\nHypertension:\nAdult: Initially, 240 mg daily in 2-3 divided doses. Max: 480 mg daily.\nChild: ?2 yr 20 mg 2-3 times daily; >2 yr 40-120 mg 2-3 times daily, depending on age and response.\nSecondary prophylaxis of myocardial infarction:\nAdult: Modified release: Initially, 360 mg daily in divided doses 1 wk after acute infarction.', 'Severe left ventricular dysfunction Hypotension or cardiogenic shock Sick sinus syndrome (except in patients with a functioning artificial ventricular pacemaker) Second or third-degree atrioventricular (AV) block (except in patients with a functioning artificial pacemaker) Patients with atrial flutter or atrial fibrillation and an accessory by pass tract (eg. Wolff-Parkinson-White, Lown-Ganong-Levine syndrome) Patients with known hypersensitivity to verapamil hydrochloride Verapamil injection should not be administered intravenously to patients on beta-blockers (except in an intensive care setting) and known hypersensitivity to Verapamil hydrochloride.\n\nPatient with bradycardia or 1st-degree AV block, attenuated neuromuscular transmission, hypertrophic cardiomyopathy. Avoid abrupt withdrawal. Renal and hepatic impairment. Childn. Pregnancy and lactation.', 'AV block, bradycardia, worsening heart failure, transient asystole, hypotension, dizziness, flushing, fatigue, headache, dyspnoea, peripheral oedema, constipation, nausea, abnormal liver function, skin reactions, gingival hyperplasia, extrapyramidal symptoms. Rarely, gynaecomastia.', 'Verapamil carries the potential to produce fetal hypoxia associated with maternal hypotension. Verapamil should not be administered intravenously during the first six months of pregnancy. There are no data on use in the first and second trimester. Verapamil should not be used in the final trimester unless the benefits clearly outweigh the risks. Verapamil should not be administered intravenously during lactation. If a nursing mother requires intravenous Verapamil, breast feeding should be discontinued for the duration of treatment.', '0000-00-00 00:00:00', 1, 1),
(57, 'GLYCERYL TRINITRATE', '', '', 'Indicated for the acute relief of an attack or\nacute prophylaxis of angina pectoris due to\ncoronary artery disease.', '', '0.5 mg Sublingual Tablet: One tablet should be\ndissolved under the tongue at the first sign\nof an acute anginal attack. The dose may be\nrepeated approximately every five minutes,\nuntil relief is obtained. If the pain persists\nafter a total of 3 tablets in a 15-minute period,\nprompt medical attention is recommended.\n400 mcg spray: At the onset of an attack, 1 or 2\nmetered sprays should be administered under\nthe tongue. No more than 3 metered sprays\nare recommended within a 15-minute period.\nIf the chest pain persists, prompt medical\nattention is recommended. Anril Spray may be\nused prophylactically 5 to 10 minutes prior to\nengaging in activities which might precipitate\nan acute attack.\nInjection: The usual dose range is 10 - 200 mcg/\nmin. Dose up to 400 mcg/min may be required\nduring some surgical procedures.\n2.6 mg SR (Sustained Release) Tablet: Adults &\nElderly Patients: Dosage should be adjusted to\nthe requirements of\nthe individual patient but will usually be 1 or 2\ntablets taken three times daily.\nThe lowest effective dose should be used.', 'Contraindicated in patients with early\nmyocardial infarction, severe anemia, increased  intracranial pressure & those with a known hypersensitivity to Nitroglycerin.\nAlso contraindicated in patients who are using sildenafil citrate since sildenafil citrate has been shown to potentiate the hypotensive Effects of organic nitrates.\nOnly the smallest dose required for Effective\ncontrol of the acute anginal attack should\nbe used. Excessive use may lead to the\ndevelopment of tolerance. This drug should\nbe used with caution in patients who may be\nvolume-depleted or are already hypotensive.', 'Headache, facial flushing, dizziness, nausea,\nvomiting, feelings of weakness, postural\nhypotension, reflex tachycardia etc.', 'Pregnancy : Pregnancy Category C.\nNitroglycerin should be given to pregnant\nwomen only if clearly needed.\nNursing Mothers: Caution should be exercised when Nitroglycerin Spray is administered to a nursing woman.', '0000-00-00 00:00:00', 1, 1),
(58, 'ISOSORBIDE DINITRATE', 'Nitrates: Coronary vasodilators', '', 'Isosorbide dinitrate tablets are indicated for the prevention of angina pectoris due to coronary artery disease. The onset of action of immediate-release oral isosorbide dinitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode.', '', 'The usual starting dose of Isosorbide Dinitrate is 5 mg to 20 mg, two or three times daily. For maintenance therapy, 10 mg to 40 mg, two or three times daily is recommended. Some patients may require higher doses. A daily dose-free interval of at least 14 hours is advisable to minimize tolerance. The optimal interval will vary with the individual patient, dose and regimen.\n\nShould be taken on an empty stomach. Take ? hr before meals', 'Severe hypotension or anaemia, hypovolaemia, heart failure due to obstruction, or raised intracranial pressure due to head trauma or cerebral haemorrhage. \n\nRaised intracranial pressure, hypotension, hypovolaemia. Mitral valve prolapse, arterial hypoxaemia, glaucoma, elderly, hypothyroidism, malnutrition, pregnancy, lactation', 'Rebound hypertension (uncommon), syncope, unstable angina flushing, hypotension/orthostatic hypotension, lightheadedness, palpitations, tachyarrhythmia, Dizziness, headache, restlessness, weakness, Nausea, Methemoglobinemia (infrequent)', 'Pregnancy Category-C. Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks\n\nLactation: Unknown whether drug is distributed into breast milk', '0000-00-00 00:00:00', 1, 1),
(59, 'ISOSORBIDE MONONITRATE', 'Nitrates: Coronary vasodilators', '', 'Isosorbide mononitrate tablets are indicated for-\nThe prevention of angina pectoris due to coronary artery disease. The onset of action of oral isosorbide mononitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode.\nLong-term treatment of blood-flow disorders of the coronary vessels (coronary heart disease)\nLong-term treatment and prophylaxis of angina pectoris (chest pain due to coronary blood-flow disorders of the coronary vessels).\nTreatment of severe myocardial insufficiency (chronic heart failure)', '', 'The recommended regimen of Isosorbide Mononitrate tablets is 20 mg (one tablet) twice daily, with the two doses given 7 hours apart. For most patients, this can be accomplished by taking the first dose on awakening and the second dose 7 hours later. Dosage adjustments are not necessary for elderly patients or patients with altered renal or hepatic function. \n\nMultiple studies of organic nitrates have shown that maintenance of continuous 24-hour plasma levels results in refractory tolerance. The dosing regimen for Isosorbide Mononitrate tablets provides a daily nitrate-free interval to avoid the development of this tolerance. Well-controlled studies have shown that tolerance to Isosorbide Mononitrate tablets is avoided when using the twice-daily regimen in which the two doses are given 7 hours apart. This regimen has been shown to have antianginal efficacy beginning 1 hour after the first dose and lasting at least 5 hours after the second dose. The duration (if any) of antianginal activity beyond 12 hours has not been studied; large controlled studies with other nitrates suggest that no dosing regimen should be expected to provide more than about 12 hours of continuous antianginal efficacy per day.\n\nIn clinical trials, Isosorbide Mononitrate tablets have been administered in a variety of regimens. Single doses less than 20 mg have not been adequately studied, while single doses greater than 20 mg have demonstrated no greater efficacy than doses of 20 mg.', 'It is contraindicated in patients who have shown hypersensitivity or idiosyncratic reactions to other nitrates or nitrites.', 'Hypotension, tachycardia, flushing, headache, dizziness, palpitation, syncope, confusion. Nausea, vomiting, abdominal pain. Restlessness, weakness and vertigo. Dry mouth, chest pain, back pain, oedema, fatigue, abdominal pain, constipation, diarrhoea, dyspepsia and flatulence.', 'There are no adequate and controlled studies to date with Isosorbide-5-mononitrate in pregnant women, and the drug should be used during pregnancy only when the potential benefit justified possible risks to the fetus. Execration of Isosorbide-5-mononitrate into human milk is unknown, so precaution should be taken when it is administered to a nursing mother.', '0000-00-00 00:00:00', 1, 1),
(60, 'TRIMETAZIDINE  HYDROCHLORIDE ', '', '', 'Long-term treatment of angina pectoris.', '', '1 tablet at mealtimes in the morning & evening.\n\n', 'Severe depression, severe renal failure (creatinine clearance <15 ml/min), as a precaution in the absence of currently available studies.', 'Rare cases of gastrointestinal disorders.', 'Pregnancy: Studies in animals have not demonstrated a teratogenic Effect. However, in the absence of clinical data & for safety reasons, prescription should be avoided during pregnancy. Breastfeeding: In the absence of data, breastfeeding is not recommended during treatment.', '0000-00-00 00:00:00', 1, 1),
(61, 'ADENOSINE ', 'Paroxysmal supraventricular tachycardia (PSVT)', '', 'Intravenous Adenosine is indicated for the following: Conversion to sinus rhythm of paroxysmal supraventricular tachycardia (PSVT), including that associated with accessory bypass tracts (Wolff-Parkinson-White Syndrome).', '', 'Adult:\nInitial dose: 6 mg given as rapid IV bolus (administered over 1-2 second period). \n\nRepeat administration: If the first dose does not result in elimination of the supraventricular tachycardia within 1-2 minutes, 12 mg should be given as rapid intravenous bolus. This 12 mg dose may be repeated for second time if required. \nPediatric:\nThe dosages used in neonates, infants, children and adolescents were equivalent to those administered to adults on a weight basis. \nBody weight < 50 kg: Initial dose - 0.05 to 0.1 mg/kg as a rapid IV bolus given either centrally or peripherally. A saline flush should follow.\nBody weight > 50 kg: The adult dose is recommended. Doses greater than 12 mg are not recommended for adult and pediatric patients\nRepeat administration: If conversion of PSVT does not occur within 1-2 minutes, additional bolus injections of adenosine can be administered at incrementally higher doses, increasing the amount given by 0.05 to 0.1 mg/kg. A saline flush should follow. This process should continue until sinus rhythm is established or a maximum single dose of 0.3 mg/kg is used.', 'Intravenous Adenosine is contraindicated in: \nSecond- or third-degree A-V block (except in patients with a functioning artificial pacemaker).\nSinus node disease, such as sick sinus syndrome or symptomatic bradycardia (except in patients with a functioning artificial pacemaker).\nKnown hypersensitivity to Adenosine.', 'Cardiovascular: Facial flushing, headache, sweating, palpitations, chest pain, hypotension. Respiratory: Shortness of breath/dyspnea, chest pressure, hyperventilation, head pressure. \n\nCentral Nervous System: Lightheadedness, dizziness, tingling in arms, numbness, apprehension, blurred vision, burning sensation, heaviness in arms, neck and back pain. \n\nGastrointestinal: Nausea, metallic taste, tightness in throat, pressure in groin. In post-market clinical experience with Adenosine, cases of prolonged asystole, ventricular tachycardia, ventricular fibrillation, transient increase in blood pressure, bradycardia, hypotension, atrial fibrillation and bronchospasm, in association with Adenosine use, have been reported.', 'US FDA pregnancy category C. Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.', '0000-00-00 00:00:00', 1, 1),
(62, 'AMIODARONE', 'Potassium channel blockers', '', 'Because of its life-threatening side effects and the substantial management difficulties associated with its use, Amiodarone is indicated only for the treatment of the following documented, life threatening recurrent ventricular arrhythmias when these have not responded to documented adequate doses of other available antiarrhythmics or when alternative agents could not be tolerated.\nRecurrent ventricular fibrillation.\nRecurrent hemodynamically unstable ventricular tachycardia.\nAs is the case for other antiarrhythmic agents, there is no evidence from controlled trials that the use of Amiodarone Tablets favorably affects survival.\n\nAmiodarone should be used only by physicians familiar with and with access to (directly or through referral) the use of all available modalities for treating recurrent life threatening ventricular arrhythmias, and who have access to appropriate monitoring facilities, including in-hospital and ambulatory continuous electrocardiographic monitoring and electrophysiologictechniques. Because of the life-threatening nature of the arrhythmias treated, potential interactions with prior therapy, and potential exacerbation of the arrhythmia, initiation of therapy with Amiodarone should be carried out in the hospital.', '', 'Oral dose is 200 mg 3 times daily for 1 week reduced to 200 mg twice daily or the minimum required to control arrhythmia.', 'Amiodarone is contraindicated in patients with cardiogenic shock; severe sinus-node dysfunction, causing marked sinus bradycardia; second- or third degree atrioventricular block; and when episodes of bradycardia have caused syncope (except when used in conjunction with a pacemaker). Amiodarone is contraindicated in patients with a known hypersensitivity to the drug or to any of its components, including iodine.', 'The most severe side effects are any symptoms of cough, fever, or painful breathing, reversible corneal microdeposits, impaired vision due to optic neuritis, peripheral neuropathy, bradycardia and conduction disturbances, phototoxicity and rarely persistent skin discoloration, hypothyroidism, hyperthyroidism, raised serum transaminases, jaundice, hepatitis and cirrhosis etc.', 'Should not be administered during pregnancy and lactation.', '0000-00-00 00:00:00', 1, 1),
(63, 'DISOPYRAMIDE', 'Membrane stabilizing agent (Sodium channel blockers)', '', 'Disopyramide is indicated for the ventricular arrhythmias, especially after myocardial infarction, supraventricular arrhythmias.', '', 'The recommended dose of Disopyramide is 400 mg /day in 4 divided doses (100 mg capsule 6 hourly).\n\nPatients with renal insufficiency should take 100 mg capsule according to the schedule given below:\n\nCreatinine clearance (ml/min) >15: Approximate dosing q 8 hrq 12 hrq 24 hr\n\nPatients in whom rapid control of ventricular arrhythmia is essential, an initial loading dose of 300 mg Disopyramide is recommended, followed by the appropriate maintenance dosage.', 'Disopyramide is contraindicated in the pre-existing A-V heart block, shock, glaucoma, urinary retention and known hypersensitivity to the drug.', 'Usually Disopyramide is well tolerated but occasionally in some cases dry mouth/ nose/ eye, nausea, vomiting, diarrhea, bloating, blurred vision, urinary problems, headache, skin rash, dizziness, nervousness & impotence (1-3%) may occur.', 'Pregnancy: There are no adequate and well-controlled studies in pregnant women. Disopyramide should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.\n\nLactation: Because of the potential for serious adverse reactions in nursing infants from Disopyramide, a decision should be made whether to discontinue nursing or to discontinue the drug , taking into account the importance of the drug to the mother', '0000-00-00 00:00:00', 1, 1),
(64, 'LIDOCAINE', '', '', '? Prevents pain associated with minor surgical procedures in the ear, nose & throat ? Prevents pain or discomfort during dental procedures (e.g., prior to an injection) ? Prevents coughing during general anesthesia ? Prevents pain during the final stages of childbirth, before the cutting or stitching of the perineum', '', 'Dosage & Administration\n? In dentistry, the normal dose is 1-5 sprays. Two sprays per quarter of the mouth is recommended, with a maximum of 3 sprays per quarter of the mouth over 30 minutes ? In sinus procedures 3 sprays are used ? Up to 20 sprays may be necessary in childbirth & procedures of the throat & windpipe\n', 'Should not be given to patients with myasthenia gravis, epilepsy, impaired cardiac condition or liver damage. Patient should be careful driving or operating machinery after use of Lidocaine Spray. Patient may be drowsy & reflexes may be slow. Patient should not eat or drink anything for at least 1 hour after using Lidocaine Spray\nin the mouth or throat area. Should be careful not to spray Lidocaine Spray near the eyes. If any of the spray does go in the eye, should rinse immediately with lots of water for at least 15 minutes.\n', 'Skin rash or irritation, drowsiness, wheezing or difficulty breathing, chest pain, severe rash or itching, increased sweating, numbness.', 'Pregnancy category B. Small amount of Lidocaine may pass to a lactating baby, but the amount is insignificant to cause any harm. Still it should be used upon physician?s judgment.\n\n', '0000-00-00 00:00:00', 1, 1),
(65, 'SOTALOL', 'Anti adrenergic agent (Beta blockers)', '', 'Arrhythmias, Cardiac arrhythmias, Supraventricular and ventricular arrhythmias', '', 'Supraventricular and ventricular arrhythmias: Initial: 80 mg/day in 1 -2 divided doses, increase gradually every 2-3 days. Usual: 160-320 mg/day in 2 divided doses. Max: 640 mg/day.\n\nLife-threatening ventricular arrhythmias: 480-640 mg/day. \n\nAcute arrhythmias: 20-120 mg, may repeat 6 hrly if needed. \n\nFor programmed electrical stimulation (to test antiarrhythmic efficacy): Initial: 1.5 mg/kg, then 0.2-0.5 mg/kg/hr infusion', 'Bronchial asthma or history of COPD, sick sinus syndrome, symptomatic sinus bradycardia, cardiogenic shock. 2nd and 3rd degree AV block, untreated phaeochromocytoma, torsades de pointes, congenital or acquired long QT syndromes, uncontrolled cardiac failure, cardiogenic shock, metabolic acidosis, hypotension, severe peripheral arterial disease, Raynaud\'s disease, anaesthesia that causes myocardial depression. Renal impairment (CrCI <10 mL/min). Concomitant use with Ca channel blockers (e.g. verapamil and diltiazem).', 'Dyspnea, Dizziness, Fatigue, Bradycardia, Chest pain, Palpitation, Weakness, Lightheadedness, Nausea/vomiting, Edema, Headache, Sleep disturbances, Abnormal ECG, Diarrhea, Extremity pain, Hypotension, Mental confusion, Congestive heart failure, ltching/rash, Syncope, Anxiety, Depression, Torsades de pointes or new ventricular tachycardia / fibrillation in patients with supraventricular arrhythmia, Peripheral vascular disorders, Impotence, Proarrhythmic effect, Torsades de pointes with history of sustained ventricular tachycardia, Catechol hypersensitivity after abrupt withdrawal, Increased insulin requirement in diabetics', 'Pregnancy Category- D. There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.', '0000-00-00 00:00:00', 1, 1),
(66, 'CILOSTAZOL', '', '', 'Cilostazol is indicated for the reduction of symptoms of intermittent claudication, as indicated by an increased walking distance.', '', 'The recommended dosage of Cilosta is 100 mg bid, taken at least half an hour before or two hours after breakfast & dinner. A dose of 50 mg bid should be considered during coadministration of Ketoconazole,\nItraconazole, Erythromycin, & Diltiazem.\n', 'Cilostazol is contraindicated in patients with congestive heart failure of any severity. Cilostazol is also contraindicated in patients with known or suspected hypersensitivity to any of its components. There is no information with respect to the efficacy or safety of the concurrent use of Cilostazol & Clopidogrel.', 'The most common side effects are headache, diarrhoea, vomiting, leg cramps, rash etc. The less frequent side effects are anorexia & oedema.', 'Pregnancy: There are no adequate & well controlled studies in pregnant women. Lactation: Transfer of Cilostazol into milk has been reported in experimental animals. Because of the potential risk to nursing infants,\na decision should be made to discontinue nursing or to discontinue Cilostazol.\n', '0000-00-00 00:00:00', 1, 1),
(67, 'CINNARIZINE', '', '', 'Cerebral circulatory disorders: a. Prophylaxis & maintenance therapy for symptoms of cerebral vascular spasms & arteriosclerosis. b. Sequelae of cerebral & cranial trauma. c. Postapoplectic disorders d. Migraine 2. Peripheral circulatory disorders: Prophylaxis & maintenance therapy for symptoms of vascular spasms & arteriosclerosis (obliterating arteritis, thromboangiitis, Raynaud?s disease, diabetes, acrocyanosis pernio, etc.) such as intermittent claudication, trophic disturbances, pregangrene, trophic & varicose ulcers, paresthesia, nocturnal cramps, cold extremities. 3. Disorders of balance.', '', 'Cinaron 15 to 30 mg three times daily.', '', 'Somnolence & gastrointestinal disturbances.', 'The safety of Cinnarizine in human pregnancy has not been established although studies in animals have not demonstrated teratogenic Effects. Therefore, it is not advisable to administer Cinnarizine in pregnancy.', '0000-00-00 00:00:00', 1, 1),
(68, 'Cinnarizine+Dimenhydrinate ', '', '', 'Vertigo & Peripheral arterial disorders.', '', '1 tablet thrice daily.', 'Not known.', 'Somnolence & GI disturbance.', 'Risk benefit ratio is considered.', '0000-00-00 00:00:00', 1, 1),
(69, 'NIMODIPINE', '', '', 'For the improvement of neurological outcome by reducing the incidence & severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition.', '', 'Initial dose is 60 mg in every four hours interval for 21 consecutive days. Oral therapy should be commence within 96 hours of the subarachnoid hemorrhage.', 'Blood pressure should be carefully monitored during treatment with Nimodipine based on its known pharmacology & the known effects of calcium channel blockers. The metabolism of Nimodipine is decreased in patients with ,impaired hepatic function.', 'Headache, dizziness, flushing, heartburn, fast heartbeat, slow heartbeat, upset stomach, stomach pain, constipation, depression etc.', 'Large doses of Nimodipine have been shown to cause birth defects in animals. Human studies have not been done. Nimodipine may pass into breast milk but has not been reported to cause problems; caution is advised.', '0000-00-00 00:00:00', 1, 1);

-- --------------------------------------------------------

--
-- Table structure for table `mims_InternationalHealth`
--

CREATE TABLE `mims_InternationalHealth` (
  `ID` bigint(20) NOT NULL,
  `Title` varchar(200) NOT NULL,
  `Description` text NOT NULL,
  `ImagePath` varchar(200) DEFAULT NULL,
  `PublishDateTime` datetime DEFAULT NULL,
  `UnpublishedDateTime` datetime DEFAULT NULL,
  `CreatedBy` bigint(20) NOT NULL,
  `LastUpdate` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `IsActive` tinyint(1) NOT NULL DEFAULT '1'
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `mims_InternationalHealth`
--

INSERT INTO `mims_InternationalHealth` (`ID`, `Title`, `Description`, `ImagePath`, `PublishDateTime`, `UnpublishedDateTime`, `CreatedBy`, `LastUpdate`, `IsActive`) VALUES
(1, ' Type II diabetes now affects 7,000 under-25\\\'s in England and Wales', 'Nearly 7,000 children and young adults in England and Wales now have type II diabetes, as the rise in obesity continues, Diabetes UK has warned.\r\n\r\nThe figure is around about 10 times the number previously reported.\r\n\r\nThe government has been warned that it must take action, and the charity is calling for a ban on junk food advertising and restrictions on supermarket promotions of unhealthy foods to help address the surge in cases of the disease, which is largely preventable.\r\n', '84a3780fdffcbcbaaac51c9c4563f8be.jpg', '2018-11-25 00:00:00', '2018-11-30 00:00:00', 3, '2018-11-25 09:54:47', 1);

-- --------------------------------------------------------

--
-- Table structure for table `mims_jobinformation`
--

CREATE TABLE `mims_jobinformation` (
  `ID` bigint(20) NOT NULL,
  `Title` varchar(200) NOT NULL,
  `Description` text NOT NULL,
  `Organization` varchar(200) NOT NULL,
  `OrganizationLogo` varchar(300) DEFAULT NULL,
  `Position` varchar(100) NOT NULL,
  `ApplicationDeadline` datetime NOT NULL,
  `Salary` varchar(20) DEFAULT 'Negotiable',
  `EducationalRequirement` text,
  `ExperienceRequirement` text,
  `NumberOfVacancy` smallint(6) DEFAULT '1',
  `AgeLimit` tinyint(4) DEFAULT NULL,
  `Location` varchar(200) DEFAULT 'Anywhere in Bangladesh',
  `JobSource` varchar(200) DEFAULT 'Online job portal',
  `JobType` varchar(200) DEFAULT NULL,
  `EmploymentType` varchar(200) DEFAULT NULL,
  `JobNature` varchar(20) DEFAULT 'Full-Time',
  `ApplyingProcedure` varchar(200) DEFAULT 'Follow job Circular image',
  `PublishDate` date NOT NULL,
  `JobCircularImagePath` varchar(200) DEFAULT NULL,
  `CreatedBy` bigint(20) NOT NULL,
  `LastUpdate` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `IsActive` tinyint(1) NOT NULL DEFAULT '1'
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `mims_jobinformation`
--

INSERT INTO `mims_jobinformation` (`ID`, `Title`, `Description`, `Organization`, `OrganizationLogo`, `Position`, `ApplicationDeadline`, `Salary`, `EducationalRequirement`, `ExperienceRequirement`, `NumberOfVacancy`, `AgeLimit`, `Location`, `JobSource`, `JobType`, `EmploymentType`, `JobNature`, `ApplyingProcedure`, `PublishDate`, `JobCircularImagePath`, `CreatedBy`, `LastUpdate`, `IsActive`) VALUES
(2, 'IBN SINA Pharmaceutical Industry Ltd ', 'IBN SINA Pharmaceutical Industry Ltd Job Circular 2018 has been published by their authority in daily online job portal and to get from the best jobs circular and education doorway website in BD Jobs Careers-www.bdjobscareers.com.  ', 'IBN SINA Pharmaceutical Industry Ltd ', '4d589973db37e12a19e311fbce3e3d51.png', 'asd p', '2019-01-29 00:00:00', 'Negotiable', 'asd e', 'asd er', 11, 23, 'Anywhere in Bangladesh', 'Online job portal', 'jy', 'et', 'Full-Time', '', '2018-09-09', '7fdd83710529ec3e3e5f801b31790914.jpg', 1, '2018-09-02 18:20:21', 1),
(3, ' Square Pharmaceuticals Ltd.', '\r\nJob Responsibilities\r\n\r\n1.Perform analytical method development for both compendia & non-compendia method\r\n2.Prepare and review of method validation protocols and reports\r\n3. Conduct analytical method validation/ verification activities\r\n4.Carry out analytical method transfer\r\n 5.Develop and validate test methods for cleaning validation\r\n6. Generate and review laboratory investigation reports\r\n7.Conduct review of analytical test data\r\n    ', 'Analytical Research & Development', '5be929adf8a5d631f2fe7f46db3ce53f.png', 'Associate Scientist', '2019-01-02 00:00:00', 'Negotiable', 'M. Pharm', 'N/A', 2, 30, 'Gazipur (Kaliakair)', 'Square Pharmaceuticals Ltd.', '', '', 'Full-Time', '', '2018-09-05', 'c1e89f44a6fc3bbb4dab2cada0e68cc0.jpg', 1, '2018-09-02 18:27:24', 1),
(4, 'Drug International Limited', 'Drug International Ltd. is a long record of solid reputation as one of the leading pharmaceutical company, having business operations both in local and internationally. Drug International Ltd. believes their mission is to ensure better life through better medicine. We are seeking for self-driven, young and energetic fresh candidates. ', 'Medical Promotion Officer (MPO)', NULL, 'MPO', '2018-10-17 00:00:00', 'Negotiable', 'B.SC, M.SC', 'N/A', 20, 30, 'Anywhere in Bangladesh', '', '', '', 'Full-Time', '', '2018-10-03', '4a8e94716bfe0eeff7305df3281fe1ad.jpg', 1, '2018-09-02 18:31:48', 1),
(5, 'Ziska Pharmaceuticals Ltd.', '\r\nJob Responsibilities:  Coordinate factory operations, Supervise the production process and manage the manpower in various departments,  Optimize resources & to undertake process control to ensure cGMP are being followed, Undertake documentation & validation activity, Additional duties as assigned or deemed necessary for effective factory operations\r\n\r\n', 'Assistant General Manager / General Manager : Biotech', '770b4f029c5cb0a189854f2b7b6674e3.png', 'Assistant General Manager', '2019-01-17 00:00:00', 'Negotiable', 'M.Pharm, MBA', '5years', 1, 40, 'Head Office', '', '', '', 'Full-Time', '', '2018-09-25', 'dc347667d02737b6b8cf0bc4a0927552.jpg', 1, '2018-09-02 18:39:29', 1),
(6, 'Novo Nordisk Pharma (Private) Ltd.', 'Job Responsibilities\r\n1, Responsible for meeting sales objective and managing multiple projects.\r\n  2,Manage & coach a group of Regional Sales Managers', 'Assistant Sales Manager ', 'a8bb4157916c9379676a97e9371e8c91.png', 'Second Line Manager', '2018-12-19 00:00:00', 'Negotiable', '', '10years', 1, 40, 'Anywhere in Bangladesh', 'Online job portal', '', '', 'Full-Time', '', '2018-10-01', '19594d1f2a299500cdc089ad92648957.jpg', 1, '2018-09-02 18:44:03', 1),
(7, 'Quality Control Officer', ' Sample, analyze & check quality of RM/PM & finished products as per SOP\\\\\\\\\\\\\\\'s.\r\n    Prepare specification & method of incoming materials (RM/PM).\r\n    Conduct method validation activities.\r\n    Perform calibration of equipment as per schedule.\r\n    Prepare reference of working standard (RWS) and maintain documents.\r\n    Ensure retention sample of all raw material (RM) as per SOP.\r\n    Prepare test solution & volumetric solution, standardize of volumetric solution with proper documents.', 'SMC Enterprise Ltd. ', 'd3b1bb502383771b795fea5b4f010d83.png', 'Quality Control Officer', '2018-12-03 00:00:00', 'Negotiable', 'Master of Pharmacy (M.Pharm), Master of Science (MSc) in Applied Chemistry, Chemistry, Bio-Chemistry\r\nPublic University preferred', '1 to 2 year(s) \r\nThe applicants should have experience in the following business area(s):\r\nPharmaceuticals', 0, 30, 'Mymensingh (Bhaluka)', '', 'Full-Time', '', 'Full-Time', '', '2018-11-19', NULL, 3, '2018-11-20 08:13:31', 1);

-- --------------------------------------------------------

--
-- Table structure for table `mims_location`
--

CREATE TABLE `mims_location` (
  `ID` bigint(20) NOT NULL,
  `CountryID` int(11) NOT NULL,
  `StateID` int(11) NOT NULL,
  `CityID` int(11) NOT NULL,
  `Address` varchar(200) DEFAULT NULL,
  `Longitude` float DEFAULT NULL,
  `Latitude` float DEFAULT NULL,
  `CreatedBY` bigint(20) NOT NULL,
  `LastUpdate` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `mims_location`
--

INSERT INTO `mims_location` (`ID`, `CountryID`, `StateID`, `CityID`, `Address`, `Longitude`, `Latitude`, `CreatedBY`, `LastUpdate`) VALUES
(1, 1, 1, 1, 'Lab Aid,\r\nHouse # 1, Road # 4', NULL, NULL, 1, '2018-07-17 20:56:47'),
(2, 1, 1, 2, 'Apollo Hospitals Dhaka:\r\nPlot # 81, Block # E, Basudhara R/A, Dhaka - 1229', NULL, NULL, 1, '2018-07-17 21:03:44'),
(6, 1, 1, 2, 'asdasdad asdasdasd', 10, 20, 1, '2018-08-28 21:24:09'),
(7, 1, 1, 2, '', 12, 21, 1, '2018-09-04 18:20:03'),
(8, 1, 1, 1, '', 23, 32, 1, '2018-09-04 18:20:03'),
(17, 1, 3, 13, 'asdsad sad asd', 123, 321, 1, '2018-09-22 04:25:53'),
(18, 1, 2, 15, 'qwewa asd asd', 0, 0, 1, '2018-09-22 04:31:01'),
(19, 1, 4, 14, '', 123, 321, 1, '2018-09-22 04:35:08'),
(20, 1, 5, 18, '', 12, 21, 1, '2018-09-22 04:35:08'),
(21, 1, 1, 5, 'wqedsdfds', 12, 21, 1, '2018-09-22 05:02:04'),
(22, 1, 2, 4, 'wedwq qweq weqw', 0, 0, 1, '2018-09-22 05:02:04'),
(24, 1, 2, 11, 'asdsad sad sa', 0, 0, 1, '2018-09-22 10:39:10'),
(25, 1, 1, 16, '1111111', 0, 0, 1, '2018-09-22 10:42:05'),
(26, 1, 3, 12, '4', 5, 6, 1, '2018-09-22 10:46:42'),
(27, 1, 1, 15, '7', 8, 9, 1, '2018-09-22 10:46:42'),
(28, 1, 3, 6, '18/F BirUttamQaziNuruzzamanSarak, West Panthapath, Dhaka - 1205, Bangladesh.', 0, 0, 1, '0000-00-00 00:00:00'),
(29, 1, 3, 6, '44 Sonargaon Road, Hatirpool, Dhaka.', 0, 0, 1, '0000-00-00 00:00:00'),
(30, 1, 3, 6, '497/2/B North Ibrahimpur, Kafrul, Dhaka', 0, 0, 1, '0000-00-00 00:00:00'),
(31, 1, 3, 6, 'Advanced Eye Center, 2/3. Humayun Road, Mohammadpur, Dhaka?1207', 0, 0, 1, '0000-00-00 00:00:00'),
(32, 1, 3, 6, 'Ahsania Mission Cancer & General Hospital, Plot no - M-1/C, Section - 14, Mirpur, Dhaka ? 1206, M-1/C, Section - 14, Mirpur, Dhaka - 1206', 0, 0, 1, '0000-00-00 00:00:00'),
(33, 1, 3, 6, 'Apollo Hospitals Dhaka, Plot # 81, Block # E, Bashundhara R/A, Dhaka - 1229, Bangladesh', 0, 0, 1, '0000-00-00 00:00:00'),
(34, 1, 3, 6, 'Apollo Hospitals Dhaka, Plot # 81, Block # E, Basudhara R/A, Dhaka - 1229', 0, 0, 1, '0000-00-00 00:00:00'),
(35, 1, 3, 6, 'Central Hospital Limited, House # 5, Road # 2, Dhaka - 1205, Bangladesh', 0, 0, 1, '0000-00-00 00:00:00'),
(36, 1, 3, 6, 'Chamber: Apollo Hospitals Dhaka: Plot # 81, Block # E, Basudhara R/A, Dhaka - 1229', 0, 0, 1, '0000-00-00 00:00:00'),
(37, 1, 3, 6, 'Chamber: SQUARE Hospitals Ltd., 18/F BirUttamQaziNuruzzamanSarak, West Panthapath, Dhaka - 1205', 0, 0, 1, '0000-00-00 00:00:00'),
(38, 1, 3, 6, 'City Hospital Ltd. 1/8, Block-E, Lalmatia, Satmasjid Road, Dhaka - 1207', 0, 0, 1, '0000-00-00 00:00:00'),
(39, 1, 3, 6, 'City Hospital Ltd., 1/8, Block-E, Lalmatia, Satmosjid Road, Mohammadpur, Dhaka - 1207, Bangladesh', 0, 0, 1, '0000-00-00 00:00:00'),
(40, 1, 3, 6, 'City Hospital Ltd., Location: 1/8, Block-E, Lalmatia, SatMasjid Road, Dhaka - 1217', 0, 0, 1, '0000-00-00 00:00:00'),
(41, 1, 3, 6, 'CMH, Dhaka', 0, 0, 1, '0000-00-00 00:00:00'),
(42, 1, 3, 6, 'Comfort Diagnostic Centre & Comfort Nursing Home, Comfort Tower, 167/B, Green Road, Dhanmondi, Dhaka, Bangladesh', 0, 0, 1, '0000-00-00 00:00:00'),
(43, 1, 3, 6, 'Conscious Health Services Ltd, House # 25A, Road # 6, Dhanmondi R/A, Dhaka-1205, Bangladesh', 0, 0, 1, '0000-00-00 00:00:00'),
(44, 1, 3, 6, 'Delta Medical College & Hospital, 26/2, Principal AbulKashem Road, Mirpur-1, Dhaka- 1212, Bangladesh', 0, 0, 1, '0000-00-00 00:00:00'),
(45, 1, 3, 6, 'Delta Medical College & Hospital, Location: 26/2, Principal Abul Kashem Road, Mirpur-1, Dhaka- 1212, Bangladesh', 0, 0, 1, '0000-00-00 00:00:00'),
(46, 1, 3, 6, 'Green View Clinic, 25/3, Green Road, Dhaka, Bangladesh', 0, 0, 1, '0000-00-00 00:00:00'),
(47, 1, 3, 6, 'Health & Hope Hospital Ltd., 152/1-H, Green Road, Panthapath, Dhaka - 1205, Bangladesh', 0, 0, 1, '0000-00-00 00:00:00'),
(48, 1, 3, 6, 'IBN Sina Diagnostic & Imaging Center, House # 48, Road # 9/A, Dhanmondi, SAtmasjid Road, Dhaka - 1209', 0, 0, 1, '0000-00-00 00:00:00'),
(49, 1, 3, 6, 'IbnSina Diagnostic & Imaging Center, House # 48, Road # 9/A, Dhanmondi, Satmasjid Road, Dhaka - 1209, Bangladesh', 0, 0, 1, '0000-00-00 00:00:00'),
(50, 1, 3, 6, 'IbnSina Medical Imaging Center, House # 58, Road # 2/A, Dhanmondi R/A, Dhaka - 1209, Bangladesh', 0, 0, 1, '0000-00-00 00:00:00'),
(51, 1, 3, 6, 'Japan Bangladesh Friendship Hospital, 55, Satmasjid Road ( Zigatola Bus Stand ), Dhanmondi, Dhaka - 1209, Bangladesh', 0, 0, 1, '0000-00-00 00:00:00'),
(52, 1, 3, 6, 'Lab Aid Cardiac Hospital, House # 1, Road # 4, Dhanmondi, Dhaka', 0, 0, 1, '0000-00-00 00:00:00'),
(53, 1, 3, 6, 'Lab Aid Cardiac Hospital,?House # 1, Road # 4, Dhanmondi', 0, 0, 1, '0000-00-00 00:00:00'),
(54, 1, 3, 6, 'Lab Aid Ltd.,?House # 1, Road # 4, Dhanmondi, Dhaka', 0, 0, 1, '0000-00-00 00:00:00'),
(55, 1, 3, 6, 'Lab Aid, House # 1, Road # 4, Dhanmond, Dhaka.', 0, 0, 1, '0000-00-00 00:00:00'),
(56, 1, 3, 6, 'Labaid Cardiac Hospital, House # 1, Road # 4, Dhanmondi, Dhaka - 1205', 0, 0, 1, '0000-00-00 00:00:00'),
(57, 1, 3, 6, 'Labaid Specialized Hospital, House # 6, Road # 4, Dhanmondi, Dhaka - 1205', 0, 0, 1, '0000-00-00 00:00:00'),
(58, 1, 3, 6, 'Labaid Specialized Hospital, Location: House # 6, Road # 4, Dhanmondi, Dhaka - 1205', 0, 0, 1, '0000-00-00 00:00:00'),
(59, 1, 3, 6, 'Labaid Specialized Hospital, Location: House # 6, Road # 4, Dhanmondi. City, Dhaka - 1205, Bangladesh', 0, 0, 1, '0000-00-00 00:00:00'),
(60, 1, 3, 6, 'Liver, Gastric, General Hospital & Research Institute, House # 100/1, Road 11/1, Satmasjid Road, Dhanmondi, Dhaka', 0, 0, 1, '0000-00-00 00:00:00'),
(61, 1, 3, 6, 'Medinova Medical Services, Hosaf  Tower, 6/9 Outer Circular Road, Malibag, Dhaka-1217, Bangladesh', 0, 0, 1, '0000-00-00 00:00:00'),
(62, 1, 3, 6, 'Monowara Hospital (pvt) Ltd, Location: 54, Siddeshwari Road , Dhaka - 1217', 0, 0, 1, '0000-00-00 00:00:00'),
(63, 1, 3, 6, 'National Institute of Cardio Vascular Diseases', 0, 0, 1, '0000-00-00 00:00:00'),
(64, 1, 3, 6, 'National Institute of Cardiovascular Diseases (NICVD), Sher-e-Bangla Nagar, Dhaka.', 0, 0, 1, '0000-00-00 00:00:00'),
(65, 1, 3, 6, 'Popular Diagnostic Centre Ltd - Dhanmondi Branch, House # 16, Road # 2, Dhanmondi R/A, Dhaka - 1205', 0, 0, 1, '0000-00-00 00:00:00'),
(66, 1, 3, 6, 'Popular Diagnostic Centre Ltd. - Shyamoli Branch, House # ( 22/7 ) 29, Bir Uttam A.N.M Nuruzzaman Sorak, (Babor road) Block# b, Mohammadpur, Dhaka-1207, Bangladesh', 0, 0, 1, '0000-00-00 00:00:00'),
(67, 1, 3, 6, 'Rushmono General Hospital, Location: 208-9, Outer Circular Road, Moghbazar, Dhaka -1217', 0, 0, 1, '0000-00-00 00:00:00'),
(68, 1, 3, 6, 'Samorita Hospital Ltd., Location: 89/1, Panthapath, Dhaka', 0, 0, 1, '0000-00-00 00:00:00'),
(69, 1, 3, 6, 'Sigma Medical Services, Location: Block - B, 22/12 Khilji Road, Mohammadpur, Dhaka - 1207, Bangladesh', 0, 0, 1, '0000-00-00 00:00:00'),
(70, 1, 3, 6, 'SQUARE Hospitals Ltd. , 18/F Bir Uttam Qazi Nuruzzaman Sarak, West Panthapath, Dhaka - 1205', 0, 0, 1, '0000-00-00 00:00:00'),
(71, 1, 3, 6, 'SQUARE Hospitals Ltd. , 18/F West Panthapath, Dhaka-1205, Bangladesh', 0, 0, 1, '0000-00-00 00:00:00'),
(72, 1, 3, 6, 'SQUARE Hospitals Ltd., 18/F BirUttamQaziNuruzzamanSarak, West Panthapath, Dhaka - 1205, Bangladesh.', 0, 0, 1, '0000-00-00 00:00:00'),
(73, 1, 3, 6, 'SQUARE Hospitals Ltd., Location: 18/F BirUttamQaziNuruzzamanSarak, West Panthapath, Dhaka - 1205, Bangladesh.', 0, 0, 1, '0000-00-00 00:00:00'),
(74, 1, 3, 6, 'SQUARE Hospitals Ltd., Location: 18/F West Panthapath, Dhaka - 1205, Bangladesh.', 0, 0, 1, '0000-00-00 00:00:00'),
(75, 1, 3, 6, 'United Hospital Limited, Plot # 15, Road # 71, Gulshan, Dhaka - 1217, Bangladesh', 0, 0, 1, '0000-00-00 00:00:00');

-- --------------------------------------------------------

--
-- Table structure for table `mims_manufacturerinformation`
--

CREATE TABLE `mims_manufacturerinformation` (
  `ID` bigint(20) NOT NULL,
  `Name` varchar(100) NOT NULL,
  `AddressID` bigint(20) DEFAULT NULL,
  `EmailID` varchar(100) DEFAULT NULL,
  `PhoneNo` varchar(100) DEFAULT NULL,
  `MobileNo` varchar(100) DEFAULT NULL,
  `FaxNo` varchar(100) DEFAULT NULL,
  `LastUpdate` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `CreatedBy` bigint(20) NOT NULL,
  `IsActive` tinyint(1) NOT NULL DEFAULT '1'
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `mims_manufacturerinformation`
--

INSERT INTO `mims_manufacturerinformation` (`ID`, `Name`, `AddressID`, `EmailID`, `PhoneNo`, `MobileNo`, `FaxNo`, `LastUpdate`, `CreatedBy`, `IsActive`) VALUES
(120, ' ACI Limited ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(121, ' Beximco Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(122, ' Concord ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(123, ' Drug International ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(124, ' Incepta ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(125, ' Kumudini Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(126, ' Labaid Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(127, ' lncepta ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(128, ' NIPRO JMI Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(129, ' Orion ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(130, ' Rephco Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(131, ' Sanofi Bangladesh ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(132, ' Square Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(133, ' Ziska Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(134, 'ACI Limiled', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(135, 'ACI Limited ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(136, 'ACME Lab ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(137, 'Alco Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(138, 'Apex Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(139, 'AriatoPharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(140, 'Aristo Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(141, 'Aristopharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(142, 'Asiatic Lab', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(143, 'Beacon Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(144, 'Beximco  Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(145, 'Beximco Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(146, 'Bio-Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(147, 'Concord ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(148, 'Delta Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(149, 'Doctor?s ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(150, 'Doctors ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(151, 'Drug Internalional ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(152, 'Drug International ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(153, 'Drug tnternational ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(154, 'Edruc ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(155, 'Eskayef', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(156, 'General Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(157, 'GlaxoSmithKline ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(158, 'Globe Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(159, 'Healthcare Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(160, 'IBN Sina ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(161, 'IBN Sins ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(162, 'Incepta ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(163, 'Jayaon Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(164, 'Jayson Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(165, 'Kumudini Pharma', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(166, 'Labaid Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(167, 'Labiad Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(168, 'lBN Sina ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(169, 'lncepta ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(170, 'Medicon ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(171, 'Monico ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(172, 'MundiPharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(173, 'Navana', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(174, 'NIPRO JMI Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(175, 'Novartis ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(176, 'Novelta', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(177, 'Opso Saline ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(178, 'Opsonin  Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(179, 'Opsonin Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(180, 'Organic Health Care ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(181, 'Orion ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(182, 'Pharmacil Limited ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(183, 'Popular Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(184, 'Radiant Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(185, 'Renata ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(186, 'Rephco Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(187, 'Sanofi Bangladesh ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(188, 'SERVIER ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(189, 'Somatec Pharm ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(190, 'Somatec Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(191, 'Sonofi Bangladesh', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(192, 'Square Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(193, 'Techno Drugs ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(194, 'UniMed & UniHealth ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(195, 'UniMed & UniHeatth ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1),
(196, 'Ziska Pharma ', NULL, NULL, NULL, NULL, NULL, '2018-10-01 14:30:47', 1, 1);

-- --------------------------------------------------------

--
-- Table structure for table `mims_newsInformation`
--

CREATE TABLE `mims_newsInformation` (
  `ID` bigint(20) NOT NULL,
  `Title` varchar(200) NOT NULL,
  `Description` text NOT NULL,
  `ImagePath` varchar(200) DEFAULT NULL,
  `PublishDateTime` datetime DEFAULT NULL,
  `UnpublishedDateTime` datetime DEFAULT NULL,
  `CreatedBy` bigint(20) NOT NULL,
  `LastUpdate` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `IsActive` tinyint(1) NOT NULL DEFAULT '1'
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `mims_newsInformation`
--

INSERT INTO `mims_newsInformation` (`ID`, `Title`, `Description`, `ImagePath`, `PublishDateTime`, `UnpublishedDateTime`, `CreatedBy`, `LastUpdate`, `IsActive`) VALUES
(8, 'Health Service through Mobile Phone', 'Our citizens can take health suggestions for free now from doctors working in government health centers. For this a mobile phone has been given to each district and sub-district hospital of Bangladesh. The numbers of these mobile phones have been publicized locally. These numbers are also given in the website of Directorate General of Health Services (www.dghs.gov.bd). Doctors receive calls in these numbers 24 hours. Local people can receive free health suggestions by calling these numbers.', 'cdec92d7dd209e39780326f0ef1c140c.jpg', '2018-11-25 00:00:00', '2018-11-30 00:00:00', 3, '2018-11-25 10:06:08', 1),
(9, '      Home     Bangladesh  Patients suffer as physicians stop services in Rajshahi pvt hospitals, clinics', '\r\n\r\n    Home\r\n    Bangladesh\r\n\r\nPatients suffer as physicians stop services in Rajshahi pvt hospitals, clinics\r\nProthom Alo English Desk | Update: 12:23, Apr 30, 2018\r\n0 Like\r\n \r\n \r\n \r\n \r\n \r\n \r\n\r\nMap of RajshahiPhysicians in Rajshahi stopped providing all sorts of healthcare services in private hospitals, clinics and diagnostic centres protesting \\\'assault\\\' on a fellow over the death of a child due to alleged wrong treatment on Saturday.\r\nThey also refrained from seeing patients in their private chambers. ', 'c125639be61899cb3461e81565245ba2.png', '2018-11-25 00:00:00', '2018-11-30 00:00:00', 3, '2018-11-25 10:30:11', 1);

-- --------------------------------------------------------

--
-- Table structure for table `mims_packsizeinformation`
--

CREATE TABLE `mims_packsizeinformation` (
  `ID` int(11) NOT NULL,
  `Name` varchar(100) NOT NULL,
  `LastUpdate` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `CreatedBy` bigint(20) NOT NULL,
  `IsActive` tinyint(1) NOT NULL DEFAULT '1'
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `mims_packsizeinformation`
--

INSERT INTO `mims_packsizeinformation` (`ID`, `Name`, `LastUpdate`, `CreatedBy`, `IsActive`) VALUES
(86, '', '2018-10-01 14:31:18', 1, 1),
(87, ' 10?s ', '2018-10-01 14:31:18', 1, 1),
(88, ' 10x10?s ', '2018-10-01 14:31:18', 1, 1),
(89, ' 1?s, ', '2018-10-01 14:31:18', 1, 1),
(90, ' 30?s ', '2018-10-01 14:31:18', 1, 1),
(91, ' 56?s ', '2018-10-01 14:31:18', 1, 1),
(92, ' 5x2?s ', '2018-10-01 14:31:18', 1, 1),
(93, ' 60?s ', '2018-10-01 14:31:18', 1, 1),
(94, ' 60mI ', '2018-10-01 14:31:18', 1, 1),
(95, ' 60ml ', '2018-10-01 14:31:18', 1, 1),
(96, '1 Combipack ', '2018-10-01 14:31:18', 1, 1),
(97, '100 ml ', '2018-10-01 14:31:18', 1, 1),
(98, '100\'s', '2018-10-01 14:31:18', 1, 1),
(99, '100?s ', '2018-10-01 14:31:18', 1, 1),
(100, '100mI ', '2018-10-01 14:31:18', 1, 1),
(101, '100ml ', '2018-10-01 14:31:18', 1, 1),
(102, '10?s ', '2018-10-01 14:31:18', 1, 1),
(103, '10?s, ', '2018-10-01 14:31:18', 1, 1),
(104, '10mI ', '2018-10-01 14:31:18', 1, 1),
(105, '10ml ', '2018-10-01 14:31:18', 1, 1),
(106, '10x1', '2018-10-01 14:31:18', 1, 1),
(107, '10x10 ', '2018-10-01 14:31:18', 1, 1),
(108, '10x10?s ', '2018-10-01 14:31:18', 1, 1),
(109, '10x15?s ', '2018-10-01 14:31:18', 1, 1),
(110, '10x1?s', '2018-10-01 14:31:18', 1, 1),
(111, '10x20?s ', '2018-10-01 14:31:18', 1, 1),
(112, '10x2?s', '2018-10-01 14:31:18', 1, 1),
(113, '10x3?s ', '2018-10-01 14:31:18', 1, 1),
(114, '10x4?s ', '2018-10-01 14:31:18', 1, 1),
(115, '10x50?s ', '2018-10-01 14:31:18', 1, 1),
(116, '10x5?s ', '2018-10-01 14:31:18', 1, 1),
(117, '10x6?s', '2018-10-01 14:31:18', 1, 1),
(118, '10x9?s ', '2018-10-01 14:31:18', 1, 1),
(119, '12x4?s ', '2018-10-01 14:31:18', 1, 1),
(120, '14?s ', '2018-10-01 14:31:18', 1, 1),
(121, '14x10?s ', '2018-10-01 14:31:18', 1, 1),
(122, '14x2?s ', '2018-10-01 14:31:18', 1, 1),
(123, '14x3?s ', '2018-10-01 14:31:18', 1, 1),
(124, '150?s ', '2018-10-01 14:31:18', 1, 1),
(125, '150ml ', '2018-10-01 14:31:18', 1, 1),
(126, '15mI ', '2018-10-01 14:31:18', 1, 1),
(127, '15ml ', '2018-10-01 14:31:18', 1, 1),
(128, '15x10?s ', '2018-10-01 14:31:18', 1, 1),
(129, '15x2?s ', '2018-10-01 14:31:18', 1, 1),
(130, '168?s ', '2018-10-01 14:31:18', 1, 1),
(131, '16x6?s ', '2018-10-01 14:31:18', 1, 1),
(132, '1?s ', '2018-10-01 14:31:18', 1, 1),
(133, '1Combipack ', '2018-10-01 14:31:18', 1, 1),
(134, '1x10?s ', '2018-10-01 14:31:18', 1, 1),
(135, '1x1?s ', '2018-10-01 14:31:18', 1, 1),
(136, '200 doses ', '2018-10-01 14:31:18', 1, 1),
(137, '200 metered doses ', '2018-10-01 14:31:18', 1, 1),
(138, '200 sprays ', '2018-10-01 14:31:18', 1, 1),
(139, '200?s ', '2018-10-01 14:31:18', 1, 1),
(140, '200ml ', '2018-10-01 14:31:18', 1, 1),
(141, '20?s ', '2018-10-01 14:31:18', 1, 1),
(142, '20?s, ', '2018-10-01 14:31:18', 1, 1),
(143, '20x10?s ', '2018-10-01 14:31:18', 1, 1),
(144, '20x2ml ', '2018-10-01 14:31:18', 1, 1),
(145, '24?s ', '2018-10-01 14:31:18', 1, 1),
(146, '250?s ', '2018-10-01 14:31:18', 1, 1),
(147, '25?s ', '2018-10-01 14:31:18', 1, 1),
(148, '28?s ', '2018-10-01 14:31:18', 1, 1),
(149, '2mlx10?s ', '2018-10-01 14:31:18', 1, 1),
(150, '2x10?s ', '2018-10-01 14:31:18', 1, 1),
(151, '2x14?s ', '2018-10-01 14:31:18', 1, 1),
(152, '2x15?s ', '2018-10-01 14:31:18', 1, 1),
(153, '2x20?s ', '2018-10-01 14:31:18', 1, 1),
(154, '2x5?s ', '2018-10-01 14:31:18', 1, 1),
(155, '2x7?s', '2018-10-01 14:31:18', 1, 1),
(156, '30?s ', '2018-10-01 14:31:18', 1, 1),
(157, '30g ', '2018-10-01 14:31:18', 1, 1),
(158, '30ml ', '2018-10-01 14:31:18', 1, 1),
(159, '3x10?s ', '2018-10-01 14:31:18', 1, 1),
(160, '3x10s ', '2018-10-01 14:31:18', 1, 1),
(161, '3x6?s ', '2018-10-01 14:31:18', 1, 1),
(162, '40?s ', '2018-10-01 14:31:18', 1, 1),
(163, '42?s ', '2018-10-01 14:31:18', 1, 1),
(164, '450ml ', '2018-10-01 14:31:18', 1, 1),
(165, '46?s ', '2018-10-01 14:31:18', 1, 1),
(166, '48?s ', '2018-10-01 14:31:18', 1, 1),
(167, '4?s ', '2018-10-01 14:31:18', 1, 1),
(168, '4x10?s ', '2018-10-01 14:31:18', 1, 1),
(169, '4x4?s ', '2018-10-01 14:31:18', 1, 1),
(170, '4x5?s ', '2018-10-01 14:31:18', 1, 1),
(171, '4x6?s ', '2018-10-01 14:31:18', 1, 1),
(172, '4x7?s ', '2018-10-01 14:31:18', 1, 1),
(173, '500?s ', '2018-10-01 14:31:18', 1, 1),
(174, '50?s ', '2018-10-01 14:31:18', 1, 1),
(175, '50mI ', '2018-10-01 14:31:18', 1, 1),
(176, '50ml ', '2018-10-01 14:31:18', 1, 1),
(177, '50s ', '2018-10-01 14:31:18', 1, 1),
(178, '50x10?s ', '2018-10-01 14:31:18', 1, 1),
(179, '56?s ', '2018-10-01 14:31:18', 1, 1),
(180, '5?s ', '2018-10-01 14:31:18', 1, 1),
(181, '5x10?s ', '2018-10-01 14:31:18', 1, 1),
(182, '5x10s ', '2018-10-01 14:31:18', 1, 1),
(183, '5x1?s ', '2018-10-01 14:31:18', 1, 1),
(184, '5x2?s ', '2018-10-01 14:31:18', 1, 1),
(185, '5x4?s ', '2018-10-01 14:31:18', 1, 1),
(186, '5x4s ', '2018-10-01 14:31:18', 1, 1),
(187, '5x5?s ', '2018-10-01 14:31:18', 1, 1),
(188, '5x6?s ', '2018-10-01 14:31:18', 1, 1),
(189, '60?s ', '2018-10-01 14:31:18', 1, 1),
(190, '60mI ', '2018-10-01 14:31:18', 1, 1),
(191, '60ml ', '2018-10-01 14:31:18', 1, 1),
(192, '6x10?s ', '2018-10-01 14:31:18', 1, 1),
(193, '6x6?s ', '2018-10-01 14:31:18', 1, 1),
(194, '70?s ', '2018-10-01 14:31:18', 1, 1),
(195, '7?s', '2018-10-01 14:31:18', 1, 1),
(196, '7x4?s ', '2018-10-01 14:31:18', 1, 1),
(197, '7x8?s ', '2018-10-01 14:31:18', 1, 1),
(198, '80?s ', '2018-10-01 14:31:18', 1, 1),
(199, '8x10?s ', '2018-10-01 14:31:18', 1, 1),
(200, '8x15?s ', '2018-10-01 14:31:18', 1, 1),
(201, '8x6?s ', '2018-10-01 14:31:18', 1, 1),
(202, '8x7?s ', '2018-10-01 14:31:18', 1, 1),
(203, '8x8?s ', '2018-10-01 14:31:18', 1, 1),
(204, '98?s ', '2018-10-01 14:31:18', 1, 1);

-- --------------------------------------------------------

--
-- Table structure for table `mims_resourceinformation`
--

CREATE TABLE `mims_resourceinformation` (
  `ID` bigint(20) NOT NULL,
  `Title` varchar(300) NOT NULL,
  `ResourceType` varchar(10) NOT NULL DEFAULT 'pdf',
  `ResourcePath` varchar(300) NOT NULL,
  `LastUpdate` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `CreatedBy` bigint(20) NOT NULL,
  `IsActive` tinyint(1) NOT NULL DEFAULT '1'
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `mims_resourceinformation`
--

INSERT INTO `mims_resourceinformation` (`ID`, `Title`, `ResourceType`, `ResourcePath`, `LastUpdate`, `CreatedBy`, `IsActive`) VALUES
(1, 'Bacteria', 'pdf', 'Bacteria.pdf', '2018-09-11 21:59:56', 1, 1),
(2, 'Common Terminology Criteria\r\nfor Adverse Events', 'pdf', 'CTCAE.pdf', '2018-09-11 21:59:56', 1, 1),
(3, 'Fungi', 'pdf', 'Fungi.pdf', '2018-09-11 22:01:07', 1, 1),
(4, 'JDMD Glossary', 'pdf', 'jdmd_glossary.pdf', '2018-09-11 22:01:07', 1, 1),
(5, 'Pre & Post Prandial Advice', 'pdf', 'Pre-And Post-Prandial Advice.pdf', '2018-09-11 22:02:00', 1, 1),
(6, 'Pregnancy Safety Index', 'pdf', 'Pregnancy Safety Index.pdf', '2018-09-11 22:02:00', 1, 1),
(7, 'Protozoa,Parasites', 'pdf', 'Protozoa Parasites.pdf', '2018-09-11 22:02:59', 1, 1),
(8, 'Viruses', 'pdf', 'Viruses.pdf', '2018-09-11 22:02:59', 1, 1);

-- --------------------------------------------------------

--
-- Table structure for table `mims_specialreports`
--

CREATE TABLE `mims_specialreports` (
  `ID` bigint(20) NOT NULL,
  `Title` varchar(300) NOT NULL,
  `LinkAddress` varchar(300) NOT NULL,
  `ImagePath` varchar(300) DEFAULT NULL,
  `LastUpdate` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `CreatedBy` bigint(20) NOT NULL,
  `IsActive` tinyint(1) NOT NULL DEFAULT '1'
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `mims_specialreports`
--

INSERT INTO `mims_specialreports` (`ID`, `Title`, `LinkAddress`, `ImagePath`, `LastUpdate`, `CreatedBy`, `IsActive`) VALUES
(8, 'Social media use more common in young with mental disorders, research shows', 'http://www.pharmatimes.com/news/social_media_use_more_common_in_young_with_mental_disorders,_research_shows_1262734', 'a29eb048487d46cee820d3fa34914c91.jpg', '2018-11-25 09:36:53', 3, 1),
(9, 'The PharmaTimes International Clinical Researcher of the Year is open for entry – with a broad range of categories for all types of candidates', 'http://www.pharmatimes.com/news/the_pharmatimes_international_clinical_researcher_of_the_year_is_open_for_entry_with_a_broad_range_of_categories_for_all_types_of_candidates_1263063', 'c903236b3f118520b4804600705f8871.png', '2018-11-25 09:39:22', 3, 1),
(10, 'Adult Cardiac Stem Cells Don’t Exist: Study', 'https://www.the-scientist.com/news-opinion/adult-cardiac-stem-cells-dont-exist--study-64752', 'a9c35c5619543306fe9b0196c195521c.jpg', '2018-11-25 09:43:35', 3, 1),
(11, 'Medical Device Safety Action Plan: Protecting Patients, Promoting Public Health', 'https://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDRH/CDRHReports/ucm604500.htm', 'e0e948eb76ddc225354f50079e1578d6.jpg', '2018-11-25 09:48:24', 3, 1);

-- --------------------------------------------------------

--
-- Table structure for table `mims_state`
--

CREATE TABLE `mims_state` (
  `ID` int(11) NOT NULL,
  `Name` varchar(100) NOT NULL,
  `CountryID` int(11) NOT NULL,
  `CreatedBY` bigint(20) NOT NULL,
  `LastUpdate` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `IsActive` tinyint(1) NOT NULL DEFAULT '1'
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `mims_state`
--

INSERT INTO `mims_state` (`ID`, `Name`, `CountryID`, `CreatedBY`, `LastUpdate`, `IsActive`) VALUES
(1, 'Barisal', 1, 1, '2018-09-13 16:38:41', 1),
(2, 'Chittagong', 1, 1, '2018-09-13 16:38:41', 1),
(3, 'Dhaka', 1, 1, '2018-09-13 16:38:41', 1),
(4, 'Khulna', 1, 1, '2018-09-13 16:38:41', 1),
(5, 'Rajshahi', 1, 1, '2018-09-13 16:38:41', 1),
(6, 'Sylhet', 1, 1, '2018-09-13 16:38:41', 1);

-- --------------------------------------------------------

--
-- Table structure for table `mims_strengthinformation`
--

CREATE TABLE `mims_strengthinformation` (
  `ID` bigint(20) NOT NULL,
  `Name` varchar(100) NOT NULL,
  `LastUpdate` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `CreatedBy` bigint(20) NOT NULL,
  `IsActive` tinyint(1) NOT NULL DEFAULT '1'
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `mims_strengthinformation`
--

INSERT INTO `mims_strengthinformation` (`ID`, `Name`, `LastUpdate`, `CreatedBy`, `IsActive`) VALUES
(30, '', '2018-10-01 14:31:09', 1, 1),
(31, ' 20mg ', '2018-10-01 14:31:09', 1, 1),
(32, ' 250mg ', '2018-10-01 14:31:09', 1, 1),
(33, ' 400mcg/spray ', '2018-10-01 14:31:09', 1, 1),
(34, ' 40mg ', '2018-10-01 14:31:09', 1, 1),
(35, ' 50mg ', '2018-10-01 14:31:09', 1, 1),
(36, ' 5mg ', '2018-10-01 14:31:09', 1, 1),
(37, '(Amiloride HCI 5mg, Hydrochlorothiazide 50mg) ', '2018-10-01 14:31:09', 1, 1),
(38, '(Amlodipine 5mg eqv. to Amlodipine Besylate 6.94mg)  ', '2018-10-01 14:31:09', 1, 1),
(39, '(Omeprazole 20mg eqv. to Omeprazole Pellets \n280mmg) ', '2018-10-01 14:31:09', 1, 1),
(40, '(Omeprazole 40mg eqv. to Omeprazole Pellets \n560mmg) ', '2018-10-01 14:31:09', 1, 1),
(41, '(Ranitidine 150mg eqv. to Ranitidine HCL BP 167.50mg) ', '2018-10-01 14:31:09', 1, 1),
(42, '(Ranitidine 50mg eqs. to Ranitidine HCL USP 55.800mg)  ', '2018-10-01 14:31:09', 1, 1),
(43, '(Ranitidine 50mg w/v 0.05% (50mg/100mL) as Ranitidine Hydrochloride)  ', '2018-10-01 14:31:09', 1, 1),
(44, '0.05%w/v ', '2018-10-01 14:31:09', 1, 1),
(45, '0.1mg ', '2018-10-01 14:31:09', 1, 1),
(46, '0.4mg ', '2018-10-01 14:31:09', 1, 1),
(47, '0.4mg/dose ', '2018-10-01 14:31:09', 1, 1),
(48, '0.5mg ', '2018-10-01 14:31:09', 1, 1),
(49, '0.5mg/mL ', '2018-10-01 14:31:09', 1, 1),
(50, '1%', '2018-10-01 14:31:09', 1, 1),
(51, '1.25mg ', '2018-10-01 14:31:09', 1, 1),
(52, '1000mg ', '2018-10-01 14:31:09', 1, 1),
(53, '100mcg ', '2018-10-01 14:31:09', 1, 1),
(54, '100mg ', '2018-10-01 14:31:09', 1, 1),
(55, '100mg+12.5mg', '2018-10-01 14:31:09', 1, 1),
(56, '100mg+25mg', '2018-10-01 14:31:09', 1, 1),
(57, '100mg/5mL ', '2018-10-01 14:31:09', 1, 1),
(58, '10g/15mL ', '2018-10-01 14:31:09', 1, 1),
(59, '10mg ', '2018-10-01 14:31:09', 1, 1),
(60, '10mg + 1600mg ', '2018-10-01 14:31:09', 1, 1),
(61, '10mg + 160mg ', '2018-10-01 14:31:09', 1, 1),
(62, '10mg + 6.25mg ', '2018-10-01 14:31:09', 1, 1),
(63, '10mg+160mg ', '2018-10-01 14:31:09', 1, 1),
(64, '10mg+20mg', '2018-10-01 14:31:09', 1, 1),
(65, '10mg+320mg ', '2018-10-01 14:31:09', 1, 1),
(66, '10mg/2mL', '2018-10-01 14:31:09', 1, 1),
(67, '10mg/5mL ', '2018-10-01 14:31:09', 1, 1),
(68, '10mg/spray ', '2018-10-01 14:31:09', 1, 1),
(69, '10mg/spray (10ml)', '2018-10-01 14:31:09', 1, 1),
(70, '10mg/spray (50ml) ', '2018-10-01 14:31:09', 1, 1),
(71, '12.5mg ', '2018-10-01 14:31:09', 1, 1),
(72, '120mg ', '2018-10-01 14:31:09', 1, 1),
(73, '125mg/5mL', '2018-10-01 14:31:09', 1, 1),
(74, '135mg ', '2018-10-01 14:31:09', 1, 1),
(75, '150mg ', '2018-10-01 14:31:09', 1, 1),
(76, '150mg + 12.5mg ', '2018-10-01 14:31:09', 1, 1),
(77, '15mg ', '2018-10-01 14:31:09', 1, 1),
(78, '160mg ', '2018-10-01 14:31:09', 1, 1),
(79, '160mg+12.5mg', '2018-10-01 14:31:09', 1, 1),
(80, '160mg+25mg', '2018-10-01 14:31:09', 1, 1),
(81, '16mg ', '2018-10-01 14:31:09', 1, 1),
(82, '1g ', '2018-10-01 14:31:09', 1, 1),
(83, '1mg ', '2018-10-01 14:31:09', 1, 1),
(84, '1mg/2 ml ', '2018-10-01 14:31:09', 1, 1),
(85, '1mg/mL ', '2018-10-01 14:31:09', 1, 1),
(86, '2%', '2018-10-01 14:31:09', 1, 1),
(87, '2.5mg ', '2018-10-01 14:31:09', 1, 1),
(88, '2.5mg + 6.25mg ', '2018-10-01 14:31:09', 1, 1),
(89, '2.5mg+10mg', '2018-10-01 14:31:09', 1, 1),
(90, '2.5mg+12.5mg', '2018-10-01 14:31:09', 1, 1),
(91, '2.5mg+12mg', '2018-10-01 14:31:09', 1, 1),
(92, '2.5mg+20mg', '2018-10-01 14:31:09', 1, 1),
(93, '2.5mg+5mg', '2018-10-01 14:31:09', 1, 1),
(94, '2.6mg ', '2018-10-01 14:31:09', 1, 1),
(95, '20 mg ', '2018-10-01 14:31:09', 1, 1),
(96, '200mcg ', '2018-10-01 14:31:09', 1, 1),
(97, '200mg ', '2018-10-01 14:31:09', 1, 1),
(98, '20mg ', '2018-10-01 14:31:09', 1, 1),
(99, '20mg + 1100mg', '2018-10-01 14:31:09', 1, 1),
(100, '20mg + 12.5mg ', '2018-10-01 14:31:09', 1, 1),
(101, '20mg +1100mg', '2018-10-01 14:31:09', 1, 1),
(102, '20mg +12.5mg ', '2018-10-01 14:31:09', 1, 1),
(103, '20mg+12.5mg ', '2018-10-01 14:31:09', 1, 1),
(104, '20mg+40mg', '2018-10-01 14:31:09', 1, 1),
(105, '20mg+50mg', '2018-10-01 14:31:09', 1, 1),
(106, '20mg/2mL ', '2018-10-01 14:31:09', 1, 1),
(107, '20mg/2mL (20mg)', '2018-10-01 14:31:09', 1, 1),
(108, '20mg/mL ', '2018-10-01 14:31:09', 1, 1),
(109, '250mg ', '2018-10-01 14:31:09', 1, 1),
(110, '250mg/5mL ', '2018-10-01 14:31:09', 1, 1),
(111, '25mg ', '2018-10-01 14:31:09', 1, 1),
(112, '25mg + 50mg ', '2018-10-01 14:31:09', 1, 1),
(113, '25mg+12.5mg', '2018-10-01 14:31:09', 1, 1),
(114, '25mg/5mL', '2018-10-01 14:31:09', 1, 1),
(115, '2Bmg ', '2018-10-01 14:31:09', 1, 1),
(116, '2mg ', '2018-10-01 14:31:09', 1, 1),
(117, '2mg+0.625mg', '2018-10-01 14:31:09', 1, 1),
(118, '2mg+1.25mg', '2018-10-01 14:31:09', 1, 1),
(119, '2mg/mL ', '2018-10-01 14:31:09', 1, 1),
(120, '3.125mg ', '2018-10-01 14:31:09', 1, 1),
(121, '3.33gm/5mL ', '2018-10-01 14:31:09', 1, 1),
(122, '3.35g ', '2018-10-01 14:31:09', 1, 1),
(123, '3.35g/5mL ', '2018-10-01 14:31:09', 1, 1),
(124, '3.35gm/5ml ', '2018-10-01 14:31:09', 1, 1),
(125, '3.4/5mL ', '2018-10-01 14:31:09', 1, 1),
(126, '3.40gm/5mL ', '2018-10-01 14:31:09', 1, 1),
(127, '3.4g/5mL ', '2018-10-01 14:31:09', 1, 1),
(128, '3.53g/5mL ', '2018-10-01 14:31:09', 1, 1),
(129, '300 mg ', '2018-10-01 14:31:09', 1, 1),
(130, '300mg ', '2018-10-01 14:31:09', 1, 1),
(131, '300mg + 12.5mg ', '2018-10-01 14:31:09', 1, 1),
(132, '30mg ', '2018-10-01 14:31:09', 1, 1),
(133, '320mg ', '2018-10-01 14:31:09', 1, 1),
(134, '35mg ', '2018-10-01 14:31:09', 1, 1),
(135, '4%', '2018-10-01 14:31:09', 1, 1),
(136, '40 mg ', '2018-10-01 14:31:09', 1, 1),
(137, '400mcg/actuation', '2018-10-01 14:31:09', 1, 1),
(138, '40mg ', '2018-10-01 14:31:09', 1, 1),
(139, '40mg & 12.5mg ', '2018-10-01 14:31:09', 1, 1),
(140, '40mg + 5mg ', '2018-10-01 14:31:09', 1, 1),
(141, '40mg +12.5mg ', '2018-10-01 14:31:09', 1, 1),
(142, '40mg+50mg', '2018-10-01 14:31:09', 1, 1),
(143, '40mg/10mL ', '2018-10-01 14:31:09', 1, 1),
(144, '40mg/2mL ', '2018-10-01 14:31:09', 1, 1),
(145, '40mg/5mL ', '2018-10-01 14:31:09', 1, 1),
(146, '40mg/vial ', '2018-10-01 14:31:09', 1, 1),
(147, '4mg ', '2018-10-01 14:31:09', 1, 1),
(148, '4mg+1.25mg', '2018-10-01 14:31:09', 1, 1),
(149, '500mg ', '2018-10-01 14:31:09', 1, 1),
(150, '50mg ', '2018-10-01 14:31:09', 1, 1),
(151, '50mg+12.5mg', '2018-10-01 14:31:09', 1, 1),
(152, '50mg+25mg', '2018-10-01 14:31:09', 1, 1),
(153, '50mg/100mL ', '2018-10-01 14:31:09', 1, 1),
(154, '50mg/10mL ', '2018-10-01 14:31:09', 1, 1),
(155, '50mg/2mL ', '2018-10-01 14:31:09', 1, 1),
(156, '50mg/5mL ', '2018-10-01 14:31:09', 1, 1),
(157, '55mg/2mL ', '2018-10-01 14:31:09', 1, 1),
(158, '5mg ', '2018-10-01 14:31:09', 1, 1),
(159, '5mg + 160mg ', '2018-10-01 14:31:09', 1, 1),
(160, '5mg + 20mg ', '2018-10-01 14:31:09', 1, 1),
(161, '5mg + 40mg ', '2018-10-01 14:31:09', 1, 1),
(162, '5mg + 6.25mg ', '2018-10-01 14:31:09', 1, 1),
(163, '5mg + 80mg ', '2018-10-01 14:31:09', 1, 1),
(164, '5mg +160mg ', '2018-10-01 14:31:09', 1, 1),
(165, '5mg+ 10mg ', '2018-10-01 14:31:09', 1, 1),
(166, '5mg+ 20mg ', '2018-10-01 14:31:09', 1, 1),
(167, '5mg+10mg', '2018-10-01 14:31:09', 1, 1),
(168, '5mg+12.5mg', '2018-10-01 14:31:09', 1, 1),
(169, '5mg+160mg ', '2018-10-01 14:31:09', 1, 1),
(170, '5mg+20mg ', '2018-10-01 14:31:09', 1, 1),
(171, '5mg+25mg', '2018-10-01 14:31:09', 1, 1),
(172, '5mg+320mg ', '2018-10-01 14:31:09', 1, 1),
(173, '5mg+50mg', '2018-10-01 14:31:09', 1, 1),
(174, '5mg+80mg ', '2018-10-01 14:31:09', 1, 1),
(175, '5mg/5mI ', '2018-10-01 14:31:09', 1, 1),
(176, '5mg/5mL', '2018-10-01 14:31:09', 1, 1),
(177, '5mg/mL ', '2018-10-01 14:31:09', 1, 1),
(178, '6.25mg ', '2018-10-01 14:31:09', 1, 1),
(179, '6.4mg ', '2018-10-01 14:31:09', 1, 1),
(180, '600mcg ', '2018-10-01 14:31:09', 1, 1),
(181, '60mg ', '2018-10-01 14:31:09', 1, 1),
(182, '62.5mg', '2018-10-01 14:31:09', 1, 1),
(183, '67g/100mL ', '2018-10-01 14:31:09', 1, 1),
(184, '67mg/mL ', '2018-10-01 14:31:09', 1, 1),
(185, '6mg/2mL ', '2018-10-01 14:31:09', 1, 1),
(186, '7.5mg ', '2018-10-01 14:31:09', 1, 1),
(187, '75mg ', '2018-10-01 14:31:09', 1, 1),
(188, '75mg + 12.5mg ', '2018-10-01 14:31:09', 1, 1),
(189, '75mg/5mL ', '2018-10-01 14:31:09', 1, 1),
(190, '80mg ', '2018-10-01 14:31:09', 1, 1),
(191, '80mg & 12.5mg ', '2018-10-01 14:31:09', 1, 1),
(192, '80mg+12.5mg', '2018-10-01 14:31:09', 1, 1),
(193, '8mg ', '2018-10-01 14:31:09', 1, 1),
(194, '8mg + 12.5mg ', '2018-10-01 14:31:09', 1, 1),
(195, '90mg ', '2018-10-01 14:31:09', 1, 1);

-- --------------------------------------------------------

--
-- Table structure for table `mims_userinformation`
--

CREATE TABLE `mims_userinformation` (
  `ID` bigint(20) NOT NULL,
  `UserName` varchar(100) NOT NULL,
  `EmailID` varchar(100) NOT NULL,
  `UserPass` varchar(255) NOT NULL,
  `FirstName` varchar(100) NOT NULL,
  `LastName` varchar(100) NOT NULL,
  `RoleID` tinyint(4) NOT NULL,
  `LastUpdate` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `IsActive` tinyint(1) NOT NULL DEFAULT '1'
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `mims_userinformation`
--

INSERT INTO `mims_userinformation` (`ID`, `UserName`, `EmailID`, `UserPass`, `FirstName`, `LastName`, `RoleID`, `LastUpdate`, `IsActive`) VALUES
(1, 'amalesh', 'amalesh.debnath@gmail.com', '96f0f08c0188ba04898ce8cc465c19c4', 'Amalesh', 'Debnath', 1, '2018-05-19 21:31:06', 1),
(2, 'maq', 'mostaque@gmail.com', 'deddd3b17a3ada8a2e05a101e25ab25b', 'Mostaq', 'Ahmed', 2, '2018-08-17 22:05:39', 1),
(3, 'pulak', 'srpulak99@gmail.com', 'd07ea2047ec93e772cf183bc02e4a7b7', 'Shahin', 'Bhai', 1, '2018-08-17 22:05:39', 1);

-- --------------------------------------------------------

--
-- Table structure for table `mims_userrole`
--

CREATE TABLE `mims_userrole` (
  `ID` tinyint(4) NOT NULL,
  `RoleName` varchar(30) NOT NULL,
  `LastUpdate` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `IsActive` tinyint(1) NOT NULL DEFAULT '1'
) ENGINE=InnoDB DEFAULT CHARSET=utf8;

--
-- Dumping data for table `mims_userrole`
--

INSERT INTO `mims_userrole` (`ID`, `RoleName`, `LastUpdate`, `IsActive`) VALUES
(1, 'Super Admin', '2018-05-19 21:30:13', 1),
(2, 'Site Admin', '2018-05-19 21:30:13', 1);

-- --------------------------------------------------------

--
-- Table structure for table `mims_visitor`
--

CREATE TABLE `mims_visitor` (
  `NymberOfVisitor` bigint(20) NOT NULL DEFAULT '0'
) ENGINE=MyISAM DEFAULT CHARSET=latin1;

--
-- Dumping data for table `mims_visitor`
--

INSERT INTO `mims_visitor` (`NymberOfVisitor`) VALUES
(11332);

--
-- Indexes for dumped tables
--

--
-- Indexes for table `mims_addresscategory`
--
ALTER TABLE `mims_addresscategory`
  ADD PRIMARY KEY (`ID`),
  ADD KEY `IN_Category_Name` (`Name`),
  ADD KEY `addresscategory_cbfk_1` (`CreatedBY`);

--
-- Indexes for table `mims_addressinformation`
--
ALTER TABLE `mims_addressinformation`
  ADD PRIMARY KEY (`ID`),
  ADD KEY `addressinformation_cbfk_1` (`CreatedBy`),
  ADD KEY `addressinformation_cbfk_2` (`AddressCategoryID`);

--
-- Indexes for table `mims_advertisementinformation`
--
ALTER TABLE `mims_advertisementinformation`
  ADD PRIMARY KEY (`ID`),
  ADD KEY `PublishDate` (`PublishDate`,`UnpublishedDate`,`AdvertisementPositionID`,`IsActive`),
  ADD KEY `Organization` (`Organization`),
  ADD KEY `advertisementinformation_ibfk_1` (`AdvertisementPositionID`),
  ADD KEY `advertisementinformation_cbfk_1` (`CreatedBy`);

--
-- Indexes for table `mims_advertisementpositioninformation`
--
ALTER TABLE `mims_advertisementpositioninformation`
  ADD PRIMARY KEY (`ID`),
  ADD UNIQUE KEY `UNIQUE_Ads_ClassName` (`ClassName`),
  ADD KEY `Name` (`Name`),
  ADD KEY `advertisementpositioninformation_cbfk_1` (`CreatedBy`);

--
-- Indexes for table `mims_brandinformation`
--
ALTER TABLE `mims_brandinformation`
  ADD PRIMARY KEY (`ID`),
  ADD KEY `GenericID` (`GenericID`),
  ADD KEY `ManufacturerID` (`ManufacturerID`),
  ADD KEY `DosageFormID` (`DosageFormID`),
  ADD KEY `StrengthID` (`StrengthID`),
  ADD KEY `GenericID_2` (`GenericID`,`ManufacturerID`,`DosageFormID`,`StrengthID`,`PackSizeID`),
  ADD KEY `PackSizeID` (`PackSizeID`),
  ADD KEY `brandinformation_cbfk_1` (`CreatedBy`);

--
-- Indexes for table `mims_city`
--
ALTER TABLE `mims_city`
  ADD PRIMARY KEY (`ID`),
  ADD UNIQUE KEY `Name` (`StateID`,`Name`,`IsActive`),
  ADD KEY `country_cbfk_1` (`CreatedBY`);

--
-- Indexes for table `mims_country`
--
ALTER TABLE `mims_country`
  ADD PRIMARY KEY (`ID`),
  ADD UNIQUE KEY `Name` (`Name`,`IsActive`),
  ADD KEY `country_cbfk_1` (`CreatedBY`);

--
-- Indexes for table `mims_doctorinformation`
--
ALTER TABLE `mims_doctorinformation`
  ADD PRIMARY KEY (`ID`),
  ADD KEY `Name` (`Name`,`IsActive`),
  ADD KEY `doctorinformation_cbfk_2` (`HomeAddressID`),
  ADD KEY `doctorinformation_cbfk_3` (`ChamberAddressID`),
  ADD KEY `doctorinformation_cbfk_1` (`CreatedBy`);

--
-- Indexes for table `mims_dosageforminformation`
--
ALTER TABLE `mims_dosageforminformation`
  ADD PRIMARY KEY (`ID`),
  ADD UNIQUE KEY `Name` (`Name`,`IsActive`),
  ADD KEY `dosageforminformation_cbfk_1` (`CreatedBy`);

--
-- Indexes for table `mims_genericinformation`
--
ALTER TABLE `mims_genericinformation`
  ADD PRIMARY KEY (`ID`),
  ADD UNIQUE KEY `Name` (`Name`,`IsActive`),
  ADD KEY `genericinformation_cbfk_1` (`CreatedBy`);

--
-- Indexes for table `mims_InternationalHealth`
--
ALTER TABLE `mims_InternationalHealth`
  ADD PRIMARY KEY (`ID`),
  ADD KEY `PublishDateTime` (`PublishDateTime`,`UnpublishedDateTime`,`IsActive`),
  ADD KEY `InternationalHealth_cbfk_1` (`CreatedBy`);

--
-- Indexes for table `mims_jobinformation`
--
ALTER TABLE `mims_jobinformation`
  ADD PRIMARY KEY (`ID`),
  ADD KEY `IN_Job_Title` (`Title`),
  ADD KEY `IN_Job_Organization` (`Organization`),
  ADD KEY `IN_Job_Position` (`Position`),
  ADD KEY `IN_Job_ApplicationDeadline` (`ApplicationDeadline`),
  ADD KEY `IN_Job_PublishDate` (`PublishDate`),
  ADD KEY `ApplicationDeadline` (`ApplicationDeadline`,`PublishDate`,`IsActive`),
  ADD KEY `jobinformation_cbfk_1` (`CreatedBy`);

--
-- Indexes for table `mims_location`
--
ALTER TABLE `mims_location`
  ADD PRIMARY KEY (`ID`),
  ADD UNIQUE KEY `location` (`CountryID`,`StateID`,`CityID`,`Address`),
  ADD KEY `location_cbfk_1` (`CreatedBY`),
  ADD KEY `location_cbfk_3` (`StateID`),
  ADD KEY `location_cbfk_4` (`CityID`);

--
-- Indexes for table `mims_manufacturerinformation`
--
ALTER TABLE `mims_manufacturerinformation`
  ADD PRIMARY KEY (`ID`),
  ADD UNIQUE KEY `Name` (`Name`,`IsActive`),
  ADD KEY `manufacturerinformation_cbfk_1` (`CreatedBy`),
  ADD KEY `manufacturerinformation_cbfk_2` (`AddressID`);

--
-- Indexes for table `mims_newsInformation`
--
ALTER TABLE `mims_newsInformation`
  ADD PRIMARY KEY (`ID`),
  ADD KEY `PublishDateTime` (`PublishDateTime`,`UnpublishedDateTime`,`IsActive`),
  ADD KEY `newsInformation_cbfk_1` (`CreatedBy`);

--
-- Indexes for table `mims_packsizeinformation`
--
ALTER TABLE `mims_packsizeinformation`
  ADD PRIMARY KEY (`ID`),
  ADD UNIQUE KEY `Name` (`Name`,`IsActive`),
  ADD KEY `packsizeinformation_cbfk_1` (`CreatedBy`);

--
-- Indexes for table `mims_resourceinformation`
--
ALTER TABLE `mims_resourceinformation`
  ADD PRIMARY KEY (`ID`),
  ADD KEY `FK_Resource_CreatedBy` (`CreatedBy`);

--
-- Indexes for table `mims_specialreports`
--
ALTER TABLE `mims_specialreports`
  ADD PRIMARY KEY (`ID`),
  ADD KEY `FK_SpecialReports_CreatedBy` (`CreatedBy`);

--
-- Indexes for table `mims_state`
--
ALTER TABLE `mims_state`
  ADD PRIMARY KEY (`ID`),
  ADD UNIQUE KEY `Name` (`CountryID`,`Name`,`IsActive`),
  ADD KEY `country_cbfk_1` (`CreatedBY`);

--
-- Indexes for table `mims_strengthinformation`
--
ALTER TABLE `mims_strengthinformation`
  ADD PRIMARY KEY (`ID`),
  ADD UNIQUE KEY `Name` (`Name`,`IsActive`),
  ADD KEY `strengthinformation_cbfk_1` (`CreatedBy`);

--
-- Indexes for table `mims_userinformation`
--
ALTER TABLE `mims_userinformation`
  ADD PRIMARY KEY (`ID`),
  ADD KEY `userinformation_urfk_1` (`RoleID`),
  ADD KEY `UserName` (`UserName`,`EmailID`,`UserPass`,`IsActive`) USING BTREE;

--
-- Indexes for table `mims_userrole`
--
ALTER TABLE `mims_userrole`
  ADD PRIMARY KEY (`ID`);

--
-- AUTO_INCREMENT for dumped tables
--

--
-- AUTO_INCREMENT for table `mims_addresscategory`
--
ALTER TABLE `mims_addresscategory`
  MODIFY `ID` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=22;

--
-- AUTO_INCREMENT for table `mims_addressinformation`
--
ALTER TABLE `mims_addressinformation`
  MODIFY `ID` bigint(20) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=7;

--
-- AUTO_INCREMENT for table `mims_advertisementinformation`
--
ALTER TABLE `mims_advertisementinformation`
  MODIFY `ID` bigint(20) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=20;

--
-- AUTO_INCREMENT for table `mims_advertisementpositioninformation`
--
ALTER TABLE `mims_advertisementpositioninformation`
  MODIFY `ID` smallint(6) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=191;

--
-- AUTO_INCREMENT for table `mims_brandinformation`
--
ALTER TABLE `mims_brandinformation`
  MODIFY `ID` bigint(20) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=1663;

--
-- AUTO_INCREMENT for table `mims_city`
--
ALTER TABLE `mims_city`
  MODIFY `ID` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=25;

--
-- AUTO_INCREMENT for table `mims_country`
--
ALTER TABLE `mims_country`
  MODIFY `ID` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=2;

--
-- AUTO_INCREMENT for table `mims_doctorinformation`
--
ALTER TABLE `mims_doctorinformation`
  MODIFY `ID` bigint(20) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=69;

--
-- AUTO_INCREMENT for table `mims_dosageforminformation`
--
ALTER TABLE `mims_dosageforminformation`
  MODIFY `ID` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=92;

--
-- AUTO_INCREMENT for table `mims_genericinformation`
--
ALTER TABLE `mims_genericinformation`
  MODIFY `ID` bigint(20) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=70;

--
-- AUTO_INCREMENT for table `mims_InternationalHealth`
--
ALTER TABLE `mims_InternationalHealth`
  MODIFY `ID` bigint(20) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=2;

--
-- AUTO_INCREMENT for table `mims_jobinformation`
--
ALTER TABLE `mims_jobinformation`
  MODIFY `ID` bigint(20) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=8;

--
-- AUTO_INCREMENT for table `mims_location`
--
ALTER TABLE `mims_location`
  MODIFY `ID` bigint(20) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=76;

--
-- AUTO_INCREMENT for table `mims_manufacturerinformation`
--
ALTER TABLE `mims_manufacturerinformation`
  MODIFY `ID` bigint(20) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=197;

--
-- AUTO_INCREMENT for table `mims_newsInformation`
--
ALTER TABLE `mims_newsInformation`
  MODIFY `ID` bigint(20) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=10;

--
-- AUTO_INCREMENT for table `mims_packsizeinformation`
--
ALTER TABLE `mims_packsizeinformation`
  MODIFY `ID` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=205;

--
-- AUTO_INCREMENT for table `mims_resourceinformation`
--
ALTER TABLE `mims_resourceinformation`
  MODIFY `ID` bigint(20) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=9;

--
-- AUTO_INCREMENT for table `mims_specialreports`
--
ALTER TABLE `mims_specialreports`
  MODIFY `ID` bigint(20) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=12;

--
-- AUTO_INCREMENT for table `mims_state`
--
ALTER TABLE `mims_state`
  MODIFY `ID` int(11) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=7;

--
-- AUTO_INCREMENT for table `mims_strengthinformation`
--
ALTER TABLE `mims_strengthinformation`
  MODIFY `ID` bigint(20) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=196;

--
-- AUTO_INCREMENT for table `mims_userinformation`
--
ALTER TABLE `mims_userinformation`
  MODIFY `ID` bigint(20) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=4;

--
-- AUTO_INCREMENT for table `mims_userrole`
--
ALTER TABLE `mims_userrole`
  MODIFY `ID` tinyint(4) NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=3;

--
-- Constraints for dumped tables
--

--
-- Constraints for table `mims_addresscategory`
--
ALTER TABLE `mims_addresscategory`
  ADD CONSTRAINT `addresscategory_cbfk_1` FOREIGN KEY (`CreatedBY`) REFERENCES `mims_userinformation` (`ID`);

--
-- Constraints for table `mims_addressinformation`
--
ALTER TABLE `mims_addressinformation`
  ADD CONSTRAINT `addressinformation_cbfk_1` FOREIGN KEY (`CreatedBy`) REFERENCES `mims_userinformation` (`ID`),
  ADD CONSTRAINT `addressinformation_cbfk_2` FOREIGN KEY (`AddressCategoryID`) REFERENCES `mims_addresscategory` (`ID`);

--
-- Constraints for table `mims_advertisementinformation`
--
ALTER TABLE `mims_advertisementinformation`
  ADD CONSTRAINT `advertisementinformation_cbfk_1` FOREIGN KEY (`CreatedBy`) REFERENCES `mims_userinformation` (`ID`),
  ADD CONSTRAINT `advertisementinformation_ibfk_1` FOREIGN KEY (`AdvertisementPositionID`) REFERENCES `mims_advertisementpositioninformation` (`ID`);

--
-- Constraints for table `mims_advertisementpositioninformation`
--
ALTER TABLE `mims_advertisementpositioninformation`
  ADD CONSTRAINT `advertisementpositioninformation_cbfk_1` FOREIGN KEY (`CreatedBy`) REFERENCES `mims_userinformation` (`ID`);

--
-- Constraints for table `mims_brandinformation`
--
ALTER TABLE `mims_brandinformation`
  ADD CONSTRAINT `brandinformation_cbfk_1` FOREIGN KEY (`CreatedBy`) REFERENCES `mims_userinformation` (`ID`),
  ADD CONSTRAINT `brandinformation_ibfk_1` FOREIGN KEY (`GenericID`) REFERENCES `mims_genericinformation` (`ID`),
  ADD CONSTRAINT `brandinformation_ibfk_4` FOREIGN KEY (`ManufacturerID`) REFERENCES `mims_manufacturerinformation` (`ID`),
  ADD CONSTRAINT `brandinformation_ibfk_7` FOREIGN KEY (`DosageFormID`) REFERENCES `mims_dosageforminformation` (`ID`),
  ADD CONSTRAINT `brandinformation_ibfk_8` FOREIGN KEY (`StrengthID`) REFERENCES `mims_strengthinformation` (`ID`),
  ADD CONSTRAINT `brandinformation_ibfk_9` FOREIGN KEY (`PackSizeID`) REFERENCES `mims_packsizeinformation` (`ID`);

--
-- Constraints for table `mims_city`
--
ALTER TABLE `mims_city`
  ADD CONSTRAINT `city_cbfk_1` FOREIGN KEY (`StateID`) REFERENCES `mims_state` (`ID`),
  ADD CONSTRAINT `city_cbfk_2` FOREIGN KEY (`CreatedBY`) REFERENCES `mims_userinformation` (`ID`);

--
-- Constraints for table `mims_country`
--
ALTER TABLE `mims_country`
  ADD CONSTRAINT `country_cbfk_1` FOREIGN KEY (`CreatedBY`) REFERENCES `mims_userinformation` (`ID`);

--
-- Constraints for table `mims_doctorinformation`
--
ALTER TABLE `mims_doctorinformation`
  ADD CONSTRAINT `doctorinformation_cbfk_1` FOREIGN KEY (`CreatedBy`) REFERENCES `mims_userinformation` (`ID`),
  ADD CONSTRAINT `doctorinformation_cbfk_2` FOREIGN KEY (`HomeAddressID`) REFERENCES `mims_location` (`ID`),
  ADD CONSTRAINT `doctorinformation_cbfk_3` FOREIGN KEY (`ChamberAddressID`) REFERENCES `mims_location` (`ID`);

--
-- Constraints for table `mims_dosageforminformation`
--
ALTER TABLE `mims_dosageforminformation`
  ADD CONSTRAINT `dosageforminformation_cbfk_1` FOREIGN KEY (`CreatedBy`) REFERENCES `mims_userinformation` (`ID`);

--
-- Constraints for table `mims_genericinformation`
--
ALTER TABLE `mims_genericinformation`
  ADD CONSTRAINT `genericinformation_cbfk_1` FOREIGN KEY (`CreatedBy`) REFERENCES `mims_userinformation` (`ID`);

--
-- Constraints for table `mims_InternationalHealth`
--
ALTER TABLE `mims_InternationalHealth`
  ADD CONSTRAINT `InternationalHealth_cbfk_1` FOREIGN KEY (`CreatedBy`) REFERENCES `mims_userinformation` (`ID`);

--
-- Constraints for table `mims_jobinformation`
--
ALTER TABLE `mims_jobinformation`
  ADD CONSTRAINT `jobinformation_cbfk_1` FOREIGN KEY (`CreatedBy`) REFERENCES `mims_userinformation` (`ID`);

--
-- Constraints for table `mims_location`
--
ALTER TABLE `mims_location`
  ADD CONSTRAINT `location_cbfk_1` FOREIGN KEY (`CreatedBY`) REFERENCES `mims_userinformation` (`ID`),
  ADD CONSTRAINT `location_cbfk_2` FOREIGN KEY (`CountryID`) REFERENCES `mims_country` (`ID`),
  ADD CONSTRAINT `location_cbfk_3` FOREIGN KEY (`StateID`) REFERENCES `mims_state` (`ID`),
  ADD CONSTRAINT `location_cbfk_4` FOREIGN KEY (`CityID`) REFERENCES `mims_city` (`ID`);

--
-- Constraints for table `mims_manufacturerinformation`
--
ALTER TABLE `mims_manufacturerinformation`
  ADD CONSTRAINT `manufacturerinformation_cbfk_1` FOREIGN KEY (`CreatedBy`) REFERENCES `mims_userinformation` (`ID`),
  ADD CONSTRAINT `manufacturerinformation_cbfk_2` FOREIGN KEY (`AddressID`) REFERENCES `mims_location` (`ID`);

--
-- Constraints for table `mims_newsInformation`
--
ALTER TABLE `mims_newsInformation`
  ADD CONSTRAINT `newsInformation_cbfk_1` FOREIGN KEY (`CreatedBy`) REFERENCES `mims_userinformation` (`ID`);

--
-- Constraints for table `mims_packsizeinformation`
--
ALTER TABLE `mims_packsizeinformation`
  ADD CONSTRAINT `packsizeinformation_cbfk_1` FOREIGN KEY (`CreatedBy`) REFERENCES `mims_userinformation` (`ID`);

--
-- Constraints for table `mims_resourceinformation`
--
ALTER TABLE `mims_resourceinformation`
  ADD CONSTRAINT `FK_Resource_CreatedBy` FOREIGN KEY (`CreatedBy`) REFERENCES `mims_userinformation` (`ID`);

--
-- Constraints for table `mims_specialreports`
--
ALTER TABLE `mims_specialreports`
  ADD CONSTRAINT `FK_SpecialReports_CreatedBy` FOREIGN KEY (`CreatedBy`) REFERENCES `mims_userinformation` (`ID`);

--
-- Constraints for table `mims_state`
--
ALTER TABLE `mims_state`
  ADD CONSTRAINT `state_cbfk_1` FOREIGN KEY (`CountryID`) REFERENCES `mims_country` (`ID`),
  ADD CONSTRAINT `state_cbfk_2` FOREIGN KEY (`CreatedBY`) REFERENCES `mims_userinformation` (`ID`);

--
-- Constraints for table `mims_strengthinformation`
--
ALTER TABLE `mims_strengthinformation`
  ADD CONSTRAINT `strengthinformation_cbfk_1` FOREIGN KEY (`CreatedBy`) REFERENCES `mims_userinformation` (`ID`);

--
-- Constraints for table `mims_userinformation`
--
ALTER TABLE `mims_userinformation`
  ADD CONSTRAINT `userinformation_urfk_1` FOREIGN KEY (`RoleID`) REFERENCES `mims_userrole` (`ID`);
COMMIT;

/*!40101 SET CHARACTER_SET_CLIENT=@OLD_CHARACTER_SET_CLIENT */;
/*!40101 SET CHARACTER_SET_RESULTS=@OLD_CHARACTER_SET_RESULTS */;
/*!40101 SET COLLATION_CONNECTION=@OLD_COLLATION_CONNECTION */;
